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Abstract
The contribution of different calcium-activated potassium channel subtypes 
to agonist-evoked whole-cell currents was studied in cultured pig coronary artery 
endothelial cells.
From a resting membrane potential of -5.9±0.5mV (n=102), 1-IOjiM ATP, 
l-lOnM substance P and l-100nM bradykinin hyperpolarised cell rafts to 
-50.7±1.6mV (n=76), -45.7±4.7mV (n=19) and -59.1±3.5mV (n=16), respectively.
In small clusters of cells, 1 OpM ATP evoked outward currents which 
reversed close to EK and were sensitive to both the SKca channel blocker UCL 1848 
(IC50 1.2nM; -65%  maximal block) and the IKca/BKca channel blocker 
charybdotoxin (-85% block at 30-100nM). Surprisingly lOpM clotrimazole, a non- 
selective blocker of IKca channels, abolished ATP-evoked currents in a total of three 
out of five cells. This requires further study.
ImM 1-EBIO, which increases the calcium sensitivity of SKca and IKca 
channels, activated currents which were sensitive to lOOnM UCL 1848 and lpM  
clotrimazole (blocked by 57.0±15.1% (n=3) and 89.0±1.6% (n=4), respectively). 
When applied in combination, these two blockers essentially abolished 1-EBIO 
evoked currents.
Buffering intracellular calcium to 1.5pM activated outward currents which 
were sensitive to lOOnM UCL 1848, lOOnM charybdotoxin and lpM  clotrimazole 
(blocked by 28.3±5.4% (n=27), 101.2±0.5% (n=3), and 82.6±3.7% (n=22), 
respectively.
Plasma membrane delimited expression of the SK3 channel protein was 
detected using fluorescence immunohistochemistry.
In many vessels endothelium-derived hyperpolarising factor (EDHF)- 
mediated vasodilation is abolished by a combination of SKca and IKca channel 
blockers, which are frequently ineffective when applied alone. This has led some to 
suggest the existence of a novel channel with unusual pharmacology. The present 
study demonstrates, however, that separate SKca and IKca channels contribute to 
endothelial cell currents underlying the EDHF pathway. Based on protein expression 
and UCL 1848-sensitivity it is further proposed that the contributing SKca channels 
are formed of SK3 subunits.
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HP ASM human pulmonary artery smooth muscle cell
hslo human homologue of slo
hSKl human orthologue of SKI
hSK2 human orthologue of SK2
hSK3 human orthologue of SK3
hSK4 see hIKl
HUVEC human umbilical vein endothelial cell
I blocker (inhibitor)
IbTx iberiotoxin
Ic intracellular electrode recording
IC50 concentration at which inhibition is 50%
IgG Immunoglobulin type-G
Ih hyperpolarisation-activated current
IK1 IKca channel Gf-subunit channel protein synonym: SK4
IKca intermediate-conductance calcium-activated potassium (channel)
inh. inhibition
IP3 inositol 1,4,5-triphosphate
IS intracellular solution
K atp ATP-sensitive potassium (channel)
Kca calcium-activated potassium (channel)
K ir inwardly-rectifying potassium (channel)
Kv voltage-dependent potassium (channel)
LAD left anterior descending
lg L-glutamine
L-NOARG L-NG-nitro arginine
MAP kinase mitogen activated protein kinase
MaxiK see BKca
MEM modified Eagle’s medium
mRNA messenger ribonucleic acid
n sample size
n
X (n signifies the Hill coefficient)
Na/K-ATPase sodium-potassium pump
NCX sodium-calcium exchanger
NO nitric oxide
NOS nitric oxide synthase
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NPPB 5-Nitro-2-(3-phenylpropylamino)benzoic acid
NPR-B natriuretic peptide receptor (subtype B)
NPR-C natriuretic peptide receptor (subtype C)
NSC non-selective cation channel
NSCca calcium-activated non-selective cation (channel)
N terminus amino terminus
P2X purinoceptor (subtype 2,X)
P2Y purinoceptor (subtype 2,Y)
Pci chloride permeability constant
PGI2 prostacyclin
PBS phosphate buffered saline
PE patch electrode
P k potassium permeability constant
PKA protein kinase A
PKB protein kinase B
PKG protein kinase G
PLC phospholipase C
P-loop pore-forming loop
?Na sodium permeability constant
P/S penicillin / streptomycin mix
py pyruvate
R right
R universal gas constant
rSK2 rat orthologue of SK2
rSK3 rat orthologue of SK3
RT-PCR real-time polymerase chain reaction
S(0-10) trans-membrane domain (0-10)
SCG superior cervical ganglion
SKI SKca a-subunit channel protein (subtype 1)
SK2 SKca osubunit channel protein (subtype 2)
SK3 SKca Qf-subunit channel protein (subtype 3)
SK4 see IK1
19
SKca small-conductance calcium-activated potassium (channel)
Slol Slopoke protein (subtype 1) synonym: BK
SM smooth muscle
SNP sodium nitroprusside
soc store-operated channel
SOD superoxide dismutase
SR sarcoplasmic reticulum
STOC spontaneous transient outward current
supp. supplement
T temperature (°K)
TBA tetrabutylammonium
TEA tetraethylammonium
TRPC transient receptor potential (canonical) protein
TRPV1 transient receptor potential (vanilloid) protein (subtype 1) formerly VR1
VR1 see TRPV1
VRAC volume-regulated anion channel
vWF von Willebrand factor
Xenopus Xenopus tropicalis
z valency
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Chapter 1; Introduction
1.1.) Introduction
Calcium-activated potassium (Kca) channels provide a mechanism through 
which changes in cytosolic calcium ion concentration can influence membrane 
potential. In excitable cells, the hyperpolarising current carried by these channels can 
reduce action potential firing rate by causing the closure of voltage-dependent 
channels. In non-excitable cells, hyperpolarisation may provide a membrane 
potential particularly suited to sustained calcium influx and thus support calcium- 
dependent processes.
Kca channels have recently been implicated in arterial dilation attributed to a 
putative ‘endothelium-derived hyperpolarising factor’ (EDHF). This thesis explores 
the role of these channels within the context of EDHF-mediated vasodilation.
By way of introduction, the basic anatomy of blood vessels including the 
function of the principal cell phenotypes is briefly described. Kca channels are then 
introduced, and their expression within the vessel wall is considered.
Since Kca channels involved in EDHF-mediated vasodilation appear to be 
located in the endothelium, the electrophysiological properties of endothelial cells, 
including responses to physiological stimuli, are also discussed.
Finally, current understanding of EDHF-mediated vasodilation is briefly 
reviewed.
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1.2) Blood vessel anatomy
Blood vessels contain two distinct major cell types relevant to this thesis, the 
endothelium and smooth muscle.
Endothelial cells form a continuous monolayer lining the innermost surface 
of the vessel, also known as the tunica intima {figure 1.1). The middle portion of the 
vessel wall, the tunica media, contains multiple layers of circular smooth muscle 
cells which are aligned perpendicularly to the flow of blood. Arterioles may contain 
only a couple of layers of smooth muscle, whilst large human conduit arteries can 
have several tens of layers. Veins generally contain less smooth muscle and have less 
vascular tone than arteries.
The outermost portion of the vessel wall, the tunica adventitia, consists 
mainly of structural and connective elements such as collagen and elastin fibres, and 
also other cell types such as fibroblasts. Also present are nerves and microvessels, 
the nervi vasorum and vasa vasorum, respectively. These serve the adventitial and 
medial layers of the vessel wall.
Once thought to provide merely a semi-permeable barrier to nutrients, the 
endothelium is now regarded as having a wide range of functions. These include 
regulation of angiogenesis, involvement in immune responses, involvement in blood 
clotting and fibrinolysis, and regulation of vascular tone, in addition to regulating the 
exchange of molecules between blood and tissues (Michiels, 2003). Endothelial cells 
respond not only to chemical stimulation through the action of neurotransmitters, 
endocrine- and paracrine-factors, but also to physical forces such as shear-stress.
Intercellular coupling between endothelial cells occurs via gap junctions 
which coordinate electrical responses, enabling regions of the monolayer to function 
as a syncytium. Gap junctions are also permeable to a number of intracellular 
mediators (see section 1.5.4.7).
Endothelial cells interact with neighbouring smooth muscle cells and also 
circulating cells of differing phenotypes. This occurs through physical contact such 
as adhesion or gap junction formation, or via the release and reception of chemical 
mediators.
Vascular smooth muscle cells are spindle-like in shape and contain an 
arrangement of contractile elements including actin, myosin, desmin and vimentin.
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The contractile apparatus shortens the cells along their longitudinal axes in response 
to raised cytosolic calcium. Simultaneous contraction of circular smooth muscle cells 
in the tunica media results in vessel constriction. Unlike endothelial cells, smooth 
muscle cells contain voltage-dependent calcium channels which can give rise to 
propagation of action potentials and so lead to contraction. Calcium release from the 
sarcoplasmic reticulum also occurs through the activation of Gq protein-linked 
receptors. Like endothelial cells, smooth muscle cells are coupled by gap junctions 
allowing fast propagation of electrical responses and exchange of intracellular 
mediators.
At the contiguous border between the tunica intima (endothelium) and the 
tunica media (smooth muscle) lies the internal elastic lamina. The region between 
and around this matrix of elastic fibres is referred to as the myoendothelial space, 
through which substances diffuse between the two cell types. In both endothelial 
and smooth muscle cells, the membrane at the myoendothelial space is convoluted, 
forming invaginations termed caveolae. These greatly increase the membrane surface 
area and form microdomains in which functionally related membrane proteins are 
co-localised. In endothelial cells this includes G-proteins and IP3 receptors.
In some vessels, gap junctions directly connect endothelial cells to adjacent 
smooth muscle, bridging the myoendothelial space. This allows direct electrical 
coupling and/or mediator transfer between the different cell types (see section 
1.5.4.7.).
myoendothelial space
tunica intima
endothelial cells
tunica media
smooth muscle 
cells
tunica adventitia
Figure 1.1) A schematic representation of an artery.
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1.3) Calcium-activated potassium channels
1.3.1) Introduction
Calcium-activated potassium (Kca) channels belong to the same structurally- 
related family of proteins as voltage-dependent potassium (Kv) channels. Channels 
of both types are formed by proteins containing six transmembrane domains with a 
pore-forming re-entrant P-loop between domains five (S5) and six (S6) {figure 1.2a). 
N and C termini are both intracellular. Those family members which exhibit voltage- 
sensitivity contain a highly conserved motif of negatively charged residues at the 
fourth transmembrane domain (S4). Both Kca and Kv channels are highly potassium- 
selective and blocked by tetraethylammonium ions (TEA) at both cytoplasmic and 
external sites.
Despite similarity in structure, the primary amino acid sequences of Kv and 
Kca channel alpha-subunit proteins are distinct with the exception of conserved 
regions encoding the pore and potassium selectivity filter.
Kca channels exist as members of three subfamilies distinguished by different 
conductances under symmetrical high potassium conditions: small (SKca); 2-18pS, 
intermediate (IKca); 18-80pS and large (BKca); 150-300pS. The three subtypes are 
also pharmacologically distinct; SKca channels are selectively blocked by apamin, 
IKca by TRAM-34 and BKca by iberiotoxin.
BKca are dissimilar to SKca and IKca channels in that they are gated by 
voltage as well as by cytosolic calcium. The BKca channel alpha subunit is also 
considerably larger than that of its counterparts with a further five hydrophobic 
domains {figure 1.2b).
Each of the channel subtypes has a distinct pattern of expression within 
mammalian tissues and will be considered throughout the following sections.
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Kv channel alpha subunit
SKCa channel alpha subunit
IKCa channel alpha subunit
Figure 1.2a) Protein structure of six-transmembrane-domain potassium channel alpha subunits. N and 
C represent amino and carboxy termini, respectively. The Kv channel voltage sensor is highlighted in 
pink. Numeric labels indicate segment (S) number. All C-termini are intracellular.
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BKca channel alpha subunit
c
BKca channel beta subunit
N C
Figure 1.2b) Protein structure of BKca channel alpha and beta subunits. N and C represent amino and 
carboxy termini, respectively. The S4 voltage sensor is highlighted in pink. Hydrophobic segments 
additional to the six-transmembrane-domain template are highlighted in blue. Numeric labels indicate 
segment (S) number. All C-termini are intracellular.
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Channel subtype Channel protein(s) Encoding gene
SK1 KCa2.1 KCNN1
SK2 KCa2.2 KCNN2
SK3 KCa2.3 KCNN3
IK1 (SK4) KCa3.1 KCNN4
BK (alpha) KCa1.1 (Slo1) KCNMA1
BK (beta 1) Slo-beta-1 KCNMB1
BK (beta 2) Slo-beta-2 KCNMB2
BK (beta 3) Slo-beta-3 KCNMB3
BK (beta 4) Slo-beta-4 KCNMB4
Table 1.1) Nomenclature of Kca channel proteins and encoding genes.
1.3.2) SKca channels
1.3.2.1) Introduction
The potassium-conductance blocking activity of apamin was first described 
by Banks et al. (1979) following reports that this peptide prevented neurotransmitter- 
evoked hyperpolarisation in a number of tissues. In the years that followed, the target 
channel was discovered to be gated by intracellular calcium and named the small- 
conductance calcium-activated potassium (SKca) channel on account of its relatively 
small single channel conductance compared with other calcium-activated potassium 
channels (Blatz & Magleby, 1986).
SKca channels afe widely expressed in both excitable and non-excitable cells 
including smooth muscle, liver cells and lymphocytes. In particular, they have been 
intensively studied regarding their role in dampening the excitability of neurones. 
The phenomenon of the after-hyperpolarisation (AHP), which follows bursts of 
firing in some neurones, is partly attributable to SKca channel activity and is thought 
to prevent excitotoxicity and facilitate spike-ffequency adaptation (Sah & Faber, 
2002).
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Upon cloning in 1996, three SKca channel protein orthologues were 
identified, each from the KCNN gene family {table 1.1) (Kohler et al., 1996). SKI, 
SK2 and SK3 proteins have since been identified in many cell types where native 
SKca channels are present.
Co-expression studies reveal that cloned SKca channel subunits can form 
heteromultimers (Ishii et al., 1997a; Benton et al., 2003; Monaghan et al., 2004) 
although it is unclear whether such channels exist in vivo. Recently, novel isoforms 
of SK2 (Strassmaier et al., 2005) and SK3 (Wittekindt et al., 2004a; Kolski- 
Andreaco et al., 2004) together with splice variants of SKI (Zhang et al., 2001) and 
SK3 (Wittekindt et al., 2004b) have also been shown to occur. These have yet to be 
fully studied.
The biophysical properties of cloned SKca channels studied in various 
expression systems concur with observations on the equivalent native channels. 
Single channel conductances recorded under conditions of high symmetrical 
potassium are approximately lOpS (Kohler et al., 1996). Currents are potassium 
selective and weakly inwardly rectifying, a property attributed to voltage-dependent 
block by intracellular divalent cations, including calcium. Channels open in response 
to intracellular calcium with reported EC50 values of 300-800nM and Hill 
coefficients of 2-4, consistent with there being a calcium binding site on each of the 
four subunits required for a functional channel. Unlike large-conductance calcium- 
activated potassium (BKca) channels and voltage-gated potassium (Kv) channels, 
SKca channels are not gated by changes in membrane potential. This is consistent 
with the absence o f the ‘voltage sensor’ motif at the fourth transmembrane domain 
(S4).
Amongst the transmembrane regions, the three SK proteins are 80-90% 
identical, although distinct N and C termini reduce this to 60% for the entire 
sequences (Kohler et al., 1996). Functionally, SKca channel subtypes are 
distinguishable by their relative sensitivity to apamin; SK2>SK3>SK1, with 
approximate IC50 values of lOOpM, 1.5nM (Hosseini et al., 2001) and 8 nM (Shah & 
Haylett, 2000), respectively. Apamin-insensitive SKca-like conductances have been 
described, and an isoform of human SK3 with this property has recently been 
identified (hSK3_ex4) (Wittekindt et al., 2004b).
In addition to apamin, SKca channels are selectively and potently blocked by 
a number of other agents including the peptide scyllatoxin (Auguste et a l, 1992) and
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UCL 1848 (Chen et a l , 2000). NS309 (Strobaek et a l , 2004), 1-EBIO, 
chlorzoxazone and zoxazolamine activate SKca channels (Syme et a l , 2 0 0 0 ).
There is no calcium-binding region o f SK alpha sub-unit proteins, calcium- 
sensitivity coming instead from the calcium-binding protein calmodulin. This is 
itself constitutively bound to an area of the C-terminal region of the SK protein, 
adjacent to the S6  domain. Upon binding calcium, calmodulin cross-links adjacent 
sub-units effecting conformational change and opening of the channel (Schumacher 
et a l , 2 0 0 1 ).
Modulation of channel activity is possible through a number of determined 
phosphorylation sites, and an interaction with putative unidentified regulatory 
subunits should not be ruled out. Studies using amino acid substitution suggest that 
selective SKca channel blockers apamin and scyllatoxin bind to the same sites on 
either side of the P-loop (Auguste et al., 1992). Appropriate mutations have also 
been shown to make channels sensitive to the intermediate- (IKca) and large- 
conductance calcium activated potassium (BKca) channel blocker, charybdotoxin 
(Jager & Grissmer, 2004).
This topic has been reviewed by Maylie et a l (2004) and Stocker (2004).
1.3.2.2) SKca channels in vascular endothelium
It is well established that calcium-activated potassium channels underlie the 
phenomenon of agonist-evoked endothelial cell hyperpolarisation, although the 
subtype(s) of channels involved has only recently been studied.
An endothelial cell potassium channel with a single channel conductance of 
9pS was first identified in a study of rabbit aorta (Sakai, 1990). The channel could be 
activated either by the whole-cell response to acetylcholine or by direct application 
of calcium to the inner face of the membrane. A further study identified a channel of 
similar conductance and calcium-sensitivity in primary cultures of pig aortic 
endothelial cells. The channel which activated upon cell stimulation by bradykinin 
was voltage-independent and blocked by tetrabutylammonium (TB A) (Groschner et 
a l , 1992).
Apamin sensitivity of a 9.1pS calcium-activated potassium channel recorded 
under conditions of symmetrical high potassium was demonstrated in excised
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endothelial cell membrane patches of intact rat aortae (Marchenko & Sage, 1996). 
The conductance was voltage-insensitive, weakly inwardly rectifying and became 
active at cytosolic calcium concentrations greater than 500nM. The channel was 
insensitive to the IKca, BKca and Ky channel blocker, charybdotoxin, but sensitive to 
d-tubocurarine, another SKca channel blocker.
Two SKca channels have been described in freshly isolated endothelial cells 
from pig coronary artery (Burnham et al., 2002). A channel with a single channel 
conductance of 10.1 pS under conditions of symmetrical high potassium, showed 
similar pharmacological properties to that described in rat aorta, although with a 
higher sensitivity to calcium and no obvious rectification. Unlike the lO.lpS channel 
which had a conductance of 6 .8 pS in quasi-physiological solutions, a less frequently 
observed channel exhibited a 2.7pS conductance under these conditions. This 
channel also exhibited SKca channel pharmacology and voltage-insensitivity, though 
its identity remains unresolved.
Whole-cell currents consistent with the activation of SKca channels have also 
been studied in endothelial cells from rat carotid artery (Kohler et a l , 2001), mouse 
mesenteric artery (Taylor et a l , 2003) and human umbilical vein (Muraki et a l , 
1997).
RT-PCR and Western blotting have revealed expression of SK3 mRNA and 
protein in endothelial cells from porcine coronary (Burnham et a l , 2002), mouse 
mesenteric (Taylor et a l, 2003) and rat carotid arteries (Kohler et a l, 2001), and 
from human saphenous vein (Sultan et a l, 2004). SK2 protein has also been detected 
in the endothelium of porcine coronary artery and human saphenous vein, although 
expression appears lower than for SK3 (Burnham et a l, 2002). Unlike SK3 which 
appears to be located at the periphery, SK2 seems to be to be located in the peri­
nuclear region of pig coronary artery endothelial cells. SK2 has been demonstrated 
to be up-regulated to similar levels to SK3 in endothelial cells from human 
saphenous vein exposed for several hours to conditions simulating shear stress 
(Taylor et a l, 2003). SKI protein appears to be absent from the endotheliu^m of rat 
carotid- (Kohler et a l, 2001) and pig coronary-arteries (Burnham et a l, 2002).
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1.3.2.3) SKca channels in vascular smooth muscle
Despite much electrophysiological study of smooth muscle originating from 
a wide range of vascular beds, there is little evidence to suggest a physiological role 
for smooth muscle SKca channels. A number of recent studies have suggested that 
these channels may in fact be present in some vascular smooth muscle although their 
function remains unclear.
Apamin-sensitive SKca channels with a single channel conductance of ~24pS 
have been described in freshly isolated rabbit aortic smooth muscle cells under 
conditions of symmetrical high potassium (Gauthier et a l , 2004).
Dioclein, a flavanoid, has been shown to relax pre-constricted endothelium- 
denuded smooth muscle in an apamin-sensitive manner (Cortes et a l, 2001). It 
should be noted, however, that apamin was applied at a very high concentration 
(lpM), far greater than the low nM concentrations required for effective SKca 
channel block. Furthermore, the effect of dioclein was also inhibited by BKca and Ky 
channel blockers, inconsistent with SKca channel pharmacology.
An earlier study of cultured rat aortic smooth muscle cells described a ‘small- 
conductance’ calcium-activated potassium channel with a single channel 
conductance of 38pS in symmetrical high potassium (Van Renterghem & Lazdunski,
1992). However, apamin-insensitivity and charybdotoxin-sensitivity suggest that this 
conductance is perhaps better described as IKca-like. Unlike either SKca or IKca, the 
channel showed no sign of rectification.
Apamin-sensitive whole-cell currents have been described in guinea pig 
carotid arteries, indicating a presence of SKca channels (Quignard et a l, 2000).
Recently, mRNA encoding SK2 and SK3 channel proteins has been detected 
in the smooth muscle of human pulmonary artery (Platoshyn et a l, 2004). In porcine 
coronary artery smooth muscle, mRNA for SK2 has been detected, although this 
appears confined to a peri-nuclear location (Burnham et a l, 2002). In smooth muscle 
of rat carotid artery, mRNA encoding SK proteins could not be detected (Kohler et 
a l, 2003).
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1.3.3) IKca Channels
1.3.3.1) Introduction
The calcium-dependent conductance now attributed to the intermediate- 
conductance calcium-activated potassium (IKca) channel was first described in 
erythrocytes (Gardos, 1958). For many years, the attribution of this conductance to 
the activity of an ion channel was controversial until the matter was finally resolved 
following the advent of single channel recording (Hamill, 1981).
IKca channels are highly expressed in epithelia, endothelia and blood cells. 
Until recently, it was generally considered that these channels were only expressed 
in non-excitable cells, although recently IKca channels have been shown to be 
present in rat sensory neurones (Mongan et al., 2005), and enteric neurones of 
several species (Furness et al., 2003; Furness et al., 2004; Neylon et al., 2004b). In 
guinea pig enteric neurones, channels with some of the characteristics of IKca 
contribute to the phenomenon of afterhyperpolarisation (AHP) (Vogalis et a l , 2002; 
Vogalis et a l , 2003). Transient expression of IKca channels in other cells may relate 
to specific stages of cell development. In particular, blockade of IKca channels 
appears to suppress proliferation of a range of tumour cells in vitro (Parihar et a l , 
2003; Jager et a l , 2004; Ouadid-Ahidouch et a l , 2004).
The only IKca channel alpha-subunit protein cloned to date was identified in 
1997 by several groups and named both SK4 (Joiner et a l , 1997) and IK1 (Ishii et 
a l , 1997b; Logsdon et a l , 1997) {table 1.1). Similarly to the respective SKca 
channel proteins, the IK1 orthologue is a product of the KCNN gene family. Since 
the primary amino acid sequence is only 40-42% identical to those of the SK 
proteins, IK1 is the sole-member of a distinct sub-family.
It is not yet known whether splice variants of the IK1 protein exist.
The biophysical properties of IK1 expressed in various expression systems 
are similar to those of the original ‘Gardos channel’ and other native IKca currents; 
potassium selective, weakly inwardly rectifying, and with a single channel 
conductance of 30-40pS for inward currents in conditions of high symmetrical 
potassium. The channels are activated by calcium, with reported EC50S ranging from
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100-700nM and Hill coefficients between 1.7 and 3.2. Similarly to SKca, IKca 
channels are not gated by changes in membrane potential.
IKca are pharmacologically distinguished from SKca channels by their 
insensitivity to apamin. The clotrimazole-based compounds TRAM-34 and TRAM- 
39 (Wulff et al., 2000), and the peptide maurotoxin (Castle et al., 2003) are 
considered the most selective IKca channel blockers, whilst charybdotoxin also 
provides potent block (Castle & Strong, 1986). Although charybdotoxin also blocks 
BKca and some Kv channels, IKca channels are insensitive to the selective BKca 
blocker, iberiotoxin, and a number of selective Kv channel blockers. As with SKca, 
IKca channels are activated by NS109 (Strobaek et al., 2004), 1-EBIO, 
chlorzoxazone and zoxazolamine (Syme et al., 2000), although an IKca-specific 
analogue of 1-EBIO, DCEBIO, has been described (Singh et a l , 2001).
Despite sharing only 40-42% primary sequence identity with the SK proteins, 
IKca channels are structurally very similar, albeit with significantly shorter N- and 
longer C- termini. As with SKca channels, it is widely assumed that IKca form as 
tetramers. Calcium sensing is believed to occur via constitutively bound calmodulin 
at the same region and in the same manner as SKca channels. As with the SK 
proteins, IK1 has no inherent calcium-sensing domain.
IK1 has several putative modulation sites, an N-linked glycosylation site, one 
recognition site for protein kinase A (PKA) and two for protein kinase B (PKB). 
Protein kinase A has been reported in different studies to have both inhibitory 
(Neylon et a l , 2004a) and facilitatory (Gerlach et a l , 2 0 0 0 ) influences on IKca 
channel conductances, the latter triggered through ATP binding at the cytoplasmic 
face of the channel.
This topic has been reviewed by Jensen et a l (2001).
1.3.3.2) IKca channels in vascular endothelium
Endothelial cell calcium-activated potassium channels of similar conductance 
to the ‘Gardos’ channel were first reported in cells cultured from bovine aorta (Sauve 
et a l, 1988). Although its pharmacology was not established, this potassium channel 
was calcium-activated, inwardly rectifying and had a single channel conductance of 
40pS under conditions of 200mM symmetrical potassium. Charybdotoxin-
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sensitivity, together with iberiotoxin-insensitivity of this channel \ya^shown a 
number of years later (Cai et a l , 1998).
In primary cultures of pig coronary artery endothelial cells, voltage- 
independent, inwardly rectifying, calcium-activated potassium channels had a single 
channel conductance of 25pS (200mM potassium at the channel outer face, 150mM 
at the cytoplasmic face) (Sharma & Davis, 1994). Calcium activated the channel 
with an EC50 of ~300nM. A subsequent study of cultured cells from the same 
vascular bed reported a single channel conductance of 30pS under conditions of high 
symmetrical potassium although with a higher EC50 of ~800nM for calcium 
activation (Sollini et al., 2002). In this later study, charybdotoxin sensitivity and 
apamin-insensitivity was established, together with channel activation by 1 -EBIO. 
Similar findings have since been reported in a study of freshly isolated endothelial 
cells from the same vascular bed; single channel conductances of ~17pS in quasi- 
physiological solutions (Bychkov et a l , 2002).
An IKca channel in microvascular endothelial cells cultured from rat brain 
has been reported to have a single-channel conductance of 40pS in symmetrical high 
potassium solutions (Van Renterghem et a l , 1995). The biophysical and 
pharmacological properties of this channel are consistent with those previously 
described in other endothelial cells. IKca channel activity recorded under similar 
conditions in endothelial cell patches from rat aorta (Marchenko & Sage, 1996) and 
cultured mouse aorta (Ahn et a l , 2004) have revealed single channel conductances 
of ~18pS. A contribution of IKca channels to whole-cell currents has also been 
demonstrated in freshly isolated endothelial cells of human mesenteric- (Kohler et 
a l , 2000), rat mesenteric- (Walker et a l , 2001) and rat carotid- (Eichler et a l , 2003) 
arteries.
Expression of mRNA encoding the IKca channel protein in the endothelium 
was first established in cells freshly isolated from human mesenteric arteries (Kohler 
et a l, 2000). Similar expression has also been reported in freshly isolated 
endothelium from pig coronary arteries (Bychkov et a l, 2002) and cultured 
endothelial cells from both human umbilical vein (Brakemeier et a l, 2003b) and 
mouse aorta (Ahn et a l, 2004).
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1.3.3.3) IKca channels in vascular smooth muscle
Until recently it was believed that IKca channels were not expressed in 
vascular smooth muscle cells. However, it has now become apparent that whilst 
mature, contractile smooth muscle does not usually express IKca channels, immature 
(proliferating) smooth muscle cells do.
A calcium-activated potassium channel with a single channel conductance of 
32pS in symmetrical high potassium solutions has been identified in immature 
smooth muscle cells cultured from rat aorta (Neylon et al., 1999). The conductance 
was sensitive to charybdotoxin and insensitive to iberiotoxin. mRNA encoding IK1 
was isolated from these cells and reversed transcribed into DNA whereupon cloning 
and expression in Xenopus oocytes allowed electrophysiological characterisation. In 
addition to the aforementioned properties, conductances were inwardly rectifying 
and voltage-independent. Calcium activated the channel with an EC50 of ~100nM 
and with a Hill coefficient of 2.9. The channel was absent from mature smooth 
muscle cells cultured from the same vascular bed.
mRNA encoding IK1 has been identified in immature but not mature smooth 
muscle cells of rat carotid artery (Kohler et al., 2003). The pharmacology of whole­
cell currents from these cells is consistent with the presence and absence of 
functional IKca channels in the immature and mature phenotype, respectively. This 
study further demonstrated that triggering proliferation of cells from the smooth 
muscle cell line, A7r5, resulted in a similar appearance of previously absent 
functional IKca channels. mRNA encoding the IKca channel protein has also been 
isolated from mature smooth muscle from human pulmonary artery (Platoshyn et al., 
2004), rat pulmonary artery and rat aorta (Saito et al., 2002). However, functional 
expression of IKca channels has yet to be demonstrated in these cells.
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1.3.4) BKca channels
1.3.4.1) Introduction
Large conductance calcium-activated potassium (BKca) channels, also 
referred to as MaxiK, have intrigued electrophysiologists since their discovery. This 
section provides only a brief overview of BKca channels, however a comprehensive 
general review is given by Vergara et al. (1998).
Immediately conspicuous by their large single channel conductance of 100- 
3OOpS, BKca channels have been extensively studied in a number of cell types. They 
were originally described in chromaffin cells (Marty, 1981), but have since been 
shown to perform key functions in smooth muscle, where they regulate contraction, 
and neurones, where they modulate excitability and action potential duration.
Although in the same family of channels as SKca and IKca, BKca channels 
are distinct in a number of ways, in particular their voltage-sensitivity. BKca 
channels are gated by both intracellular calcium and cell depolarisation in a co­
dependent manner. Under conditions of high intracellular calcium, the voltage- 
activation curve for the channel is shifted considerably in the hyperpolarised 
direction. In some studies, extreme depolarisation has been demonstrated to activate 
the channel in the complete absence of intracellular calcium, however, others report 
the channel failing to open in the absence of calcium.
The pore-forming alpha protein subunit of the BKca channel is encoded by 
the Slo 1 gene, first cloned from Drosophila (Atkinson et al., 1991) (table 1.1). 
Although containing the familiar six transmembrane region of SKca, IKca and Kv 
channel proteins, the BKca alpha subunit is much larger with an additional 
transmembrane domain, SO, between SI and the N-terminus, and a large C-terminus 
containing four additional hydrophobic regions, S7-S10. The SO domain results in an 
extracellular N terminus, and the S7-S10 domains are predicted to reside within the 
cytosol despite their hydrophobic nature. So large is the intracellular region from S6  
to the C terminus, that it accounts for two thirds of the entire channel protein.
As with other six trans-membrane domain potassium channels, BKca are 
predicted to form as alpha-subunit tetramers. They also contain the familiar pore 
forming ‘P-loop’ between domains S5 and S6 , encoding the highly potassium-
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selective pore region. As with Kv channels, key positive residues implicated in 
voltage sensing are conserved at the S4 domain. Calcium-binding appears to be 
dissimilar to that in SKca and IKca channels, indeed many BKca channels are 
noticeably less sensitive to calcium (EC50 >5fiM at OmV). A high-affinity calcium 
binding domain, the ‘calcium bowl’, has been identified between S9 and S10 on the 
intracellular C-terminal ‘tail’, although a number of further lower affinity calcium 
binding sites have also been proposed. The interdependence of channel gating on 
voltage and calcium is still incompletely understood; a simple model in which 
calcium binding is dependent on voltage has been ruled out. Current theories on 
BKca channel gating are critically appraised in a review by Magleby (2003).
Although there are considerable differences in the pharmacology and 
biophysics of different native BKca channels, no further genes encoding alpha 
subunits have been identified. Other members of the Slo gene family have been 
described, but these encode channels which are biophysically distinct from BKca 
channels. Diversity of BKca channel activity appears to be entirely due to interaction 
with optional beta subunits, splice-variation and phosphorylation.
Four beta subunits have been identified, all of which significantly influence 
the biophysical and/or pharmacological properties of BKca channels. Beta subunits 
are not essential for channel function, and many native BKca channel assemblies do 
not include these proteins. Each beta subunit comprises two transmembrane domains 
with an extracellular loop and cytoplasmic N&C termini. One beta binds at the 
external region of the SO domain of each alpha subunit resulting in a channel 
comprising four alpha and four beta proteins, ft was initially identified in smooth 
muscle, and forms channels which are more sensitive to depolarisation and cytosolic 
calcium, and more sensitive to charybdotoxin. f t  is expressed in chromaffin cells 
and the brain, and forms channels which rapidly inactivate. Like channels that 
incorporate f t, those that include f t  are more sensitive to cytosolic calcium and 
depolarisation, however, their charybdotoxin sensitivity is lower compared to 
channels that lack beta subunits, f t  which has been identified in testis, pancreas and 
spleen, has three functional splice variants which confer different degrees of 
inactivation on BKca channels, f t  is found in the brain and is unlike the other 
accessory subunits since it decreases sensitivity to calcium. Similarly to ft, f t  
reduces channel sensitivity to charybdotoxin. The role of BKca channel ftsubunits is 
detailed in a review by Orio et al. (2002).
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Facilitation of gating by cyclic nucleotides such as cAMP and cGMP, and 
other endogenous ligands, occurs with some native BKca channels. Functional 
changes in response to these molecules are conferred through the activation of 
phosphorylation ‘switches’.
BKca channels can be potently blocked by a number of peptides including 
iberiotoxin and limbatoxin, and charybdotoxin which also blocks IKca channels. 
Each of these structurally related peptides binds to the outer pore of the channel, 
physically occluding the ion pathway. Non-peptide selective inhibitors include 
paxilline, penitrem-A and tetrandrine. Some BKca channels may also be sensitive to 
the IKca channel blocker clotrimazole (Rittenhouse et al., 1997; Wu et al., 1999b), 
although this does not appear to be the case for all BKca channels since some 
physiological responses which show sensitivity to iberiotoxin are insensitive to 
clotrimazole (Femandez-Femandez et a l , 2002; Sobey et al., 1998).
A number of BKca channel activators have been identified including 
benzimidazoline derivatives NS1619 and NS004, structurally related NS1608 and 
chlorzoxazone (Liu et al., 2003b). DHS-I is a further example of a BKca channel 
opener, although it acts only on channels containing beta subunits.
This topic has been reviewed by Vergara et al (1998), Calderone (2002), 
Orio et a l (2002) and Magleby (2003)
1.3.4.2) BKca channels in vascular endothelium
The first evidence of large conductance calcium-activated potassium 
channels in endothelium was presented in a study of cells cultured from bovine aorta 
(Fichtner et a l , 1987). Activated jointly by calcium and voltage, with a single 
channel conductance of ~150pS in symmetrical high potassium solutions, the 
channel was selective for potassium ions and non-rectifying.
BKca channels have subsequently been observed in cultures of porcine aortic 
(Graier et a l , 1993) and coronary (Baron et a l , 1996) endothelial cells, human 
coronary endothelial cells (Liu et a l , 2003a) and both primary cultures (Kestler et 
a l , 1998) and cell lines (Wu et a l , 1999a; Haburcak et a l , 1997) derived from 
human umbilical vein endothelium. Cultures of human capillary endothelial cells
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have also been shown to exhibit whole-cell currents with an iberiotoxin-sensitive 
voltage-dependent component (Jow et al., 1999).
It has been suggested that BKca channels are not present in freshly isolated 
endothelium, and that channel expression occurs during culture (Gauthier et al., 
2002b). In some instances this may be true since, in cultures of endothelium from 
human umbilical vein (Kestler et al., 1998) and human coronary artery (Liu et al., 
2003a; Zunkler et al., 1995), cells from early passages do not express functional 
BKca channels. Altering culture conditions also appears to influence expression of 
BKca channels in human capillary and bovine aortic endothelial cells (Jow et al., 
1999; Fichtner et al., 1987). However, BKca channel activity has been recorded in 
both freshly isolated endothelium and patches from the endothelium of intact vessels, 
including rabbit aorta (Rusko et al., 1992), rat aorta (Hoyer et al., 1996) and porcine 
renal artery (Brakemeier et al., 2003a).
In a study of human mesenteric arteries, endothelial cell patches of vessels 
from patients with colonic adrenocarcinoma contained iberiotoxin-sensitive BKca 
channels with a conductance of ~210pS (Kohler et al., 2000). Interestingly, these 
channels were not present in the endothelium of subjects without this condition. 
mRNA encoding hslo was detected in cells from adrenocarcinoma patients, but not 
those originating from the control population.
The occurrence of BKca channel beta subunits has not been widely studied in 
endothelial cells, however BKca channels observed in pig aortic endothelium are 
reported to be insensitive to DHS-I, suggesting an absence of beta subunits 
(Papassotiriou et al., 2000). Accordingly, cells from this study were found to express 
mRNA encoding the Slol alpha, but not the ft subunit. Expression of Slo 1 has also 
been determined in cultured bovine aortic endothelial cells, using PCR and Western 
blotting (Wang et al., 2005).
The negative range of endothelial cell membrane potentials may not appear 
suited to the activation of BKca channels, however, raised intracellular calcium may 
be sufficient to enable activation at these potentials. Also, since in some vessels 
electrical events originating from the smooth muscle can be recorded in the 
endothelium (Coleman et al., 2001b), endothelial cells may at times become 
considerably depolarised.
A further aid to activation of endothelial BKca channels may be through 
gating modulation by endogenous substances. Nitric oxide has been demonstrated to
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directly facilitate activation of BKca channels in some vascular smooth muscle, and a 
similar effect has been reported in patches of intact porcine renal artery endothelium 
(Brakemeier et a l , 2003a), although not in EA.hy926 cells (Haburcak et a l , 1997). 
Epoxyeicosatrienoic acids (EETs), which are synthesised by and stored in the 
endothelium, have also been shown to facilitate BKca channel opening in inside-out 
patches of cultured porcine coronary endothelial cells (Baron et a l , 1997). 
Intracellular cAMP (Graier et a l, 1993) and cGMP (Begg et a l, 2003) also activate 
BKca channels in endothelial cells.
Because, in some vascular beds at least, BKca channels appear to be 
expressed in both the endothelium and smooth muscle, care should be taken when 
interpreting effects of BKca channel blockers on functionally intact vessels. 
Bradykinin-evoked iberiotoxin-sensitive currents were recently recorded from the 
endothelium of intact vessels, but since these were absent following inhibition of gap 
junctions, it was concluded that the channels in question were located in the smooth 
muscle (Weston et a l, 2005).
1.3.4.3) BKca channels in vascular smooth muscle
The occurrence of BKca channels in vascular smooth muscle is well 
documented, with expression occurring in practically all vascular beds (Nelson, 
1993). In addition to extensive single-channel studies, a physiological role for BKca 
channels in vascular smooth muscle has also been identified.
Under resting conditions, vascular smooth muscle generates ‘spontaneous 
transient outward currents’ (STOCs) due to bursts of BKca channel activity. STOCs 
occur in response to ‘calcium sparks’ which are caused by calcium entering the 
cytosol from the sarcoplasmic reticulum (SR) or through L-type voltage-dependent 
calcium channels. Co-localisation of BKca channels, L-type calcium channels and/or 
SR ryanodine receptors enables rapid coupling between calcium sparks and STOCs.
STOCs serve to dampen electrical excitability by hyperpolarising smooth 
muscle cells and thus reducing the open probability of voltage-dependent calcium 
channels. As a result, STOCs help maintain a relaxed resting muscle tone (Nelson et 
a l, 1995). BKca channels in vascular smooth muscle consist of both Of- and fi\- 
subunits, so are more sensitive to calcium tjjefi those found in the endothelium.
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Accordingly, mice lacking ft, have been shown to suffer hypertension due to vessel 
constriction (Brenner et al., 2000). Close examination of vessels from these animals 
revealed that smooth muscle calcium sparks failed to efficiently trigger STOCs.
Various agonists act on vascular smooth muscle to cause a rise in cytosolic 
calcium and thus trigger contraction. This calcium rise occurs predominantly through 
calcium release from the SR with subsequent capacitative calcium entry (see section
1.4.3), or through the opening of voltage-gated- or receptor-operated- calcium 
channels. However, vasoconstriction by angiotensin II, 5-HT or phenylephrine is 
also attributable to G-protein-mediated inhibition of BKca channels and hence 
inhibition of STOCs (Alioua et al., 2002).
The first BKca channels to be detected in vascular smooth muscle were TEA 
and quinine-sensitive potassium channels, with a unitary conductance of 100-150pS. 
These original recordings were made from rabbit portal vein smooth muscle cells 
(Beech & Bolton, 1987).
BKca channels with a single channel conductance of ~ 2 1 0  pS in high 
symmetrical potassium have been described in freshly isolated rat mesenteric artery 
smooth muscle cells (Mistry & Garland, 1998). These channels were voltage- 
dependent, activated by calcium and blocked by iberiotoxin. BKca channels from pig 
coronary artery smooth muscle have been studied in lipid bilayers. The channels had 
single channel conductances of 250-300pS under conditions of high symmetrical 
potassium, were activated by membrane depolarisation or intracellular calcium and 
were sensitive to nanomolar concentrations of charybdotoxin (Toro et al., 1991).
Expression of Slol or beta subunits in smooth muscle of rat mesenteric artery 
or pig coronary artery has not been studied. However, mRNA encoding f t has been 
detected in smooth muscle of rat aorta (Tsang et al., 2004), and BKca channels in 
human coronary artery smooth muscle are sensitive to the channel opener DHS-I, 
also indicating the presence of beta-subunits (Tanaka et al., 1997).
This topic has been reviewed by Tanaka et al. (2004) and Nelson & Quayle
(1995).
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1.4) Electrophysiological properties of endothelial cells
1.4.1) Introduction
Endothelial cells perform a wide range of functions in response to chemical 
stimuli by neuroendocrine factors, or to mechanical stimuli such as shear-stress. 
These include secretion of vasodilators including nitric oxide and prostacyclin, 
release o f ‘endothelium-derived contracting factor’, and exocytosis of the platelet 
adhesion molecule von Willebrand factor.
Many of these responses involve a rise in cytosolic calcium which occurs 
through the release of calcium ions from the endoplasmic reticulum and/or opening 
of calcium-permeable channels in the plasmalemma. Since endothelial cells also 
contain calcium-activated potassium (Kca) channels, such stimuli also cause cell 
hyperpolarisation. This may serve a number of purposes including the creation of a 
more favourable driving force for sustained calcium influx.
The nature of endothelial cell responses are determined by factors including: 
resting conductances; origin, maintenance and localisation of raised cytosolic 
calcium; Kca channel subtype(s) activated; and electrical coupling, both within the 
endothelium, and between endothelial- and smooth muscle-cells. Each of these will 
be discussed throughout the following sections.
1.4.2) The endothelium under resting conditions
Endothelial cells are described as non-excitable, reflecting a lack of voltage- 
dependent ion channels.
Few membrane ion channels are open when endothelial cells are 
unstimulated, resulting in a high input resistance. Under these conditions, the 
opening or closing of only a few channels will have a relatively large impact on the 
determined resting membrane potential. This, along with differential channel 
expression, explains why such a large range of resting membrane potentials (-80 to 
OmV) have been described in endothelial cells from different vascular beds.
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The measurement of resting membrane potential (Em) will also be influenced 
by the nature of the recording method. Damage to the cell membrane caused by 
introduction of an intracellular electrode may allow entry of extracellular calcium 
and therefore activate calcium-dependent ion channels and processes. For similar 
reasons, the ffee-calcium concentration of ‘patch’ electrode filling solutions is also 
critical when measuring membrane potential tftperfrgh current-clamp. Also, in intact 
vessels, coupling of smooth muscle cells to the endothelium is known to influence 
endothelial cell Em, whilst the culture of isolated cells can cause alteration of ion 
channel expression, again affecting recorded values.
In many endothelial cells, Em is dominated by an inwardly rectifying 
potassium conductance (K ir). The greater the dominance, the closer Em is to the 
reversal potential for potassium ions (EK), typically between -80 and -90mV. 
Expression of K ir2.1, K ir2.2 and K ir2.4 channel subunits have been identified in 
some endothelial cells (Forsyth et al., 1997; Fang et al., 2005).
Kir channels are not dominant or necessarily present in all endothelial cells. 
The less negative membrane potential of such cells is influenced by chloride 
channels and/or by non-selective cation (NSC) channels. These conduct currents 
which reverse at potentials closer to zero mV depending on precise properties of the 
channel. Examples of such channels active in non-stimulated endothelial cells 
include the volume-regulated anion channel (VRAC), and the NSC 
hyperpolarisation-activated current (Ih).
Electrogenic activity of the sodium-potassium pump has been demonstrated 
under resting conditions in some endothelial cells, since ouabain-block or removal of 
extracellular potassium results in cell depolarisation. Usually, the pump extrudes 
three sodium- in exchange for two potassium- ions, and thus causes a net build-up of 
negative charge within the cell.
This topic has been reviewed by Adams & Hill (2004) and Nilius & 
Droogmans (2001).
43
1.4.3) Effects o f vasoactive substances on cytosolic calcium
A number of vasoactive agents including ATP, bradykinin and substance-P 
{table 1.2) trigger a rise in endothelial cell cytosolic calcium which occurs as a rapid 
peak followed by a lower plateau. Provided that the resting membrane potential is 
not already close to EK, this causes hyperpolarisation through the activation of 
calcium-activated potassium channels. In some cells, the hyperpolarisation is 
biphasic, apparently following the rise and fall in cytosolic calcium (Schilling,
1989).
For agonists acting via a Gq-coupled receptor, the initial phase of calcium 
increase is both rapid and transient, and can occur in the absence of extracellular 
calcium. It is mediated by the release of calcium from the endoplasmic reticulum in 
response to IP3 generated through activation of phospholipase C (PLC). The second 
phase consists of a low plateau and is entirely dependent on extracellular calcium. 
This is due to influx of calcium through putative ‘store operated channels’ (SOC) 
that remain open until calcium stores are replenished. Such ‘capacitative calcium 
entry’ (CCE) was first described in Jurkat cells and is well established in 
endothelium (Himmel et al., 1993).
Upon store release, a signal is established between the endoplasmic reticulum 
(ER) and SOC, causing them to open. Despite much study, the nature of this signal 
has yet to be elucidated. Also unclear is the identity of the SOC, a family of channels 
which vary in selectivity for calcium ions (Nilius et a l , 2003). It is believed that 
SOC subunits may belong to the ‘canonical transient receptor potential’ (TRPC) 
family of channel proteins, of which endothelial cells variously express six of the 
seven currently identified isoforms.
Endothelial CCE can be disrupted either through inhibition of the ER 
refilling pump by thapsigargin, or via a number of non-specific SOC blockers 
including lanthanum, econazole and 5-Nitro-2-(3-phenylpropylamino)benzoic acid 
(NPPB). The gating signal for the channels appears to involve MAP kinase and can 
be inhibited by PKG or calmodulin.
In addition to store depletion through IP3 - operated channels, ER ryanodine 
receptor-operated calcium channels provide a further calcium-release pathway.
These provide a positive feedback for store depletion by opening in response to
44
raised intracellular calcium, and can also be activated by sub-micromolar 
concentrations of ryanodine (a non-endogenous alkaloid).
In response to the aforementioned agonists of Gq-linked receptors, 
endothelial cells also release stored vasoactive substances including ATP and 
acetylcholine. ATP not only acts through P2Y receptors to trigger calcium store 
depletion and CCE, but may also directly trigger calcium entry via P2X channels. 
Non-selective calcium-permeable cation channels which open in response to cyclic 
nucleotides have also been described in endothelial cells.
This topic has been reviewed by Nilius & Droogmans (2001) and Adams & 
Hill (2004).
Ligand Receptor G-protein Second-messengers References
acetylcholine muscarinic
M-i, M 3, M5 Gq IP3 /  DAG i
m2 Gi reduces cAMP
nicotinic
aZ, a5, a7, 02, /?4 - - ii
ATP P2Y-I, P2Y2, P2Y6 G q IP3 / DAG iii
P2X1t P2X2) P2X3i 
P2 X 4 P2X5> P2Xe, 
P2X7
- - iv
bradykinin B1, B2 Gq IP3 /  DAG v, vi
histamine H i G q IP3 / DAG vii
h 2 G s increases cAMP
h 3 Gj reduces cAMP viii
substance-P NKi Gq IP3 / DAG ix
Table 1.2) Some substances which evoke a rise in endothelial cell cytosolic calcium (column 1) 
together with their relevant endothelial cell receptors (column 2) and second messenger pathways 
(column 3-4). Bold print indicates the predominantly expressed receptor(s). Expression of receptors 
varies between vascular beds. References: i(Walch et al., 2001), ii(Sharma & Vijayaraghavan, 2002), 
iii(Guns et al., 2005), iv(Pulvirenti et al., 2000), v(McLean et al., 2000), vi(Mombouli et al., 1992), 
vii(Schaefer et al., 2003), viii(Ea Kim et al., 1992), ix(Quartara & Maggi, 1998).
I
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1.4.4) Effects o f raised cytosolic calcium
Calcium-activated potassium (Kca) channels are the dominant endothelial 
channels which open in response to an agonist-mediated rise in cytosolic calcium. 
Endothelium from different vascular beds differentially express the three Kca 
channel subtypes: SKca, IKca and BKca (see sections 1.3.2 to 1.3.4).
In some endothelial cells, hyperpolarisation evoked by vasoactive substances 
(table 1.2) is abolished by blocking SKca channels, whilst in other cells, IKca 
channels are implicated. In many cells, only a combination of apamin and 
charybdotoxin, but not apamin and iberiotoxin, is sufficient to abolish 
hyperpolarisation indicating that both SKca and IKca channels are active. This topic 
has been reviewed by Coleman et al. (2004).
Sensitivity of agonist-evoked endothelial hyperpolarisation to the selective 
BKca channel blocker iberiotoxin is apparent in only a few vessels, indicating that in 
the majority of vessels these channels play only a minor role or remain inactive. This 
may in part be due to the lower sensitivity of BKca channels to calcium compared 
with IKca and SKca channels. Activation of endothelial BKca channels may require 
additional factors.
It has been demonstrated that in cultured pig coronary artery endothelium, 
substance P activates SKca but not BKca channels, whilst the converse is true of 
bradykinin (Frieden et al., 1999). This suggests subtle differences in intracellular 
signalling between these agonists which have yet to be elucidated. Both agonists 
activate IKca channels in these cells (Sollini et al., 2002).
Both calcium-permeable (Baron et al., 1996) and calcium-impermeable (Suh 
et al., 2002) calcium-activated non-selective cation (NSCca) channels have been 
identified in endothelial cells. The activity of either would be expected to counteract 
membrane hyperpolarisation although paradoxically, calcium-permeable NSCca 
channels would also provide an additional calcium-entry route and thus support 
hyperpolarising Kca currents.
Sodium entry via NSCca channels is believed to trigger a reversal of the 
sodium-calcium transporter (NCX), resulting in a further mechanism for calcium- 
influx and generation of a hyperpolarising current. Blockade of the reversed mode of
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NCX can inhibit the plateau phase of rat aortic endothelial cell hyperpolarisation in 
response to acetylcholine (Bondarenko, 2004).
Calcium-activated chloride (Clca) (also CaCC or CLCA) channels with 
differing properties have been described in vascular endothelial cells. These channels 
require intracellular ATP to activate and carry a current which, under physiological 
chloride conditions, would reverse at a membrane potential positive to that of 
potassium. This would have the effect of limiting the magnitude of 
hyperpolarisation.
This topic has been reviewed by Nilius & Droogmans (2001).
1.4.5) Effects o f mechanical stimuli
Mechanosensitive ion channels, which open in response to physical forces 
acting on the cell membrane, have been described in endothelial cells. These include 
potassium channels, chloride channels and non-selective cation channels. The 
identity of many of these conductances has yet to be determined, and it is unclear 
whether they represent previously identified channels which open in response to 
other stimuli, or are distinct channels opened only through exposure to mechanical 
forces. Also to be determined is which of these channels have intrinsic 
mechanosensing properties and which are functionally coupled to other elements 
which respond to physical forces, such as the endoplasmic reticulum (ER).
In vivo, endothelial cells are exposed to two different physical stimuli: shear 
stress caused by the movement of blood over the cell surface and biaxial tensile 
stress caused by blood pressure and vessel stretching. Whilst chronic alteration to the 
levels of these stimuli results in altered gene transcription and protein 
phosphorylation, acute effects on ion channels and ER calcium handling also occur.
Release of calcium from the endoplasmic reticulum without the involvement 
of IP3 has been reported in endothelium exposed to simulated mechanical stress.
Such conditions also cause the opening of some calcium-permeable non-selective 
cation channels.
Secondary to rises in cytosolic calcium are the activation of calcium- 
activated conductances (see section 1.4.4), some of which themselves exhibit altered
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behaviour in response to mechanical stress. Endothelial BKca channels, for example, 
become more sensitive to calcium when the plasmalemma is exposed to mechanical 
forces.
In vivo, the result of these continual mechanical stimuli, particularly shear 
stress, is vasodilation through endothelial release of nitric oxide, prostacyclin and 
activation of the EDHF-pathway. Such vasodilation is proportional to the degree of 
stress exerted on the endothelium.
This topic has been reviewed by Nilius & Droogmans (2001).
1.4.6) Additional ion conductances
Endothelial cells are coupled by gap junctions both to one another 
and, in a number of vessels, to vascular smooth muscle. Such is the extent of 
myoendothelial coupling in some vessels that electrical events originating at the 
smooth muscle can be recorded in the endothelium. Gap junctions are also 
permeable to other molecules including second messengers, so it is likely that in 
such vessels, smooth muscle will influence endothelial cell ion conductances in a 
number of ways. Gap junctions are described further in section 1.5.4.7.
Section 1.4 has discussed a variety of ion conductances likely to bear 
relevance to endothelium-dependent vasodilation. Information about endothelial ion 
channels not discussed here can be found in reviews by Nilius & Droogmans (2001) 
and Adams & Hill (2004).
1.5) EDHF-mediated vasodilation
1.5.1) Endothelium-dependent regulation of vascular tone
Dilation of constricted vessels by a number of agents including acetylcholine, 
substance-P and bradykinin (table 1.2), occurs in an endothelium-dependent manner
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(Furchgott & Zawadzki, 1980). This occurs via three established mechanisms each 
of which ultimately effect a lowering of smooth muscle cytosolic calcium and thus 
inhibit contraction; a calcium-dependent process.
1.) Nitric oxide produced by and released from the endothelium activates 
smooth muscle soluble guanylate cyclase. The resulting increase in cGMP causes 
both lowering of cytosolic calcium and reduction in the sensitivity of contractile 
elements to calcium.
2.) Prostacyclin release from the endothelium activates smooth muscle 
adenylyl cyclase and G-proteins. Increased levels of cAMP cause the opening of 
ATP-dependent potassium channels and large conductance calcium-activated 
potassium channels which results in smooth muscle hyperpolarisation. Subsequent 
closure of voltage-dependent calcium channels, hence lowering of cytosolic calcium, 
is accompanied by a reduction in the sensitivity of contractile elements to calcium.
3.) ‘EDHF-type’ vasodilation occurs independently of both nitric oxide and 
prostacyclin, and relaxes smooth muscle via hyperpolarisation. EDHF responses are 
also insensitive to inhibition of guanylate cyclase, and are absent when vessels are 
pre-constricted using raised extracellular potassium. Initially, it was postulated that a 
soluble endothelium-derived hyperpolarising factor (EDHF) caused the opening of 
smooth muscle potassium channels and thus led to hyperpolarisation.
There continues to be considerable disagreement surrounding the components 
and order of events that occur during the EDHF phenomenon. These will be 
considered throughout the following sections.
The nitric oxide, prostacyclin and EDHF pathways occur to varying degrees 
in different vascular beds. Endothelium-dependent dilation of small resistance 
vessels is generally mediated via ‘EDHF’ whilst in large conduit vessels, nitric oxide 
is the predominant factor. In many arteries, the three mediators play more equal 
roles, the triggering of either able to cause full dilation. In vivo, there is evidence for 
‘cross-talk’ between different pathways, including suppression of ‘EDHF’ by nitric 
oxide.
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In addition to relaxing factors, the endothelium also releases agents which 
contract smooth muscle. Vasoconstrictors such as angiotensin II cause endothelial 
production and release of endothelin which binds to smooth muscle receptors. This 
triggers both calcium release from the sarcoplasmic reticulum and the opening of 
non-selective cation channels which increase levels of smooth muscle cytosolic 
calcium, leading to contraction. In vivo, endothelin release is largely suppressed by 
nitric oxide, further demonstrating crosstalk between the various factors which 
influence vascular tone. Thromboxane A2 and endoperoxidases have also been 
described as endothelium-derived contracting factors.
A complex equilibrium between vaso -constrictor and -dilator pathways 
serves to regulate vascular tone in response to both chemical and mechanical stimuli. 
These act alongside further mechanisms which alter vascular tone independently of 
the endothelium.
1.5.2) Introduction to ‘EDHF’
Simultaneous hyperpolarisation and relaxation of contracted vascular smooth 
muscle was first established in carbachol-stimulated guinea pig mesenteric arteries 
(Bolton et al., 1984). Both responses were determined as being endothelium- 
dependent, and it was postulated that hyperpolarisation may support smooth muscle 
relaxation by instigating the closure of voltage-dependent calcium channels. At the 
time, intertwining pathways involving prostacyclin and the yet elucidated nitric 
oxide (NO) had yet to be separated.
Following identification of agents which blocked the NO pathway, these 
were used in combination with cyclooxygenase (COX) inhibitors, to establish 
residual vascular responses to vasodilator agonists. The first such study was carried 
out in rat aorta and pulmonary artery in vitro, and revealed that endothelium- 
dependent smooth muscle hyperpolarisation was insensitive to both agents (Chen et 
al., 1988). It was suggested that the remaining response could be explained by 
release of a putative endothelium-derived hyperpolarising factor (EDHF) which 
triggers activation of smooth muscle potassium channels. Although in this initial 
study vasodilation in response to ‘EDHF’ was small, further studies revealed that in
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other vascular beds, ‘EDHF’ provided full reversal of smooth muscle contraction. As 
already mentioned, it is now recognised that with few exceptions, ‘EDHF’ is more 
prominent in resistance vessels (Shimokawa et al., 1996), whereas NO is the main 
endogenous vasodilator in conduit vessels. In a significant number of vessels, NO 
and ‘EDHF’ are both able to provide full vasodilation, with NO acting as principal 
dilator, and ‘EDHF’ as a reserve. In some of these arteries, agonist-evoked relaxation 
is also partly mediated through release of endothelium-derived prostacyclin.
Distinguishing between the three pathways is important from an experimental 
standpoint since both NO and prostacyclin have also been demonstrated to cause 
smooth muscle hyperpolarisation through activation of BKca and K Atp channels, 
respectively. EDHF-mediated vasodilation is commonly defined as that which 
remains following inhibition of COX and endothelial nitric oxide synthase (eNOS). 
Some studies also include inhibitors of cGMP, further blocking the pathway through 
which NO predominantly acts. Recent studies have suggested that in some vessels, 
other precautions should be taken to ensure complete isolation of the EDHF 
response. These include application of nitric oxide chelators such as 
oxyhaemoglobin, to prevent the action of NO released from putative NO stores 
(Chauhan et al., 2003a; Stoen et al., 2003), and depletion of nerve terminals with 
capsaicin to prevent agonist-evoked release of relaxing factors from the nervi 
vasorum (Hogestatt et al., 2000).
The initial focus of studies aimed at characterising the ‘EDHF’ pathway was 
to identify the putative soluble factor and the smooth muscle potassium channels on 
which it was believed to act. At that time, the electrical involvement of the 
endothelium was overlooked, despite the description elsewhere in the literature of 
agonist-evoked endothelial hyperpolarisation. The discovery that EDHF-responses 
are potently inhibited by a combination of S K ca and IK ca channel blockers was a 
factor behind a rethink of the mechanism of the EDHF-pathway (Edwards &
Weston, 1998). SKcaand IKca channels were known not to be prominently expressed 
in smooth muscle, but had been identified in endothelial cells. Additionally, no 
soluble candidate for EDHF had received wide acceptance.
Revision of the EDHF model to include hyperpolarisation of the endothelium
J
opened up more mechanistic opportunities for the pathway. This include^ the 
possibility that myoendothelial gap junctions may convey hyperpolarisation directly 
to the muscle and thus circumvent the requirement of a soluble EDHF. For those
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models which still propose a soluble factor, the question of smooth muscle 
potassium conductances is still relevant and, despite some strong candidates, remains 
an incompletely resolved issue. The following sections will consider the sensitivity 
of the EDHF-pathway to blockers of potassium conductances, and then discuss a 
number of proposed candidates suggested as the ‘link’ between the endothelium and 
smooth muscle.
1.5.3) Involvement o f potassium conductances in the EDHF pathway
Early studies into EDHF suggested that potassium channels underlay the 
hyperpolarisation, as judged by rubidium efflux studies and electrophysiology (Chen 
et al., 1988). According to the original model of the EDHF pathway, the relevant 
channels were presumed to be located on the smooth muscle.
An insensitivity of the EDHF response to agents which selectively block 
ATP-sensitive and voltage-gated potassium channels was established early on (Bray 
& Quast, 1991; Zygmunt & Hogest’att, 1996; Zygmunt et al., 1997a; Petersson et al., 
1997). However, less selective potassium channel blockers such as TEA, TBA and 
4-AP were shown to attenuate hyperpolarisation and relaxation in some vessels 
(Hasunuma et al., 1991; Hecker et al., 1994; Kitagawa et al., 1994).
The first examples of selective potassium channel blockers inhibiting the 
EDHF response were that of apamin in the rat mesenteric vascular bed (Adeagbo & 
Triggle, 1993) and charybdotoxin in rabbit aorta and carotid artery (Cowan et al.,
1993). In a number of other vascular beds however, neither apamin nor 
charybdotoxin produced substantial inhibition of the EDHF response. Interestingly, 
it was discovered that in these vessels effective block could be achieved by co­
application of the two toxins (Waldron & Garland, 1994; Zygmunt & Hogestatt, 
1996; Coats et al., 2001). Sensitivity of vascular smooth muscle hyperpolarisation 
and relaxation to a combination of apamin and charybdotoxin remains one of the 
hallmarks of the EDHF pathway.
Apamin is believed to block only SKca channels, and the concentrations used 
in these studies were consistent with selective block of this channel. Since 
charybdotoxin blocks both IKca and BKca channels, an important consideration was
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which channel subtype(s) are involved. Since, in the presence of apamin, the 
selective BKca channel blocker iberiotoxin is an inadequate substitute for 
charybdotoxin, it was concluded that IKca and not BKca channels are involved in the 
EDHF response (Zygmunt & Hogestatt, 1996). Recent studies have shown that 
TRAM-34 or TRAM-39, novel IKca channel blockers with very little BKca channel 
blocking activity, can abolish the EDHF response in combination with apamin 
(Eichler et al., 2003; Hinton & Langton, 2003).
In a few vascular beds such as the rabbit renal (Kwon, 2001) or canine 
coronary arteries (Nishikawa et al., 1999), EDHF responses are significantly 
attenuated by iberiotoxin suggesting a role for BKca channels in these vessels.
A number of studies have since demonstrated that both SKca (Burnham et al., 
2002; Frieden et al., 1999) and IKca channels (Kohler et a l, 2000; Bychkov et al., 
2002; Sollini et al., 2002) are located on the endothelium (see sections 1.3.2.2 &
1.3.3.2). It has also been demonstrated that a combination of apamin and 
charybdotoxin is effective when selectively applied to the intimal, but not the 
adventitial surface of blood vessels (Doughty et al., 1999).
There are few reports of these channels also being located on the smooth 
muscle (see sections 1.3.2.3 & 1.3.3.3).
In many vessels, EDHF responses are also sensitive to ouabain or a 
combination of ouabain and barium (Edwards et al., 1998). At sub-micromolar 
concentrations, ouabain is believed to be selective for a2 and o3 isoforms of the 
sodium-potassium pump (Na/K-ATPase) which are expressed in vascular smooth 
muscle (Weston et al., 2002). o2 and o3 are inducible isoforms whereas a l, the 
housekeeping isoform is believed to be constitutively active and is less sensitive to 
ouabain. Although initially demonstrated to block EDHF responses at ImM, ouabain 
was subsequently shown to be equally effective at sub-micromolar concentrations 
(Edwards et al., 1999b). This is particularly important since ouabain is shown to 
have non-selective effects at high micromolar concentrations, including block of gap 
junctions (Weingart, 1977) and inhibition of sodium nitroprusside (SNP) -mediated 
dilation (Sathishkumar et al., 2005). Despite this, many researchers studying 
‘EDHF’ have continued to use ouabain at non-selective concentrations.
In some vessels, a sub-micromolar concentration of ouabain is effective in 
abolishing the EDHF response alone (Beny & Schaad, 2000).
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At a concentration of 30/xM, barium ions are considered to selectively block 
inwardly rectifying potassium (K ir )  channels. Although barium is frequently 
reported to have little or no effect on the EDHF response when applied alone, it can 
be additive to the blocking actions of ouabain (Edwards et a l, 1998).
Both Na/K-ATPase and Kir channels are known to be expressed in both 
endothelial cells and smooth muscle. However, since in some endothelium-denuded 
vessels, EDHF-mimicking actions of potassium ions are blocked by a combination 
of ouabain and barium, it has been suggested that the relevant proteins are located on 
the smooth muscle (Edwards et al., 1998).
In a substantial number of studies, a combination of sub-micromolar ouabain 
and 30|iM barium is unable to significantly block EDHF-mediated smooth muscle 
hyperpolarisation and relaxation (Coleman et al., 2001a; Buus et a l, 2000; McIntyre 
et a l, 2001). This may reflect an involvement of other smooth muscle potassium 
channels such as those sensitive to 4-aminopyridine (Quignard et a l, 2000).
This topic has been reviewed by Coleman et al (2004) and Busse et a l
(2002).
1.5.4) EDHF candidates
1.5.4.1) Criteria
In order to be considered an endogenous EDHF, candidates should 
fulfil the following criteria:
In the case of soluble EDHF candidates:
> The Candidate should be able to both hyperpolarise and relax vascular 
smooth muscle in the absence of a functional endothelium. The response 
evoked by the Candidate should not be sensitive to any agent to which the 
native EDHF response is insensitive
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> The Candidate should be synthesised at or stored in the endothelium and 
released upon application of agonists known to evoke EDHF responses. 
Release should be at a concentration sufficient to cause hyperpolarisation and 
relaxation comparable to the native EDHF response
> A combination of apamin and charybdotoxin should prevent release of the 
Candidate from the endothelium in response to agonists known to evoke 
EDHF responses, but not inhibit the actions of the Candidate when applied 
exogenously to endothelium-denuded smooth muscle
> In an intact vessel, prevention of synthesis, or chelation of the Candidate 
should abolish the native EDHF response
A role for myoendothelial gap junctions:
> The native EDHF response should be sensitive to gap junction uncouplers. If 
available, agents should be used which are believed to preferentially uncouple 
myoendothelial gap junctions over homocellular gap junctions
> The uncoupling agent should not affect the native NO or PGI2 -mediated 
dilator responses of the vessel in question. Neither should it affect native 
EDHF attributed responses in vessels where it is believed that myoendothelial 
gap junctions play no role
> For a given vessel, the presence of myoendothelial gap junctions should be 
established using electron microscopy
> Electrophysiology should be used to determine similarity of endothelial and 
smooth muscle responses. It may also be possible to record smooth muscle 
electrical events (e.g. spontaneous transient outward currents) at the 
endothelium.
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The following sections will briefly discuss some of the candidates which 
have been proposed to account for the ‘endothelium-to-smooth muscle signal’ in the 
EDHF pathway.
1.5.4.2) Anandamide
The endogenous cannabinoid, anandamide, was first proposed as an EDHF 
following the observation that EDHF responses of rat mesenteric arteries were 
sensitive to the selective CB1 receptor antagonist, SR141716A (Randall et a l,
1996). Furthermore, anandamide was demonstrated to be released from blood vessels 
stimulated with carbachol, and exogenous application of the cannabinoid caused 
vasodilation sensitive to raised external potassium. Subsequently it was confirmed 
that anandamide is able to elicit smooth muscle hyperpolarisation in an endothelium- 
independent manner (Plane et a l, 1997; White & Hiley, 1997). Smooth muscle 
responses to anandamide have been deemed sensitive to a number of different agents 
including potassium channel blockers TBA (Randall & Kendall, 1997), TEA and 
barium, and the Gj protein inhibitor, pertussis toxin (White & Hiley, 1997).
The vasodilatory action of anandamide has proven to be highly varied.
Across different vessels, exogenous application of anandamide not only appears to 
mimic EDHF responses but can also trigger mdo\he\ium-dependent smooth muscle 
hyperpolarisation (Zygmunt et a l, 1997b), cyclooxygenase-dependent endothelium- 
independent smooth muscle hyperpolarisation (Fleming et a l, 1999) and smooth 
muscle relaxation in the absence of hyperpolarisation (Zygmunt et a l, 2000).
Native EDHF responses are frequently described as insensitive or poorly 
sensitive to concentrations of  SR-1-71614A considered selective for CB1 receptors 
(Plane et a l, 1997; Zygmunt et a l, 1997b; Vanheel & Van de Voorde, 2001). 
Selective CB2 receptor antagonists do not affect EDHF-responses (Harris et a l, 
1999).
Smooth muscle responses to anandamide show sensitivity to SRT7-1611A in 
some studies (Zygmunt et a l, 1997b; O'Sullivan et a l, 2004), but not in others 
(Plane et a l, 1997; Vanheel & Van de Voorde, 2001). Structurally-unrelated CB1 
agonists appear unable to mimic the effects of anandamide in these vessels (Plane et 
al, 1997; Vanheel & Van de Voorde, 2001).
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Further inconsistencies between native EDHF responses and those to 
exogenous anandamide include the difference in the time course of smooth muscle 
hyperpolarisation (Vanheel & Van de Voorde, 2001), and the sensitivity of 
anandamide- but not EDHF-mediated smooth muscle responses to ouabain and 
cooling (Zygmunt et al., 2000).
Anandamide has been demonstrated to exert effects on vascular smooth 
muscle by acting on vanilloid receptors located on the nervi vasorum (Zygmunt et 
al., 1999). This appears to be mediated through release of calcitonin gene related 
peptide (CGRP) since pre-treatment with capsaicin or antagonists of the TRPV1 
vanilloid receptor prevent the actions of anandamide on endothelium-denuded 
vessels. Further vasodilator effects of anandamide may be mediated via endothelial 
cells (O’Sullivan et al., 2004).
Paradoxically, anandamide and other CB1 receptor agonists have also been 
shown to block the native EDHF response in a number of different arteries (Fleming 
et al., 1999). This appears to be due to an inhibitory effect on gap junction 
communication (Brandes et al., 2002).
This topic has been reviewed by Randall et al. (2004) and McGuire et al.
(2001).
1.5.4.3) C-type natriuretic peptide
C-type natriuretic peptide (CNP) is a paracrine factor which mediates 
endothelium-dependent vasodilation independently of cyclooxygenase and nitric 
oxide. In some large conduit vessels, CNP relaxes smooth muscle by binding to 
natriuretic peptide receptor (subtype B) (NPR-B) receptors and triggering a cGMP- 
dependent pathway. In smaller vessels, CNP has been shown to cause smooth 
muscle hyperpolarisation and relaxation through binding to the NPR-C receptor 
(Chauhan et al., 2003b). Until recently, the NPR-C receptor was believed only to 
serve as a ‘clearance receptor’ involved in the binding and degradation of CNP.
CNP is formed upon conversion of its pro-hormone which is expressed in the 
endothelium and catabolised to the active form during cell stimulation by cytokines 
and ‘EDHF agonists’ such as ACh and bradykinin. Once released, CNP activates
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smooth muscle NPR-B and NPR-C receptors and is degraded by endopeptidases or 
through the clearance activity of NPR-C.
Consistent with EDHF pharmacology of denuded vessels, smooth muscle 
hyperpolarisation and relaxation to CNP is sensitive to TEA or a combination of 
barium and ouabain, but not apamin and charybdotoxin (Honing et a l , 2001;
Chauhan et a l, 2003b). Activation of NPR-C by CNP or cANF4'23, a selective 
agonist of NPR-C, has been demonstrated to trigger opening of putative G-protein 
linked inwardly-rectifying potassium channels (GIRK) as defined by 
pharmacological sensitivity to tertiapin, a GIRK-specific inhibitor, and pertussis 
toxin, the classic G* protein inhibitor (Chauhan et a l, 2003b). Responses to 
exogenous CNP are blocked by the selective NPR-C antagonist M372049 (Hobbs et 
al, 2004). Furthermore, native EDHF responses but not those mediated by NO have 
been demonstrated as sensitive to these inhibitors.
In small rat mesenteric arteries, blockade of NPR-B receptors by HS-142-1 
has a negligible effect on responses to CNP or ACh-evoked EDHF, suggesting that 
CNP effects are mediated purely through NPR-C (Chauhan et a l, 2003b).
‘EDHF-like’ responses to CNP have been demonstrated as being abolished b(j 
the gap junction uncoupler 18of-GA (Chauhan et a l, 2003b), a finding which has 
been interpreted by some as a reason for discounting CNP as an EDHF candidate. It 
is possible, however that sensitivity to this agent reflects blockade of homocellular 
gap junctions at the endothelium or smooth muscle which are likely to play a role in 
propagating the EDHF response within the vessel wall. Determining the sensitivity 
of CNP responses to other gap junction uncoupling agents may help clarify this.
This topic has been reviewed by Chauhan et al (2004).
1.5.4.4) Epoxyeicosatrienoic acids
Arachidonic acid can be metabolised into various vasoactive substances via 
three groups of enzymes: cyclooxygenases, lipoxygenases and cytochrome P-450 
epoxygenases (cP450). The last is responsible for the formation of 
epoxyeicosatrienoic acids (EETs) which have been implicated as putative EDHFs. 
These molecules are variously produced and released by endothelial and smooth 
muscle cells, and mediate a range of functions.
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EETs were the earliest of the proposed EDHF candidates, and though their 
identity was not formally established until 1996, the sensitivity of EDHF responses 
to inhibitors of cP450 had been previously described (Singer et a l , 1984; Hecker et 
al., 1994; Campbell et al., 1996). Although the enzyme inhibitors used in these early 
studies were largely non-selective, the findings are supported by more recent studies 
using such approaches as the selective ‘inhibition’ of specific EETs and antisense 
targeting of specific cP450 isoforms (Fisslthaler et a l , 1999; Gauthier et a l , 2002a).
Evidence for endothelial release of a cP450-related EDHF has also been 
provided via ‘sandwich’ bioassays where, in an organ bath preparation, an 
endothelium-denuded vessel is placed in close proximity to an intact vessel. If the 
endothelium-denuded tissue is able to respond to ‘EDHF agonists’ in the presence of 
an intact tissue, this is assumed to be via the release of a soluble factor(s) from the 
endothelium of the intact vessel (Feletou & Vanhoutte, 1988).
In some vessels, direct application of specific EET isoforms including 11,12- 
EET and 14,15-EET can be shown to hyperpolarise and relax endothelium-denuded 
smooth muscle (Campbell et a l , 1996; Pratt et a l, 2001).
Despite evidence for EETs as EDHFs in some vessels, in others blockade of 
cP450 or EET action does not affect the native EDHF response. Further still, where 
exogenously applied EETs are shown to mimic EDHF in denuded vessels, these 
responses are often sensitive to iberiotoxin or glibenclamide, blockers of BKca and 
K atp channels respectively (Eckman et a l, 1998; Fukao et a l, 1997). This is 
inconsistent with the native EDHF responses from the vessels in question.
EETs have also been implicated in endothelium intracellular calcium 
signalling and gap junction function (Graier et a l, 1995; Popp et a l, 2002). Such 
mediatory roles are likely to account for the sensitivity of native EDHF to blockade 
of EET formation or function in some vessels.
Whilst EETs are unlikely to account for EDHF in most vessels, in some they 
may provide an intracellular signalling function within the endothelium, critical to 
the generation and/or transmission of endothelial hyperpolarisation.
This topic has been reviewed by Fleming (2004).
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1.5.4.5) Hydrogen peroxide
Activity of enzymes in the endothelium including nitric oxide synthase 
(eNOS), cyclooxygenase and lipoxygenase results in the production of superoxide 
which subsequently degrades into hydrogen peroxide. In the case of eNOS, 
generation of superoxide may continue even during inhibition of NO production by 
the stable L-arginine analogue L-NOARG (Stroes et a l , 1998).
During agonist stimulation (Matoba et al., 2000; Hatoum et a l, 2005) or in 
response to shear-stress (Miura et al., 2003), enzyme activity, and hence hydrogen 
peroxide release from the endothelium, is increased. Direct application of 
physiological concentrations of hydrogen peroxide has been demonstrated to 
hyperpolarise and relax endothelium-denuded vascular smooth muscle (Matoba et 
al., 2000; Matoba et a l, 2002). In the same vessels, EDHF-mediated 
hyperpolarisation and relaxation is sensitive to the hydrogen peroxide catabolic 
enzyme, catalase (Pomposiello et a l, 1999; Matoba et a l, 2000). Catalase is without 
effect on non-EDHF vasodilatory responses.
Superoxide dismutase (SOD) catabolises superoxide into hydrogen peroxide. 
Tiron, a membrane-permeable agent which mimics the actions of SOD, has been 
shown to enhance native EDHF responses in some studies (Matoba et a l, 2003; 
Fujiki et a l, 2005).
Reduced EDHF responses of mesenteric arteries from eNOS knockout- 
compared to control-mice suggest that eNOS activity accounts for the major source 
of endothelial hydrogen peroxide (Matoba et a l, 2000).
Further to the direct effects of hydrogen peroxide on smooth muscle, an 
autocrine effect at the endothelium cannot be ruled out. Application of exogenous 
hydrogen peroxide has been demonstrated to cause endothelium-dependent dilation 
in human sub-mucosal arteries (Hatoum et a l, 2005), and be sensitive to blockade by 
a combination of apamin & charybdotoxin in human coronary arteries (Miura et a l, 
2003). The latter observation could alternatively be due to the blockade of smooth 
muscle BKca channels by charybdotoxin, since the blockers were not studied in 
isolation.
The manner in which hydrogen peroxide triggers smooth muscle 
hyperpolarisation has yet to be fully studied, although it has been demonstrated that 
catalase-sensitive dilations are sensitive to ouabain at a concentration believed to be
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selective for inducible isoforms of the sodium-potassium pump (Pomposiello et al., 
1999).
It should also be noted that in some relaxed vessels, hydrogen peroxide 
causes vasoconstriction via a number of mechanisms (Gao et al., 2003).
This topic has been reviewed by Shimokawa & Matoba (2004).
1.5.4.6) Potassium ions
Endothelium-independent vessel dilation in response to raised extracellular 
potassium has been described in numerous vascular beds throughout the past 70 
years. Barium and/or ouabain are able to abolish these responses at concentrations 
which selectively block inwardly rectifying potassium channels and the o2 or o3 
isoforms of the sodium-potassium pump respectively (Chen et al., 1972; McCarron 
& Halpem, 1990; Edwards et al., 1999b).
In conditions of raised extracellular potassium, inwardly rectifying potassium 
( K ir)  channels open at more depolarised potentials, which may result in a 
hyperpolarising current. Increased external potassium also activates sodium- 
potassium pumps (Na/K-ATPases) causing a net outward current via exchange of 
ions at a 3:2 ratio (sodium out, potassium in). In some vessels, block of the Na/K- 
ATPases alone may depolarise the membrane potential enough to prevent outward 
potassium flux via Kir channels.
Edwards et al. (1998) were the first to provide evidence for potassium- 
evoked smooth muscle hyperpolarisation in EDHF vasodilation. Opening of apamin 
and charybdotoxin sensitive channels located on the endothelium was proposed to 
release sufficient potassium into the myoendothelial space to trigger smooth muscle 
hyperpolarisation.
Agonist-evoked EDHF responses in rat hepatic and mesenteric arteries were 
shown to be abolished by a combination of ouabain and barium, as were identical 
responses of endothelium-denuded vessels to exogenous potassium (Edwards et al., 
1998; Coleman et al., 2001b; Buus et al., 2000). Later studies also demonstrated the 
ability of an externally applied ‘potassium-chelator’ to reversibly inhibit agonist- 
evoked EDHF responses in other vessels (Beny & Schaad, 2000; Bussemaker et a l, 
2002).
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Where potassium-induced dilation has been described, increasing 
extracellular potassium to <15mM causes smooth muscle hyperpolarisation and 
vasodilation, whereas higher concentrations cause depolarisation and constriction.
In order for potassium to qualify as an EDHF, agonist-evoked dilations 
should be sensitive to inhibition of the smooth muscle potassium ‘sensors’ (Na/K- 
ATPase and Kir channels). Furthermore, exogenously applied potassium should 
hyperpolarise and relax smooth muscle in the absence of a functional endothelium.
Numerous studies have been unable to reproduce endothelium-independent 
vasodilations in response to raised extracellular potassium, or block agonist-evoked 
EDHF responses with barium and/or ouabain. Many laboratories have produced 
conflicting results despite adopting a similar experimental design. Potassium-evoked 
phenomena often occur in only a proportion of tissues (Andersson et a l, 2000; 
Doughty et a l, 2000), or more commonly are small (Lacy et a l, 2000), transient, 
absent or inverted (depolarisation with constriction) (Vanheel & Van de Voorde, 
1999).
In some of these studies, inconsistencies may relate to the necessity of pre­
constricting vessels with phenylephrine or similar agents which depolarise smooth 
muscle and raise cytosolic calcium (Dora & Garland, 2001). Under these conditions, 
a build-up of external potassium caused by efflux via BKca channels may prevent 
Kir channel conduction and saturate Na/K-ATPases, rendering the smooth muscle 
‘potassium sensor’ ineffective (Richards et a l, 2001; Dora et a l, 2002).
However, constrictor agents were not present in all studies in which vessels 
failed to respond to raised potassium, and in some vessels, barium and/or ouabain are 
without effect (Andersson et a l, 2000) or only partially reduce agonist-evoked 
EDHF responses (Vanheel & Van de Voorde, 1999). Other study design factors such 
as the manner of potassium administration (Beny & Schaad, 2000; Nelli et a l, 2003) 
and the temperature at which studies are performed (Zygmunt et a l, 2000) may be 
key factors in these further inconsistencies, although it is likely that potassium does 
not act as an EDHF in some vessels. For example, since agonist-evoked EDHF 
responses in guinea-pig sub-mucosal arterioles (Coleman et a l, 2001a) and human 
sub-cutaneous vessels (Buus et a l, 2000; McIntyre et a l, 2001) are insensitive to 
combinations of barium and ouabain, and as raised extracellular potassium neither 
hyperpolarises nor dilates these arteries following denudation, it is assumed that 
potassium is not an EDHF in these vessels.
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Despite the simplistic appeal of potassium as an EDHF, a potential obstacle 
is the relative robustness of agonist-induced responses. Whereas dilations to 
potassium are highly sensitive to the presence of vasoconstrictors, agonist responses 
are clearly not. It may well be relevant that external application of potassium ions 
will lead to a global increase in myoendothelial potassium concentration whereas 
agonists may cause highly localised potassium increases in putative myoendothelial 
microdomains.
The ability of a monolayer of endothelial cells to provide the required 
concentration of potassium to sustain minutes of hyperpolarisation of multiple layers 
of smooth muscle may also be questioned. With limited capacity, endothelial cells 
would be expected to become depleted of potassium within a short period of time.
This topic has been reviewed by Busse et a l (2002) and Edwards & Weston
(2004).
1.5.4.7) Myoendothelial gap junctions
Gap junctions provide aqueous pores linking the cytosol of adjacent cells, 
allowing the controlled exchange of various ions and molecules of up to ~lkDa in 
size. Such connections can be homo- or hetero-cellular in nature, forming between 
cells of the same or differing phenotype respectively. Within some tissues, gap 
junctions form hexagonal clusters conferring dense regions of intercellular 
communication.
A gap junction is formed by the docking of a pair of protruding connexons 
situated on adjacent cells. These in turn consist of six subunits termed connexins. 
Gap junctions can be homo- or hetero-typic, hence comprise of identical or non­
identical connexons respectively. Connexons themselves are either homo- or hetero- 
meric, formed from identical or non-identical connexins.
The biophysical properties of gap junctions are dependent on their precise 
connexin make-up and regulation through phosphorylation. Expression studies in 
cell lines reveal single channel conductances of 30-300pS for channels formed from 
connexins found in vascular endothelial and smooth muscle cells. Gating can occur 
via a number of mechanisms including intracellular pH or calcium, or voltage-
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sensing. The channels variously exhibit co-selectivity for a range of ions and second 
messengers including Ca2+, cAMP and IP3.
Homocellular endothelial gap junctions are large and abundant, whilst those 
which occur between smooth muscle cells or between the endothelium and smooth 
muscle (myoendothelial) are relatively small and sparse. Both cell types variously 
express connexins Cx37, Cx40, Cx43 and Cx45. Of the agents which block gap 
junction communication, so called ‘uncouplers’, the ‘Gap’ connexin-mimetic 
peptides and 18o«-glycyrrhetinic are considered to have the fewest non-specific 
effects {table 1.3).
Prior to 1998, only a few studies had explored the effect of non-specific gap 
junction uncoupling agents on EDHF responses, with varied results. Following 
revision of the location of apamin- and charybdotoxin- sensitive channels to the 
endothelium however, the contribution of putative myoendothelial gap junctions to 
EDHF-mediated vasodilation became of great interest.
Sensitivity of agonist-evoked EDHF responses to selective gap junction 
uncouplers or connexin antisense has since been demonstrated in many vascular beds 
(Taylor et al., 1998; Yamamoto et al., 1999; Edwards et al., 1999a; Hill et al., 2000; 
De Vriese et al., 2002; Luksha et al., 2004). EDHF phenomena in some vessels are 
only partially sensitive to gap junction interruption whilst in others, responses are 
completely abolished.
Electron micrographs of vessels in which EDHF occurs reveal structures 
identified as myoendothelial gap junctions in addition to the homocellular variety 
amongst endothelial and smooth muscle cells (Sandow & Hill, 2000; Sandow et al., 
2003).
Loss of EDHF responses in arteries from ovariectomised rats is shown to 
correlate with reduced connexin expression (Liu et al., 2002). Developmental 
changes in connexin expression (Sandow et al., 2004) together with varied 
expression patterns within the rat mesenteric vascular tree (Sandow & Hill, 2000) 
may also explain why laboratories report differing EDHF responses in this and other 
vascular beds.
In intact vessels, endothelial and smooth muscle hyperpolarisation has been 
shown to occur almost simultaneously and with the same waveform; cells in the 
vessel wall appearing to act as a single syncytium (Emerson & Segal, 2000). 
Furthermore, smooth muscle action potentials can be recorded in the non-excitable
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endothelium (von der Weid & Beny, 1993). These findings suggest a high degree of 
electrical coupling across the myoendothelial space, consistent with gap junction 
activity.
In addition to directly conveying hyperpolarisation, gap junctions could 
alternatively transfer a soluble intracellular EDHF from the endothelium to the 
smooth muscle. In several vascular beds, increases in smooth muscle cAMP which 
occur during the EDHF response are dependent on gap junction activity (Griffith & 
Taylor, 1999). Furthermore, cAMP has been shown to facilitate gap junction 
communication and could therefore provide a vital regulatory function rather than 
act as an EDHF per se (Griffith et al., 2002). Inhibition of adenylate cyclase or 
prevention of cAMP hydrolysis have been shown to attenuate or prolong agonist- 
evoked EDHF phenomena respectively (Taylor et al., 2001; Chaytor et a l , 2001). 
Increased cAMP-specific phosphodiesterase activity has also been linked to reduced 
EDHF responses in a rat model of diabetes (Matsumoto et a l , 2003).
In considering the findings of studies in which gap junction inhibitors 
attenuate the EDHF response, it is important to consider the effects of these agents 
on homocellular gap junctions. Since gap junction inhibitors are not selective for 
hetero- over homo-cellular connections, data are open to misinterpretation since 
blockade of the EDHF response may reflect a reduced spread of hyperpolarisation 
within the smooth muscle or endothelium (Tare et a l , 2 0 0 2 ).
A further consideration is whether a monolayer of endothelial cells can 
provide sufficient current to hyperpolarise a considerably larger volume of smooth 
muscle. If myoendothelial gap junctions do account for EDHF then this may explain 
why this dilatory pathway is more prevalent in small vessels which have a lower 
ratio of smooth muscle to endothelium than their larger counterparts. Interestingly, 
and relevant to this study, the pig coronary artery is reported to comprise of between 
15 and 20 smooth muscle layers, yet still exhibits EDHF-mediated vasodilation. 
However, EDHF-phenomena in these vessels have been deemed insensitive to gap 
junction inhibitors in some studies. Accordingly, in such large vessels such as this 
the EDHF-pathway may not involve myoendothelial gap junctions.
Reviewed by Griffith (2004), Griffith et al (2004), Sandow (2004) and 
Moreno (2004).
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~cke»;n
Long Ghoin alcohols
Octanol
Heptanol
non-selective
Halothane non-selective
Palmitoleic acid non-selective
Glycyrrhetinic acid (GA) derivatives
18a GA 
18/? G A*
Carbenoxolone (a salt of 18aGA)*
*lphibit smooth muscle contraction and 
depolarises endothelium (Chaytor et 
al., 2000; Coleman et al., 2001b)
Conpeton  mimetic peptides
37.43Gap27
"“Gap 27 
43Gap26
xGapY where X  denotes connexin 
specificity and Y  denotes binding 
domain
Table 1.3) Gap junction uncoupling agents.
1.5.5.) Summary
EDHF-mediated vasodilation is initiated by agonists or mechanical stimuli 
which trigger a rise in endothelial cytosolic calcium. This is accompanied by 
hyperpolarisation of endothelial cells in response to opening of calcium-activated 
potassium channels.
Communication between the endothelium and smooth muscle may occur via 
a number of different mechanisms:
> Release of soluble factors such as C-type natriuretic peptide, hydrogen 
peroxide, or, where the EDHF response is sensitive to iberiotoxin, EETs. 
As with nitric oxide, these factors may be released in a calcium- 
dependent manner and then directly or indirectly affect the activity of 
smooth muscle potassium conductances, leading to hyperpolarisation.
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> The opening of endothelial calcium-activated potassium channels will 
raise the potassium concentration in the myoendothelial space. This may 
affect the activity of smooth muscle potassium conductances, triggering 
hyperpolarisation.
> Myoendothelial gap junctions could directly convey endothelial cell 
hyperpolarisation to the smooth muscle.
It seems unlikely that a single identity for EDHF will emerge owing to the 
considerable differences in pharmacology of the pathway between different vascular 
beds. Individual studies each involving a number of different arteries are particularly 
useful in highlighting this since they circumvent concerns about differing 
experimental conditions between laboratories (Dong et al., 2000; Coleman et al., 
2001b; McNeish et al., 2003). In some arteries, it appears that responses may be due 
to the simultaneous activity of a number of EDHF candidates (table 1.4).
The EDHF pathway in general appears to play a more prominent role in the 
microvasculature and may therefore provide an additional useful therapeutic target.
Alterations in the contribution of ‘EDHF’ to vascular tone have been 
determined in vessels affected by a number of pathophysiological conditions. These 
include hypertension (Coleman et al., 2004), diabetes (Triggle et al., 2004) and pre­
eclampsia (Gillham et al., 2003). Pharmacological targeting of the EDHF pathway 
may prove therapeutically beneficial in these and other conditions.
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Vascular bed / vessel Anandamide
C-type
natriuretic
peptide
C-P450
metabolites
Hydrogen
peroxide
Potassium
ions
Myo­
endothelial 
gap junctions
Pig coronary (arterial) - -
(Fisslthaler et 
al., 2000) 
(Edwards et 
al., 2001)
(Matoba et al., 
2003)
(Beny & 
Schaad, 2000) 
(Quignard et 
al., 1999)
(Edwards et 
al., 2001) 
(Beny & 
Schaad, 2000)
Rat mesenteric (arterial)
(Randall et al., 
1997) 
(Vanheel & 
Van de 
Voorde, 1999)
(Chauhan et 
al., 2003b)
(Adeagbo, 
1997) 
(Fukao et al., 
1997)
-
(Edwards et 
al., 1998) 
(Doughty et 
al., 2000)
(Hill et al., 
2000)
Human subcutaneous resistance 
(arterial) - -
(Coats et al., 
2001) 
(Luksha et al., 
2004)
(Luksha et al., 
2004)
(Coleman et 
al., 2001b)
(Luksha et al., 
2004)
Guinea pig carotid artery - - (Chataigneau et al., 1998) -
(Quignard et 
al., 1999)
(Edwards et 
al., 1999a)
Rabbit renal (arterial) - -
(Wang et al., 
2003) 
(Kagota et al., 
1999)
- - (Kagota et al., 1999)
Table 1.4) Evidence in support of (green) and in opposition to (red) various EDHF candidates in different vascular beds.
1.6) Aims and Objectives
In many vessels, EDHF-mediated vasodilation can be blocked by a 
combination of apamin and charybdotoxin but not apamin and iberiotoxin. This 
pharmacology implicates a role for SKca and IKca, but not BKca channels. However, 
application of either apamin or charybdotoxin alone is sometimes entirely without 
effect on the smooth muscle relaxation. That these toxins are effective only when 
applied in combination implies a synergistic activity. The reason for this is 
undetermined and could relate either to redundancy amongst separate populations of 
channels, or the presence of hitherto uncharacterised channels.
The majority of studies regarding the role of Kca channels in EDHF-mediated 
vasodilation have explored the effect of channel blockers on smooth muscle 
hyperpolarisation and/or relaxation in intact vessels. Since it is now widely accepted 
that the channels in question are situated on the endothelium, such studies may not be 
best suited to determining the relative contribution that different channel subtypes 
make to the EDHF phenomenon.
For studies of ion channels, voltage-clamp techniques offer the most effective 
way to determine the behaviour of cell currents since they allow control over cell 
membrane potential. Furthermore, measurement of current gives an accurate 
representation of channel activity whereas measurement of membrane potential does 
not. This is because, using potassium channels as an example, when channels 
open/close, the corresponding absolute increase/decrease in membrane potential will 
vary according to the initial distance from EK.
Voltage-clamp is only effective, however, in single cells or 2-3 electrically 
coupled cells. This is an important limitation in relation to the study of endothelial 
cells which form vast electrical syncytia when in situ.
Several subtypes of Kca channels have recently been identified in endothelial 
cells using a combination of single channel electrophysiology, and identification of 
expressed channel subunit proteins or encoding mRNA. In order to study the relative 
contribution that these channels make to agonist-evoked currents, it is necessary to 
measure the response of the entire cell(s). This is best achieved through the whole-cell 
voltage-clamp configuration of the patch-clamp technique.
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The main objective of this study, therefore, was to investigate the 
pharmacology of agonist-evoked whole-cell currents in endothelial cells from vessels 
where the EDHF pathway is present. It was intended that this would help determine 
whether SKca, IKca and/or channels of novel pharmacology contribute to EDHF 
responses.
The aims of this study were as follows:
> To isolate, from vessels in which EDHF-responses have been documented, 
vascular endothelial cells which could be used in the following experiments
> To study changes in membrane potential in response to agonists known to 
cause EDHF-mediated vasodilation
> To study, in response to EDHF-agonists, changes in whole-cell currents, and to 
investigate sensitivity of these to blockers of Kca channels
> To determine whether currents similar to those evoked by EDHF-agonists 
could be activated by dialysing cells with micromolar intracellular calcium, or 
by applying pharmacological Kca channel ‘openers’
> To identify the presence of Kca channel subunits using immunohistochemistry 
and/or biochemical techniques
Previous to this study, our laboratory had no experience of working with 
vascular endothelium, and it became clear from the outset that the above objectives 
would not be easy to achieve. In particular, endothelial cells can be difficult to isolate, 
are liable to alter rapidly during culture, and are very flat; making electrophysiological 
study particularly arduous. Nevertheless, this investigation seemed worthwhile even if 
the intrinsic technical difficulty was to ultimately limit what could be achieved in the 
available time.
70
Chapter 2: Methods & Materials
2.1) Cell culture
2.1.1) Tissue harvesting
2.1.1.1) Rat vessels
Sprague Dawley rats of either sex and weighing approximately 250g were 
sacrificed either by exposure to a rising concentration of carbon dioxide, or by 
concussion with immediate cervical dislocation. These procedures were carried out in 
accordance with the UK ‘Animals (Scientific Procedures) Act, 1986’.
A cotton ligature was secured around the superior mesenteric artery where it 
branches from the abdominal aorta. Both aorta and intestines were then excised, and 
the mesentery separated by blunt dissection. Isolated mesentery was spread over the 
base of a Sylgard-lined Petri dish and covered with sterile Hanks balanced salt solution 
(HBSS). The superior mesenteric artery was relocated by gently pulling a loose end of 
the ligature, and a section of vessel (~2 0 mm) was removed.
Mesenteric artery, together with sections of abdominal aorta and carotid 
arteries were rinsed in sterile HBSS. Connective tissue was then carefully removed 
using sharp dissection.
2.1.1.2) Pig vessels
Hearts from domestic pigs (Sus scrofa) of either sex were obtained from and 
dissected at an abattoir. Sections of both left anterior descending and right coronary 
arteries were excised and submerged in ice cold Krebs solution for transport to the 
laboratory. Principles of aseptic technique were followed as much as possible, and care 
was taken to ensure that no air remained in the vessels. The time between slaughter 
and immersion in Krebs is estimated at 30 minutes.
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2.1.2) Endothelial cell isolation
2.1.2.1) Enzymatic digestion
A number of similar protocols were followed in attempts to release endothelial 
cells from vessels using proteolytic enzymes. In some of these protocols, vessels were 
dissected into small segments and placed into enzyme solutions. In other protocols, 
intact vessels were luminally perfused with enzyme-containing solutions.
Enzymes: collagenase class II (1 mg/ml), collagenase type la (1 mg/ml), 
protease (0.2 mg/ml) and papain/dithiothreitol (0.8 and 0.9 mg/ml, respectively) were 
dissolved in sterile HBSS and applied to vessels in various combinations. Tissues were 
incubated with enzymes over a range of durations (10-60mins) either at room 
temperature (~23°C), or 37°C. Some tissues were pre-exposed to neuraminidase type- 
V (0.1 U/ml) to increase sensitivity to collagenase. In some preparations, tissues were 
exposed to gentle shaking throughout incubation whilst in others, tissue was triturated 
using a wide-bore polished Pasteur pipette.
Enzyme activity was quenched by dilution with complete medium ‘A’ (see 
section 2.1.3.4). Vessel fragments were removed and the solution centrifuged for five 
minutes at 180g. The supernatant was discarded and any pellet re-suspended in 
complete medium ‘A’. This was then transferred to vented cell culture dishes (A- 
surface range, Nunc) and incubated under standard conditions (see section 2.1.3.1).
2.1.2.2) Mechanical isolation
Vessels were slit longitudinally, opened and pinned, intimal side up, to the base 
of a Sylgard-lined Petri dish. In the case of rat vessels, tissues were covered with 
sterile HBSS. Pig vessels were first dissected free of connective tissue, then rinsed and 
covered with sterile Dulbecco’s phosphate buffered saline (DPBS).
A sterile rounded scalpel blade was gently dragged longitudinally along the 
intimal surface of the vessel. Cells that had collected on the blade were dispersed into 
complete culture medium (‘A’ for rat vessels, ‘C’ or ‘D’ for pig vessels) and 
centrifuged for three minutes at 180g. Supernatant was discarded and the cell pellet
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suspended in fresh culture media. The cell suspension was transferred to vented cell 
culture dishes (A-surface range, Nunc) and incubated under standard conditions (see 
section 2.1.3.1).
2.1.2.3) Explant culture
Collagen gel was prepared according to suppliers instructions. Briefly, 1ml of 
collagen gel contained: tissue culture water (0.45ml), collagen solution (0.44ml), PBS 
(0.1ml) and 1M sodium hydroxide (0.01ml). The mixture was held on ice before 
aliquoting 0.2ml into the bottom of individual 10mm diameter culture wells (A-surfece 
range, Nunc). Well-plates were then left undisturbed for 40mins at room temperature, 
allowing the collagen gel to set.
Wells were then partially filled with complete medium ‘B’ and incubated for 
four hours under standard conditions (see section 2.1.3.1).
Vessels were sliced into rings or short segments, and laid at the bottom of gel- 
based wells. The majority of culture media was removed to ensure that tissues were in 
contact with the gel, to allow for adherence. Well-plates were incubated overnight 
under standard conditions.
Once tissues had adhered to the gel, wells were topped up with culture medium 
‘B’. Well-plates were returned to the incubator for a further 2-4 days to allow for 
outgrowth of cells.
Collagenase (type 1 A) solution was prepared at a concentration of 0.25% in 
HBSS, and sterilised by 0.2/mi filtration.
Culture medium was aspirated and tissue carefully removed using sterilised 
forceps. 0 .2 ml collagenase solution was then added to each well and plates returned to 
the incubator until the collagen gel had dissolved (~20mins). Enzyme activity was 
quenched by dilution with complete medium ‘B’, and solutions centrifuged at 180g for 
three minutes. Supernatant was discarded and the cell pellet re-suspended in complete 
medium ‘B \ The cell suspension was transferred to a 25cm dulture flask (A-surface 
range, Nunc) and returned to the incubator.
This culture method is based on that described by McGuire & Orkin (1987).
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2.1.3) Cell culture
2.1.3.1) General protocol
The principles of aseptic technique were observed to limit the risk of culture 
infection. Gloves were worn and, wherever practical, procedures carried oufc inside a 
class I or II biological safety cabinet. Culture solutions were purchased as sterile and 
single-use sterile plasticware used. Other equipment was sterilised by flaming or by 
spraying with 70% ethanol.
Cultures were maintained in a research CO2 incubator. Standard conditions are 
defined as a temperature of 37°C with 5% atmospheric CO2 . A tray of copper sulphate 
solution was positioned inside the incubator cavity in order to maintain a high 
humidity whilst deterring infection.
For all cultures, medium was replaced twice weekly.
2.1.3.2) Lifting cells
In order to yield isolated cells from cultures, or to seed cells on to coverslips, 
the following protocol was observed:
Culture medium was removed and cells rinsed with sterile HBSS. Cells were 
then exposed to trypsin-EDTA solution and returned to the incubator for one minute. 
Trypsin activity was quenched by dilution in the appropriate complete culture medium 
and cells dispersed by gentle trituration using a wide-bore transfer pipette. The cell 
suspension was centrifuged for three minutes at 180g and supernatant discarded. Cells 
were re-suspended in fresh complete culture medium and re-plated as required.
2.1.3.3) Freezing / thawing cells
For freezing, cells were lifted (see section 2.1.3.2) and re-suspended in 90% 
complete culture medium, 10% dimethylsulphoxide. Suspensions were then aliquoted 
into cryovials (NUNC), sealed, and placed in a container insulated with isopropyl
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alcohol. After overnight freezing at -70°C, cryovials were removed from the insulated 
container and stored in a liquid nitrogen freezer at -120°C.
For thawing, cryovials were removed from the nitrogen freezer and rapidly 
warmed to room temperature. Defrosted suspensions were diluted in complete culture 
medium and centrifuged for three minutes at 180g. Following discarding of the 
supernatant and re-suspension in fresh complete culture medium, cells were plated and 
cultured as normal.
2.1.3.4) Culture media
The following complete culture media were used in these studies:
Complete medium ‘A’ (enzyme digestion):
89% Dulbecco’s modified Eagle’s medium (DMEM)
10% foetal bovine serum (FBS)
1% penicillin/streptomycin mix (P/S)
Complete medium ‘B’ (explant culture):
90% RPMI-1640 medium 
10% FBS
50/xg/ml endothelial cell growth supplement (ECGS)
Complete medium ‘C’ (pig cell culture):
89% Medium 199 
10% FBS 
1%P/S
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Complete medium ‘D’ (supplemented pig cell culture):
85.4% Medium 199 
10% FBS
1.3% ‘modified Eagles medium’ vitamin supplement 
1.3% non-essential amino acids supplement 
1% 200mM L-glutamine solution 
1%P/S
2.2) Electrophysiology
2.2.1) Overview
2.2.1.1) General equipment arrangement
Experiments were performed on the moveable stage of an inverted microscope. 
This was mounted on an anti-vibration air table surrounded by an open-fronted 
Faraday cage. All metal within the Faraday cage was joined from a single point to a 
common earth.
A 35mm culture dish containing cells was placed into a custom-made Perspex 
holder, together constituting the ‘bath’. Cells were viewed under phase contrast at 
600x magnification. A digital video camera attached to the microscope enabled cells to 
be observed on a remote monitor. Since cells were very flat and difficult to see, this 
aided positioning and monitoring of the patch electrode.
Extracellular solutions (ES) were held in plastic syringe barrels above the 
microscope and continually delivered to the bath under gravity via silicone tubing. A 
series of taps allowed diversion of different solutions into the bath, and a gate-clamp 
enabled adjustment of flow rate to ~5ml/min. At the opposite side of the bath from the 
inflow, an outflow, connected to a remote vacuum pump, maintained a constant bath 
volume of ~1.5ml. Excess bath solution was removed to waste. The inflow was placed 
as close to the studied cell as possible to ensure efficient delivery of extracellular 
solutions.
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Recordings were made using a patch clamp amplifier (EPC7, List Medical), the 
headstage of which was mounted on a water-filled hydraulic micromanipulator. This in 
turn was mounted on a coarse manipulator secured to the anti-vibration table.
A patch electrode (PE) (see section 2.2.1.2) was mounted in an electrode holder 
(Q-series, Harvard), in turn connected to the amplifier headstage. Electrical continuity 
between the headstage and the PE was achieved using a silver wire, coated at the PE- 
end with silver chloride.
An isolated bath electrode was formed from a silver chloride pellet connected 
to the signal ground input of the amplifier headstage. The pellet was housed in a small 
isolated ES-filled reservoir adjacent to the bath. A conducting agar bridge connected 
the isolated reservoir with the bath solution.
A side port in the electrode holder allowed application of negative pressure 
within the PE.
2.2.1.2) Patch electrodes
Micropipettes were formed from filamented glass capillaries (GC150TF-15, 
Harvard) using a 2-stage vertical pipette puller (L/M-3P-A, List Medical). Fluid 
Sylgard (Dow Coming) was carefully applied to the shank of each pipette under a 
dissection microscope, and then rapidly cured using a heating coil. Pipette tips were 
smoothed by ‘fire polishing’ on a micro-forge (MO-103R, Narashige).
Immediately prior to use, a micropipette was backfilled with 0.2pm-filtered 
intracellular solution (IS). This constituted a patch electrode (PE).
Adjustments were made to the pipette puller settings so that patch electrodes 
had a resistance of 2.5-6 MQ when mounted as described in section 2.2.1.1 and 
lowered into the bath ES.
77
2.2.2) Rat cell studies
2.2.2.1) Recording equipment setup
The current output of the patch amplifier was internally filtered at ten kHz, and 
connected, along with the unfiltered voltage output, to a digitising computer interface 
(Digidata 1200, Axon Instruments). Amplifier outputs were simultaneously monitored 
on a digital storage oscilloscope and a chart recorder.
Data was recorded on a Windows 3.1-based computer using acquisition 
software (Clampex 6 , Axon Instruments) and sampling at a rate of 5kHz. A connection 
from the Digidata interface to the stimulus input of the amplifier allowed the software 
to control voltage-clamp potential.
Holding potential was set and capacitance transients balanced using controls on 
the front of the amplifier.
2.2.22) Protocol
Single cells or small clusters of 2-3 cells were selected for recording. After 
lowering a mounted PE onto a cell, a gigaseal was formed through application of 
negative pressure within the PE. Fast transients, owing to electrode capacitance, were 
balanced, and holding potential set to -20mV. Whole-cell mode was entered by further 
increasing negative pressure until the appearance of capacitance transients. Slow 
transients, owing to cell membrane capacitance and ruptured patch resistance, were 
balanced where possible, and the holding current allowed to stabilise.
In order to characterise whole cell currents, sequential 100ms voltage pulses 
(steps) were applied, clamping cells from -60 to +1 2 0 mV in increments of 2 0 mV.
Cells were exposed to ES containing a range of different pharmacological 
agents. Whole cell responses were assessed by comparing voltage steps applied prior 
to, during and following the washout of these agents. Following a change of solution, 
resting whole-cell currents were allowed to stabilise prior to application of voltage 
steps. For an individual voltage-step, the corresponding current trace was measured by 
averaging the current plateau.
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All experiments were performed at room temperature (~23°C).
2.2.3) Pig cell studies
2.2.3.1) Recording equipment setup
The current (I) and voltage (V) outputs of the amplifier were connected to both 
a digitising computer interface (Digidata 1320A, Axon Instruments) and a laboratory 
digital audio tape (DAT) recorder (DTR 1204, Bio Logic). Ioigidata and IDa t  signals 
were filtered by the amplifier at ten and three kHz, respectively.
Data was recorded on a Windows 2000-based PC, using acquisition software 
(Clampex 8 , Axon Instruments). Outputs from both the Digidata interface and a 
stimulator (Physiological Stimulator, Famell) were connected to the stimulus input of 
the amplifier. These inputs were alternated by means of a manual two-way switchbox 
and allowed generation of voltage-clamp ramps and pulses by the computer and 
stimulator, respectively.
Holding potential was set and capacitance transients balanced using controls on 
the front of the amplifier.
Whole-cell currents were continually recorded in Clampex ‘gap-free’ mode.
In voltage clamp studies, a combination of voltage pulses and ramps were used 
to determine changes to whole-cell currents. Since the acquisition software does not 
allow for generation of voltage-ramps during gap-free recording, data was continually 
acquired to DAT at a sampling rate of 48kHz. The acquisition software was used to 
generate voltage ramps whilst simultaneously recording amplifier output at a sampling 
rate of 10kHz. Other events were simply ‘viewed’ via the acquisition software. At the 
end of each study, signals from relevant portions of gap free recordings were located 
on DAT, played into Digidata interface, and recorded at a sampling rate of 2kHz by 
the acquisition software. Raw data therefore consisted of files containing gap-free 
recordings and files containing data from single ramps.
In a small number of studies, the DAT recorder was substituted with a digitiser 
(VR-10, Instrutech Corporation) and a video cassette recorder. These were used in an 
identical manner to the DAT recorder and recorded at a sampling rate of 18.5kHz.
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Current-clamp protocols were recorded directly by the acquisition software. In 
some experiments, current pulses were applied by the external stimulator via the 
stimulus input.
2.2.3.2) Voltage-clamp protocol
Single cells or small clusters of 2-3 cells were selected for voltage clamp 
experiments. Whole-cell recordings were obtained following the procedure outlined in 
section 2.2.2.2. Holding potential was set to -50mV.
In a few unsuccessful studies, attempts were made at the ‘perforated-patch’ 
modification of the voltage-clamp technique. Briefly, amphotericin-B was prepared 
and diluted in intracellular solution (IS) to a concentration of 125pg/ml. The tip of a 
micropipette was dipped into freshly-filtered amphotericin-free IS, and then the pipette 
back-filled with amphotericin-containing IS. In some cases, tip-dipping was omitted. 
The pipette was lowered on to the chosen cell within 45s of filling, and gigaseal 
formation attempted. Where seals were obtained, the electrode was left undisturbed to 
allow amphotericin to diffuse to the tip of the electrode.
Holding potential was set to -50mV and whole-cell current allowed to stabilise. 
Capacitance transients were balanced where possible for recordings using 30nM and 
500nM free-calcium IS (see section 2.4.2.2). For recordings made using 1.5fxM free- 
calcium IS, balancing of capacitance transients was not usually undertaken since this 
interrupted recording of current activation.
In order to characterise whole cell currents, regular +50mV voltage-pulses 
(~200mS, 0.5Hz) were applied using the external stimulator. For studies using 30nM 
and 500nM free-calcium IS, voltage ramps (-120 to +50mV over 200ms) were applied 
prior to and at the peak of cell responses to agonists.
For analysis, holding current was measured by averaging a stable portion of the 
recording across 1000ms. Pulses were measured by averaging a 100ms portion of the 
pulse plateau. Ramps were measured by applying a linear fit to the approximately 
linear portion (-70 to -40mV) of the current trace.
All experiments were performed at room temperature (~23°C).
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2.2.3.3) Current-cl amp protocol
Single cells or multi-cellular ‘rafts’ were selected for current clamp 
experiments. The whole-cell mode of the voltage-clamp technique was achieved as 
discussed in section 2.2.2.2. The patch amplifier was then switched to current-clamp 
mode.
In some recordings, current pulses of various dimensions were applied.
For analysis, membrane potentials prior to and at the peak of agonist responses 
were measured by averaging stable portions of the trace over 1000ms. Pulses were 
used only as a visual indicator of membrane resistance and therefore not measured.
All experiments were performed at room temperature (~23°C).
2.2.4) Data Analysis
Owing to the varied amplitude of ATP- and 1 -EBIO- evoked currents, 
sensitivity to blockers is expressed as a percentage of the block of the activated 
current; where activated current is defined as the difference between the resting current 
and the current recorded at the response peak.
Current voltage relationships (CVR)s for ATP- or 1-EBIO-evoked currents are 
calculated as the difference between the C VR prior to addition of agonist and the C VR 
at the response peak. CVRs for blocker-sensitive currents are calculated as the 
difference between the CVR of the ‘agonist-evoked current prior to blocker’ and the 
CVR of the ‘agonist-evoked current in the presence of blocker’.
Where currents were activated by dialysing cells with 1.5pM free-calcium, no 
value for resting current could be established because of the rapid onset of current 
activation. For these experiments, amplitude of the blocked current (the difference 
between net-outward current prior to blocker and net-outward current in the presence 
of blocker) is expressed as a percentage of the net-outward current prior to blocker.
Unless otherwise stated, data in the text and tables are given as ‘mean ± 
standard error of the mean (SEM)’, followed by the sample size.
One- or two-tailed unpaired or paired Student’s t-tests were used to compare 
numerical data where appropriate. Significance is defined as P<0.05.
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2.3) Imaging Studies
2.3.1) Immunohistochemistry
On the day prior to study cells were seeded onto glass coverslips, then placed 
in 35mm culture dishes and incubated overnight under standard conditions.
All solutions were made in phosphate-buffered saline (PBS) and the entire 
method performed at room temperature.
Culture medium was aspirated and cells rinsed once in PBS prior to fixing with 
1% paraformaldehyde solution for 20mins. Cells were then rinsed three times in PBS 
and permeabilised in pure methanol for lOmins. Following a further three rinses with 
PBS, cells were exposed for one hour to an antigen blocking buffer (ABB) consisting 
of 3% bovine serum albumin and 2 % horse serum.
Primary antibodies were diluted as appropriate in ABB {table 2.1) and applied 
to cells for four hours. Antibody solutions were aspirated and cells rinsed three times 
in 0.1% Tween-20 detergent, each rinse lasting for three minutes on an orbital shaker. 
Cells were rinsed a further three times in PBS to remove remaining detergent.
Secondary antibodies were also diluted in ABB {table 2.2) and applied to cells 
for one hour. Antibody solutions were aspirated and cells treated to the same rinsing 
protocol as with removal of primary antibodies.
Coverslips were inverted and mounted on microscope slides using Vectashield 
preservative mounting agent. Samples were immobilised by applying a continuous 
border of nail varnish around the perimeter of the coverslip.
Slides were stored in darkness at 4°C for up to a week prior to study by 
confocal microscopy.
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Name Origin species Target Working dilution Supplier
A0082 rabbit von Willebrand factor (human) 1:200 DakoCytomation1
ab6994 rabbit von Willebrand factor (human) 1 :2 0 0 -1 :8 0 0 Abeam
M0581 mouse smooth muscle actin (1A4) (human) 1 :2 5 -1 :5 0 DakoCytomation
M1 rabbit SK2 (human /  rat) for epitope see appendix i 1:2 0 -1 :2 0 0 GlaxoSmithKline2
AB5350 rabbit SK3 (human / rat) for epitope see appendix ii 1:2 0 -1 :2 0 0 Chemicon
M4 rabbit IK1 (human) for epitope see appendix iii 1:2 0 -1 :2 0 0 GlaxoSmithKline2
R212 rabbit IK1 (rat) for epitope see appendix iii 1:2 0 -1 :2 0 0 GlaxoSmithKline3
Table 2.1) Primary antibodies.
Name Origin species Target Fluorophore Working dilution Supplier
PA42004 goat rabbit IgG Cy-2 1:200 Amersham
PA43004 goat rabbit IgG Cy-3 1:200 Amersham
AQ300F sheep mouse IgG FITC 1:1 0 -1 :2 0 Chemicon
Table 2.2) Flurophore-conjugated secondary antibodies.
Kindly provided by T Carter. National Institute for Medical Research, London, UK
(Chen et al., 2004) Kindly provided by DJ Trezise, MX Chen and AJ Jowett. GlaxoSmithKline, Stevenage, UK 
(Bahia et al., 2005) Kindly provided by DJ Trezise, MX Chen and AJ Jowett. GlaxoSmithKline, Stevenage, UK
2.3.2) Acetylated-LDL labelling
In preparation, cells were seeded onto glass coverslips placed in 35mm 
culture dishes and incubated under standard conditions overnight.
Dil-conjugated acetylated low density lipoprotein (aLDL) was briefly 
centrifuged to clear the solution of aggregates, and diluted to 1 0 /zg/ml in complete 
medium ‘C \
Culture medium was aspirated from cells and replaced with medium 
containing aLDL. Cells were then returned to the incubator for four hours. aLDL 
medium was removed and cells rinsed three times in PBS before fixing with 1% 
paraformaldehyde in PBS for 20mins. Cells were rinsed a further three times and 
then mounted on microscope slides as described in section 2.3.1.
Slides were stored in darkness at 4°C for up to a week prior to study by 
confocal microscopy.
2.3.3) Silver staining
Arterial segments were cleaned of connective tissue, opened longitudinally 
and pinned, intimal-side up in a Sylgard-lined Petri dish containing PBS. Vessels 
were then fixed with 2.5% glutaraldehyde for five minutes and rinsed in PBS then 
water. Vessels were exposed to 1% silver nitrate for one minute, followed by a 
mixture of 1% ammonium bromide / 3% cobalt bromide for a further minute. 
Tissues were then rinsed and left in PBS and exposed to the light from an ordinary 
lamp for ten minutes.
Vessels staining was observed under an upright microscope.
2.3.4) Image capture
Immunostained and aLDL-labelled cells were studied under a laser-scanning 
confocal microscope (LSM 510-Meta, Carl Zeiss or TCS, Leica) and images 
captured using associated software.
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Images of silver-stained vessels, explant cultures and isolated cells were 
captured using a digital camera attached to an upright microscope.
2.4) Physiological solutions
2.4.1) General
All solutions were formulated in purified, deionised water. Unless otherwise 
stated, all concentrations are given in millimolar.
For calcium-buffered solutions, free calcium concentrations are calculated 
assuming a working temperature of 25°C, using WinMAXC32 v2.5 software4 
(Patton et al., 2004). Constants used in this program are those currently published by 
the US Federal National Institute for Standards and Technology.
2.4.2) Electrophysiology
2.4.2.1) Extracellular solutions
Standard extracellular solution:
NaCI 126mM
KCI 5mM
CaCI2 1mM
MgCI2 1.2mM
Glucose 11mM
HEPES (free acid) 10mM
NaOH (to pH 7.4)
4 http://www.stanford.edu/~cpatton/maxc.htrnl
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‘Sollini et a l extracellular solution:
NaCI 130mM
KCI 5.6mM
CaCI2 2mM
MgCI2 1mM
Glucose 10mM
HEPES (free acid) 8mM
NaOH (to pH 7.5)
Sodium-free extracellular solution:
N-methyl-D-glucamine 130mM
KCI 5mM
CaCI2 1mM
MgCI2 1.2mM
Glucose 11mM
HEPES (free acid) 10mM
HCI (to pH 7.4)
Low-chloride extracellular solution:
Sodium isethionate 126mM
KCI 5mM
CaCI2 1mM
MgCI2 1.2mM
Glucose 11mM
HEPES (free acid) 10mM
NaOH (to pH 7.4)
2A.2.2) Intracellular solutions
‘30nM free-calcium’ intracellular solution:
KCI 130mM
CaCI2 (added) 0.08mM
Ca2+ (free) ~30nM
MgCI2 (added) 1mM
Mg2* (free) ~1mM
EGTA 0.5mM
HEPES (free acid) 10mM
KOH (to pH 7.2)
‘Sollini et a l ’ intracellular solution:
KCI 130mM
MgCI2 1 mM
Mg-ATP 5mM
HEPES (free acid) 10mM
NaOH (to pH 7.3)
‘1.5jiM free-calcium’ intracellular solution:
KCI 130mM
CaCI2 (added) 1.19mM
Caz+ (free) ~1.5/jM
HEDTA 5mM
HEPES (free acid) 10mM
KOH (to pH 7.2)
‘500nM free-calcium’ intracellular solution:
KCI 130mM
CaCI2 (added) 0.383mM
Ca2+ (free) ~500nM
MgCI2 (added) 1mM
Mg2* (free) ~1mM
EGTA 0.5mM
HEPES (free acid) 10mM
KOH (to pH 7.2)
‘30nM free-calcium, low chloride’ intracellular solution:
Potassium gluconate 130mM
KCI 3.98mM
CaCI2 (added) 0.08mM
Ca2+ (free) ~30nM
MgCI2 (added) 1mM
Mg2" (free) ~1mM
EGTA 0.5mM
HEPES (free acid) 10mM
KOH (to pH 7.2)
2.4.3) Other solutions 
Krebs solution:
NaCI 94m M
KCI 4.7mM
CaCI2 2.52mM
M g S 04 0.45mM
k h 2p o 4 1.18mM
N aH C 03 25mM
Glucose 11mM
(solution gassed with 95% 0 2/5% C 0 2)
Phosphate buffered saline (PBS):
NaCI 137.5mM
KCI 2.7mM
Na2HP04 9.2mM
KH2PO4 1.8mM
NaOH (to pH 7.4)
2.5) Reagents & Drugs
2.5.1) Cell culture
Reagent Notes Supplier
collagen’ type I (from rat tail) BD Biosciences
collagenase type IA Sigma
collagenase type II Worthington
DL-dithiothreitol Sigma
Dimethylsulphoxide* Sigma
Dulbecco’s MEM* + lg, py and 1000mg/l gl Invitrogen
Dulbecco’s PBS* - Ca2+ and Mg2+ Invitrogen
endothelial cell growth supp. Sigma
foetal bovine serum* Invitrogen
L-glutamine’ 200mM (100x) Invitrogen
Hanks’ balanced salt solution’ - Ca2+ and Mg2+ Invitrogen
medium 199* + Earle’s salts and gx Invitrogen
MEM non-essential amino acids* 100x Invitrogen
MEM vitamins’ 100x Invitrogen
neuraminidase type V Sigma
papain Sigma
penicillin (P)/streptomycin (S )’ 10“ U/ml P and 104;ug/ml S Invitrogen
protease type XIV Sigma
RPMI-1640 + lg and py Sigma
trypsin-EDTA* in HBSS - Ca2* and Mg2* Sigma
water Sigma
Table 2 3 )  Details of cell culture reagents. Abbreviations: glucose (gl), L-glutamine (lg), Glutamax™ 
stable L-glutamine substitute (gx), Hanks’ balanced salt solution (HBSS) sodium pyruvate (py), 
modified Eagle medium (MEM), phosphate buffered saline (PBS), supplement (supp.). *Items 
marked with an asterisk were purchased as sterile solutions. The remainder were dissolved in Hanks’ 
balanced salt solution and passed through a sterile 0.2pm-pore filter prior to use.
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2.5.2) Other reagents and drugs
Reagent Notes Supplier
acetylated LDL (Dil labelled)2 Biogenesis
acetylcholine (ACh) Sigma
ammonium bromide Aldrich
amphotericin-BT HPLC grade Sigma
apamin synthetic, HPLC grade Sigma
ATP (magnesium salt) Sigma
ATP (sodium salt) Sigma
bovine serum albumin fraction V ICN Biomedicals
bradykinin Sigma
calcium chloride AnalaR grade solution BDH
carbachol BDH
charybdotoxin (ChTx)5 recombinant Sigma
clotrimazole* (CTZ) Sigma
cobalt (II) bromide Aldrich
dimethylsulphoxide (DM SO) AnalaR grade BDH
EGTA* Sigma
1-EBIO4 Aldrich
ethanol AnalaR grade BDH
(D) glucose AnalaR grade BDH
glutaraldehyde (dialdehyde) Aldrich
HEDTA5 Sigma
HEPES6 free acid Calbiochem
histamine Sigma
Table 2.4) General reagents and drugs, fThese drugs are sparingly soluble in water and were 
dissolved in DMSO. Cells were not exposed to concentrations of DMSO exceeding 0.1%.
2 Kindly provided by T Carter. National Institute for Medical Research, London, UK
3 Ethylene glycol-bis(2-aminoethylether)-Ar,iV,iV',7V'-tetraacetic acid
4 l-ethyl-2-benzimidazolinone
5 A^-(2-Hydroxyethyl)ethylenediamine-iVr/V'//'-triacetic acid
6 4-(2-hydroxyethyl)-l-piperazineethanesulfonic acid, 4-(2-hydroxyethyl)-l-piperazineethanesulphonic 
acid
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(Continued)
Reagent Notes Supplier
iberiotoxin (IbTx) recombinant Sigma
ketoconazolet Sigma
magnesium chloride AnalaR grade BDH
magnesium sulphate AnalaR grade BDH
methanol AnalaR grade BDH
N-methyl D-glucamine Sigma
paraformaldehyde Sigma
potassium chloride AnalaR grade BDH
potassium gluconate Sigma
potassium hydroxide AnalaR grade BDH
potassium phosphate monobasic AnalaR grade BDH
silver nitrate Hopkin & Williams
sodium chloride AnalaR grade BDH
sodium hydrogen carbonate AnalaR grade BDH
sodium hydroxide AnalaR grade BDH
sodium isethionate Sigma
sodium phosphate dibasic AnalaR grade BDH
substance P Sigma
Sylgard™ type 184 Dow Corning
tetraethyl ammonium chloride Sigma
Tween-20 Promega
UCL 18487T Chemistry Dept., UCL
Vectashield™ Vector Laboratories
Table 2.4 continued) General reagents and drugs. fThese drugs are sparingly soluble in water and 
were dissolved in DMSO. Cells were not exposed to concentrations of DMSO exceeding 0.1%.
7 8,14-diaza-1,7(1,4)-diquinolinacyclotetradecaphanedium ditrifluoroacetate
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Chapter 3: Endothelial cell culture
3.1) Isolation of cells
3.1.1) Rat cells
Since EDHF-mediated responses have been extensively studied in rat 
mesenteric arteries, initial attempts at endothelial cell isolation focussed on these 
vessels. EDHF contributes most to vasodilation in secondary and tertiary mesenteric 
artery branches (Shimokawa et al., 1996), however these were considered 
impractical for endothelial cell isolation owing to their diminutive size. Instead, the 
superior mesenteric artery was used.
Attempts were also made to isolate endothelial cells from segments of 
thoracic aorta and carotid arteries.
Initial endothelial cell isolation protocols used proteolytic enzymes to digest 
structural proteins within the vessel wall. In some cases, vessels were pre-treated 
with neuraminidase, which has been shown to render endothelial cells more 
susceptible to protease activity (Gorog & Pearson, 1985). Despite many attempts, 
however, no endothelial cells could be isolated using these methods.
Alternatively, in some studies the endothelium was physically separated from 
the underlying smooth muscle by gentle scraping or teasing away of the intimal 
surface of the vessel (see figure 3.1). Cells derived in this manner did not survive in 
culture.
Subsequently, an explant culture was investigated since this method has been 
reported to produce a pure endothelial cell culture (McGuire & Orkin, 1987).
Briefly, small segments of vessel were incubated in culture medium on a collagen 
gel matrix. As vascular cells proliferated over a number of days, these spread 
throughout the matrix surrounding the tissue {figure 3.2). Following three to five 
days in culture, vessel tissue was removed and the matrix digested with collagenase, 
allowing the release of proliferated cells. These were then plated in tissue culture 
dishes and cultured under standard conditions.
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aFigure 3.1) The silver 
stained intimal surface of a 
segment of rat thoracic 
aorta. Endothelial cell ‘tiles’ 
(E) can be seen in the 
foreground running from left 
to right (parallel to blood 
flow). Smooth muscle cells 
(SM) run from top to bottom 
and can be seen in patches 
where the endothelium has 
been damaged. Viewed 
under phase contrast using a 
water-immersion objective. 
Scale bar: ~50pm.
Figure 3.2) A ring of rat 
thoracic aorta (A) and 
segment of superior 
mesenteric artery (B) in 
explant culture. Cells can be 
seen in the otherwise clear 
matrix surrounding the 
tissue. Viewed under phase 
contrast. Scale bars: 
~250pm.
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3.1.2) Pig cells
Owing to difficulties in both the identification of (see section 3.2.2) and 
study of rat explant cells, an alternative was sought. Porcine coronary arteries were 
chosen, as a small number of studies had recently described EDHF-type responses in 
this vascular bed e.g. (Edwards et al., 2001). Furthermore, endothelial cell isolation 
from these vessels is regarded as relatively straightforward.
Sections of right (R) or left anterior descending (LAD) coronary artery, 5- 
10cm in length, were used for harvesting endothelial cells. Scraping the vessel intima 
with a scalpel blade yielded endothelial tissue which could then be cultured {figures 
3.3 to 3.5). Harvesting was most effective when the blade was lightly dragged, tilted 
in the direction of motion. Best results were achieved when the scrape was 
completed as a smooth, uninterrupted sweep. Endothelial tissue could be clearly seen 
as a smear on the underside of the blade, which was then dispersed into culture 
medium. A second scrape of the vessel using a clean blade yielded no smear, 
indicating that mainly endothelial cells are removed using this method.
Following overnight incubation, a proportion of tissue fragments would be 
adhered to the bottom of culture dishes. Culture medium was then replaced, 
removing non-adhered tissue. Cells proliferated at various rates, and cultures 
developed as small ‘islands’ of cells surrounding ‘scraped’ endothelial tissue (figure
3.4). Some cultures reached confluence within three to four days (figure 3.5).
Cultures were more successful from R than LAD arteries. This may be because the 
convoluted nature of R arteries is likely to confer greater protection against drying 
following exsanguination.
Owing to the need for single or small clusters of cells for electrophysiology 
studies, cells were lifted and re-plated at a lower density on the evening prior to 
study.
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Figure 3.3) The silver 
stained intimal surface of a 
segment of pig right 
coronary artery. Endothelial 
cells (E) can be seen in the 
left half of the picture. 
Smooth muscle cells (SM) 
can be seen on the right side 
of the picture where the 
endothelium has been 
scraped away. Viewed under 
phase contrast using a water- 
immersion objective.
Scale bar: ~ 100pm.
Figure 3.4) Isolated pig 
right coronary artery 
endothelial cells following 
one day in culture. Viewed 
under phase contrast.
Scale bar: ~50pm.
Figure 3.5) Pig right 
coronary artery endothelial 
cells following four days in 
culture. Viewed under 
phase contrast using a 
water-immersion objective. 
Scale bar: -25 pm.
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3.2) Identification of cells
3.2.1) Introduction
As discussed in section 1.2, blood vessels contain two major cell types of 
functional significance; endothelial cells and vascular smooth muscle cells. When 
isolating cells from the vascular wall, it is important to determine identity because 
cultures will frequently contain a mixture of the two cell phenotypes. Although 
endothelial and smooth muscle cells have distinct classical morphologies, these can 
alter during culture.
Typically, cultured endothelial cells grow as tight clusters, eventually 
forming polygonal or ‘cobblestone’ monolayers (for example, see figures 3.4 and
3.5). The most common endogenous marker used to identify endothelial cells is the 
clotting mediator ‘von Willebrand factor’ (vWF) (Ulger et al., 2002). vWF is not 
expressed in all endothelial cells, although where present, is mainly confined to 
Weibel Palade bodies (storage granules) located in the cytosol. A further 
distinguishing feature of endothelial cells is their expression of macrophage 
scavenger receptors which enable them to internalise acetylated low density 
lipoprotein (aLDL) (Dhaliwal & Steinbrecher, 1999).
Vascular smooth muscle cells usually grow as sharp spindles and can be 
identified by immunostaining for smooth muscle actin. Actin filaments become 
visible as thin strands crossing the cytosol (for example, see figure 3.7).
3.2.2) Rat explant cells
3.2.2.1) Morphology
Rat aortic, mesenteric- and carotid artery explant cells were more similar to 
endothelial cells than smooth muscle cells in terms of morphology. Generally, cells 
were spread flat rather than spindle-shaped, however confluent monolayers were 
noticeably flatter than the cobblestone morphology associated with endothelial cells.
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3.2.2.2) Expression of von Willebrand factor
vWF expression in explant cells was determined by immunostaining using 
one of two polyclonal antibodies. Primary antibody binding was then detected using 
a Cy2-conjugated secondary antibody.
No above-background fluorescence was identified in passaged cells or those 
studied immediately following isolation from the explant culture. The absence of 
vWF was confirmed by repeating the study in excess of five times, using varied 
antibody concentrations (see table 2.1). On the contrary, primary cultures of human 
umbilical vein endothelial cells (HUVEC)8 exhibited a classical pattern of vWF 
staining when subjected to the same immunostaining protocol (figure 3.6). No 
above-background fluorescence was detected when the primary antibody was 
omitted from the procedure.
Both of the antibodies used in these studies have been reported to detect the 
rat isoform of vWF, and detection has previously been reported in the endothelium 
of rat mesenteric artery (Goto et al., 2004).
3.2.2.3) Internalisation of acetylated LDL
Mesenteric and carotid artery explant cells, which had been frozen following 
three weeks in culture (passage four), were thawed and cultured for a further three 
days. Unlike HUVEC (see figure 3.8), explant cells did not internalise fluorescently 
labelled aLDL.
8 Kindly provided by T Carter. National Institute for Medical Research, London
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3.2.2.4) Expression of smooth muscle actin
Mesenteric and carotid artery explant cells, which had been frozen following 
three weeks in culture (passage four), were thawed and cultured for a further three 
days. Immunostaining was carried out using a monoclonal primary antibody raised 
against human smooth muscle actin (clone 1A4). Primary antibody binding was then 
detected using a FITC-conjugated secondary antibody.
In both cultures, filamentous actin staining could be clearly seen in the 
majority of cells (figure 3.7). Similar results were seen when cultured human 
pulmonary artery smooth muscle cells (HPASM)9 were subjected to the same 
immunostaining protocol (figure 3.7). No above-background fluorescence occurred 
in either study when the primary antibody was omitted from the procedure.
3.2.2.5) Summary
Although it was initially considered that explant cultures bore a closer 
morphological resemblance to endothelial than smooth muscle cells, they did not 
express vWF. It was also noted that removing endothelial cell growth supplement 
(ECGS) from the complete culture medium did not affect cell growth or morphology 
(data not shown). The observation that passaged explant cells expressed smooth 
muscle actin, and failed to internalise aLDL, further suggests that they are not 
endothelial; though it is possible that these cells may have changed during several 
weeks in culture.
In published studies, similar explant cultures have been used with the 
purpose of culturing vascular smooth muscle cells e.g. (Leik et al., 2004). The 
explant cells in the present study could alternatively be fibroblasts which are known 
to be flat when in culture, and can also express smooth muscle actin.
9 Kindly provided by L Clapp. UCL Clinical Pharmacology
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Figure 3.6) A single HUVEC immunostained with a primary antibody raised against von 
Willebrand factor (abeam). Primary antibody detected using a Cy2-conjugated secondary 
antibody. The flecks at the top half of the fluorescence image are likely to be Weibel Palade 
bodies; storage vesicles which contain vWF. Corresponding brightfield and green fluorescence 
images are displayed in the left and right panels, respectively. Scale bar: 10 pm.
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Figure 3.7) Rat carotid artery explant cells (passage 4) (A) and a human pulmonary artery smooth 
muscle cell (B) immunostained with a primary antibody raised against smooth muscle actin 
(DakoCytomation). Primary antibody detected using a FITC-conjugated secondary antibody. 
Corresponding brightfield and green fluorescence images are displayed in the left and right panels, 
respectively. Scale bars: 50pm (A) and 20pm (B).
3.2.3) Pig coronary artery cells
3.2.3.1) Morphology
Cells isolated from R or LAD pig coronary arteries grew to confluence in 
‘cobblestone’ morphology, typical of endothelial cells. When plated at a low density, 
cells became quite flat.
3.2.3.2) Expression of von Willebrand factor
Consistent with reports that vWF is not significantly expressed in the 
endothelium of pig coronary arteries (Rand et al., 1987), immuno-fluorescence 
studies failed to demonstrate the presence of this protein in pig R or LAD coronary 
artery cells (see section 3.2.2.2 for procedure).
3.2.3.3) Internalisation of acetylated LDL
Pig R and LAD coronary artery cells, cultured for less than five days, 
internalised fluorescently labelled aLDL in a similar manner to HUVEC (figure 3.8).
In a further study, cells which had been frozen following 2-3 weeks in culture 
(passage 2), were thawed and cultured for a further three days. Although a 
proportion of cells retained the ability to internalise fluorescently labelled aLDL, 
many did not.
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3.2.3.4) Expression of smooth muscle actin
Smooth muscle actin immunostaining (see section 3.2.2.4 for procedure) was 
carried out on cells which had been frozen following 2-3 weeks in culture (passage 
2) then cultured for a further three days. Although a small number of pig coronary 
artery cells {figure 3.9) exhibited similar staining to that seen in explant cells and 
HP ASM {figure 3.7), many did not show above-background staining. Other cells 
appeared to express smooth muscle actin in the sub-plasmalemmal region, but this 
did not cross the cytosol. Above-background fluorescence did not occur in any cells 
when the primary antibody was omitted from the procedure.
3.2.3.5) Summary
Cells which had been in culture for less then one week grew to the same 
classical ‘cobblestone’ morphology associated with endothelial cells, and were also 
capable of internalising aLDL. Following one week in culture, however, monolayers 
became flattened and some cells lost the ability to internalise aLDL. Expression of 
actin was not studied in short-term cultures, however it is possible that actin became 
expressed as cells de-differentiated. In a process termed endothelial-mesenchymal 
trans-differentiation, cells from purified endothelial cultures have been demonstrated 
to gradually spontaneously down-regulate endothelial markers (Frid et al., 2002).
The same cells then begin to express smooth muscle proteins, including actin, fully 
transforming into smooth muscle cells within several weeks.
3.2.4) Conclusion o f cell identification studies
A disappointing conclusion of these studies is that cells cultured from rat 
vessels using explant cultures are unlikely to be endothelial. However, those cultured 
from pig coronary arteries are of the expected morphology for endothelial cells and, 
for at least seven days retain the ability to internalise the specific endothelial cell 
marker, aLDL.
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Figure 3.8) Pig right coronary endothelial cells (passage 0) (A) and HUVEC (B) cultured with 
Dil-labelled acetylated LDL. Corresponding brightfield and red fluorescence images are displayed 
in the left and right panels, respectively. Scale bars: 20/mi.
Figure 3.9) Pig right coronary artery cells (passage 2) immunostained with a primary antibody 
raised against smooth muscle actin, and detected using a FITC-conjugated secondary antibody. 
Corresponding brightfield and fluorescence images are displayed in the left and right panels, 
respectively. Scale bar: 50pm.
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Chapter 4: Rat explant cell electrophysiology
4.1) Foreword
As discussed in chapter J, although similar in morphology to endothelial 
cells, rat explant cells did not express vWF or internalise aLDL. Preliminary studies 
were carried out to further clarify whether these cells might in fact exhibit 
electrophysiological characteristics of endothelial cells.
4.2) Introduction
Rat explant cells were particularly difficult to study using the patch clamp 
technique. This was principally due to the poor ability of patch electrodes to form 
seals with the cells. Gigaseals were possible with less than one cell in twenty, and 
altering pipette dimensions did little to improve this.
A further obstacle to successful recording was the very flat geometry of the 
cells. In early studies, it was difficult to place a patch electrode anywhere on a cell 
without it making contact with the bottom of the bath and thus puncturing the cell 
membrane. Attempts were made to round the cells by exposure to trypsin-EDTA or 
calcium/magnesium-ffee solutions, however, these procedures tended to result in 
cells lifting without rounding. The problem was partially relieved by lifting and re­
plating cells between two and four hours prior to study. Using this method it was 
possible to place a patch electrode onto the nuclear region a cell when approached at 
a steep angle.
Cells used for patch clamp studies had been in culture for between two and 
four weeks (passage 1-3).
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4.3) Studies with 30nM intracellular calcium
4.3.1) Control recordings
Explant cells were studied using patch electrodes filled with a 30nM free- 
calcium-containing intracellular (patch pipette) solution. The following data were 
recorded in cells cultured from mesenteric artery.
Resting membrane potentials were between -15 and -5mV, and whole-cell 
input resistances were between 1 and 8 Gfi at -20mV (n=5). Cells were held at - 
20mV, and current voltage relationships (CVR)s determined by a series of 100ms 
steps from -60 to +120mV, in increments of 20mV. CVRs were shallow and linear at 
potentials negative to +60mV, outwardly rectifying at more positive potentials 
(figure 4.1A). Currents reversed at between -50 and OmV.
4.3.2) Application of pharmacological agents
0.1-3 pM histamine was without effect on the whole-cell currents of five 
cells. At these concentrations, histamine has been shown to evoke EDHF-mediated 
vasodilation in rat mesenteric arteries (Adeagbo & Triggle, 1993).
In order to determine whether BKca channel activity could account for 
voltage-dependence of control currents, ketoconazole, which has been demonstrated 
to activate (Rittenhouse et al., 1997) or block (Wu et al., 1999b) different 
populations of BKca channels, was applied to cells. Whole-cell currents of three cells 
remained unaltered in the presence of 20-30pM ketoconazole.
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Figure 4.1) Whole-cell current voltage relationships recorded in explant cells dialysed with an 
intracellular (patch pipette) solution containing 30nM (A) or 1.5pM (B) free-calcium. Each line 
represents a different cell; colours bear no relevance other than to enable distinction of traces. 
Inset figures are example recordings.
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4.3.3) Summary
Since histamine is able to trigger EDHF-attributed vasodilation in rat 
mesenteric arteries, it can be assumed that this occurs via hyperpolarisation of the 
endothelium (Adeagbo & Triggle, 1993). This has been demonstrated in isolated 
endothelial cells from other vascular beds. While the lack of a response to histamine 
in this study may cast doubt on the cells being endothelial, a down-regulation of 
histamine receptors, associated transduction pathways or ion channels, during 
culture, cannot be ruled out. Down-regulation of agonist and calcium-activated 
responses of pig coronary artery endothelial cells are reported in chapter five.
The outwardly rectifying component of whole-cell CVRs indicates an 
activity of voltage-dependent potassium channels. Of these, BKca channels are the 
most commonly expressed type in endothelial cells. The effects of ketoconazole on 
BKca channels have only been reported in a small number of studies, so it remains 
unclear whether all BKca channels are sensitive to this agent.
Other channels that could account for outwardly rectifying currents recorded 
in this study include members of the Kv family, however these have only 
occasionally been reported in endothelial cells (Nilius & Droogmans, 2001; Adams 
& Hill, 2004).
4.4) Studies with 1.5jiM intracellular calcium
4.4.1) Control recordings
Cells were further studied using patch electrodes filled with a 1.5pM free- 
calcium-containing intracellular (patch pipette) solution. Dialysing cells with this 
concentration of calcium should activate most Kca channels. The following data are 
from cells cultured from rat aorta or mesenteric artery.
Following stabilisation of the whole-cell current, input resistances were 
typically 100-500MQ at -20mV (n=9). At this potential, input resistances were 
significantly less than for cells dialysed with 30nM free-calcium (4.2±1.2GQ n=5,
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0.5±0.2Gfi n=9, for 30nM and 1.5pM, respectively; P=0.019, one-tailed unpaired 
Student’s t-test). This is consistent with the activation of Kca channels.
Cells were held at -20mV and voltage pulses applied as described previously 
(see section 4.3.1). Although reversal potentials for whole cell currents varied widely 
between -70 and OmV, similar to cells dialysed with 30nM calcium, outward currents 
were significantly larger (0.4±0.1nA n=5, 1.5±0.3nA n=9, for 30nM and 1.5pM, 
respectively; currents recorded at +120mV; P=0.002, one-tailed unpaired Student’s t- 
test). Most CVRs were linear at membrane potentials negative to +40mV, outwardly 
rectifying at more positive potentials {figure 4. IB). One exception was a cell with an 
approximately linear whole-cell CVR (green trace, figure 4.1), however there was 
no reason to suppose that this was not a valid recording.
4.4.2) Application of pharmacological agents
In three cells, 10-20pM clotrimazole reversibly blocked an approximately 
linear component of the whole-cell CVR, constituting ~4-20% of the control current 
at +120mV. Clotrimazole blocked a current with an expected reversal potential o f— 
70mV in one cell {figure 4.2) whilst in the remaining two, blocked currents reversed 
at -50 and OmV.
In two out of three cells, 2-50pM ketoconazole reversibly blocked an 
approximately linear component of the whole-cell CVR, constituting —13-39% of the 
control current at +120mV. In the same cell as featured in figure 4.2, 20pM 
ketoconazole blocked a current with an expected reversal potential o f—70mV 
(figure 4.3). In a second cell, 2pM ketoconazole blocked a current which reversed at 
approximately OmV, whilst in a third, 30pM ketoconazole was without effect.
5mM TEA reversibly blocked an approximately linear component of the 
whole-cell CVR when applied to the cell featured in figures 4.2 and 4.3 {figure 4.4). 
The blocked current had an expected reversal potential o f—70mV and accounted for 
~18% of the control whole-cell current at +120mV. ImM TEA blocked a smaller, 
similar current in the same cell.
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Figure 4.2) Effect of 10pM clotrimazole on the whole-cell current of a rat aortic explant cell dialysed with an intracellular (patch pipette) solution 
containing 1.5pM free-calcium. Panel A: Plots of the control current (black) and that recorded two minutes into application of clotrimazole (red). The 
difference current is plotted in panel C. Whole-cell current recordings in response to voltage steps are displayed in panel B, including that recorded 
3mins following wash out. Zero current is highlighted by a dotted line on graphs and by a red line on each current plot.
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Figure 4.3) Effect of 50pM ketoconazole on the whole-cell current of a rat aortic explant cell dialysed with an intracellular (patch pipette) solution 
containing 1.5pM free-calcium. Panel A: Plots of the control current (black) and that recorded two minutes into application of ketoconazole (red). The 
difference current is plotted in panel C. Whole-cell current recordings in response to voltage steps are displayed in panel B, including that recorded 3mins 
following wash out. Zero current is highlighted by a dotted line on graphs and by a red line on each current plot.
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Figure 4.4) Effect of 5mM TEA on the whole-cell current of a rat aortic explant cell dialysed with an intracellular (patch pipette) solution 
containing 1.5(iM free-calcium. Panel A: Plots of the control current (black) and that recorded two minutes into application of TEA (red). The 
difference current is plotted in panel C. Whole-cell current recordings in response to voltage steps are displayed in panel B, including that 
recorded 3mins following wash out. Zero current is highlighted by a dotted line on graphs and by a red line on each current plot.
Whole-cell currents were not affected by 30nM apamin (n=l) or 50nM UCL 
1848 (n=l) (see figure 4.5).
control 30nM  apam in
50nM  UCL 1848control
1nA
500m s
Figure 4.5) Example traces showing insensitivity of rat aortic explant cell whole-cell currents to 
apamin and UCL 1848. Both cells were dialysed with intracellular (patch pipette) solution 
containing 1.5pM free-calcium. Zero current is marked by the red line. Currents are in response to 
voltage steps from -60 to +120mV; the holding potential was -20mV.
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4.4.3) Summary
Cells dialysed with an intracellular solution containing 1.5pM free-calcium 
had significantly lower input resistances, and larger outward currents, compared to 
those dialysed with 30nM free-calcium. Whilst no significant change in whole-cell 
current reversal potentials occurred, a voltage-dependent component became active at 
less positive membrane potentials than with lower cytosolic calcium. This is 
consistent with activation of BKca channels.
In three cells, clotrimazole-sensitive components of whole-cell currents had 
approximately linear CVRs. Consistent with block of IKca channels, in one cell the 
clotrimazole-sensitive current had a reversal potential within 15mV of that calculated 
for potassium ions (-85mV under these conditions). In the two other cells, 
clotrimazole-sensitive currents reversed at -50 and OmV, suggesting possible voltage- 
clamp inaccuracies in some of these experiments. BKca channel block does not 
account for clotrimazole sensitivity of these cells since the inhibited currents were not 
voltage-dependent.
TEA also blocked a linear component of the whole-cell current of one cell. 
This could also be explained by block of IKca but not BKca or Kv channels.
Ketoconazole blocked a linear component of the whole-cell CVR which was 
noticeably larger than that blocked by clotrimazole or TEA. Although structurally 
related to clotrimazole, ketoconazole is ineffective in blocking IKca channels. Whilst 
ketoconazole has been shown to block BKca and some Ky channels, it is not reported 
to block voltage-independent channels that could account for its activity in this study.
Insensitivity of whole-cell currents to apamin and UCL 1848 suggest that 
these cells do not express functional SKca channels.
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4.5) Conclusion of rat explant cell studies
Rat explant cultures were employed following other unsuccessful attempts at 
isolating rat arterial endothelial cells. Although it has been reported that this method 
produces a predominantly endothelial cell culture (McGuire & Orkin, 1987), similar 
protocols have also been used to culture smooth muscle cells. Whilst the cells 
cultured in this study appeared to be morphologically similar to endothelial cells, 
particularly when plated at low density, they did not internalise aLDL or express 
vWF. This was true of cells cultured for the shortest possible period of time using this 
culture method (5 days). Explant cells also expressed smooth muscle actin, usually 
found in smooth muscle and fibroblasts, but not endothelial cells.
Electrophysiological study of rat explant cells was particularly arduous since 
cells rarely sealed to electrodes. Over several weeks, only a small number of whole­
cell recordings were achieved. Cells were unresponsive to histamine, and calcium- 
activated currents were insensitive to SKca channel blockers. As cells were studied 
only following two to three weeks in culture, a down-regulation of channel proteins 
involved in agonist-evoked hyperpolarisation cannot be ruled out.
On account of these various findings, further attempts to isolate and study 
endothelial cells from rat vessels were abandoned. Since it is unlikely that rat explant 
cells were endothelial, data described in this chapter will not be considered further in 
this thesis.
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Chapter 5: Pig endothelial cell electrophysiology
5.1) Introduction
As previously discussed, various approaches to isolating rat vascular 
endothelial cells were unsuccessful. Recent studies e.g. (Burnham et al., 2002; Sollini 
et al., 2002) suggested, however, that endothelium could be relatively easily isolated 
from pig coronary arteries. In keeping with this, endothelial cells were successfully 
isolated and cultured from pig coronary arteries, and used in all further studies.
Pig coronary artery endothelial cells, like rat explant cells, are very flat 
making them difficult to study. When plated at a low density, cells became flatter the 
longer they remained attached to tissue culture plastic, so were routinely lifted and re­
plated on the evening prior to study.
By adopting a steep angle of approach, a patch electrode could be placed on 
the cell membrane overlying the nucleus. The small distance between the tip of the 
cell-attached patch electrode and the base of the perfusion bath remained a constant 
difficulty. Recordings were frequently lost through sub-micron drift of the hydraulic 
micromanipulators.
The ability of electrodes to seal with cell membranes, and ease of entry into 
whole-cell configuration varied greatly between culture batches. Cells were also 
prone to ‘resealing’ i.e. whole-cell configuration would revert back to cell attached 
configuration.
Initially cells were studied following one to two weeks in culture, however 
outward currents could not be evoked in these cells. This was true both in response to 
agonists and when cells were dialysed with an intracellular solution containing 1.5pM 
free-calcium. It was subsequently determined that outward currents could only be 
evoked in cells cultured for less than five days. After only one day in culture, cells 
were often sickly in appearance and did not easily seal to patch electrodes. As a 
result, all studies were carried out on cells cultured for between two and four days.
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5.2) Current-damp studies
5.2.1) Introduction
The initial studies were carried out on large rafts of pig right or left anterior 
descending coronary artery endothelial cells, using current-clamp. The size of such 
rafts varied considerably from small clumps containing approximately eight cells, to 
vast confluent monolayers comprising in excess of one hundred cells.
Membrane potential was monitored continuously (gap-free recording) in order 
to fully capture agonist-evoked responses. Patch electrodes were filled with 
intracellular solution containing 30nM free-calcium.
5.2.2) Cells at rest
As expected, the typical input resistances of large cell rafts (<200MO) were 
much lower than those of small clusters of cells used in voltage-clamp studies 
(>1GQ) (see section 5.3.2.2).
The mean resting membrane potentials (Ems) for right (R) and left-anterior 
descending (LAD) coronary artery cells are shown in table 5.1. Ems were similar for 
cells cultured from both arteries, with a small but significant difference between cells 
cultured for three days. No significant differences were found between mean Ems of 
cells cultured for different lengths of time. Pooling all data gives a mean Em of 
-5.9±0.5mV (n=102). Distributions of Ems according to artery of origin and length of 
time in culture are shown in figure 5.7. In subsequent studies, no distinction is made 
between cells on the basis of originating artery or time in culture.
In some experiments, Em gradually depolarised towards zero mV over the first 
few minutes of recording (data not shown).
The Ems reported in this study are substantially less negative than values given 
in published studies of isolated pig coronary artery endothelial cells. To determine 
whether this was due to the experimental conditions, both intracellular and 
extracellular recording solutions were replaced with those used by Sollini et al.
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(2002). Additionally, some batches of cells were cultured in medium equivalent to 
that used by Sollini et al. Neither intervention had any noticeable effect on Em (data 
not shown) (see also section 5.3.2.3). The low membrane potentials reported in these 
studies are further discussed in chapter seven.
Cells
(Days in culture)
2 3 4
R -8.3±2.0mV (14) -7.2±0.7mV (23)f -5.7±0.8mV (10)
LAD -5.4±1,1mV (18) -4.5±1.3mV (21)+ -4.9±2.6mV (15)
Table 5.1) Resting membrane potentials recorded from rafts of cultured pig right (R) and left 
anterior descending (LAD) coronary artery endothelial cells. Data given as mean ± standard error 
(sample size). Using an unpaired two-tailed Student’s t-test, statistical comparison was made 
between R and LAD groups (controlling for time in culture), and between different length of time 
in culture (controlling for artery of origin). All differences were non-significant (P>0.05), except 
between marked groups (t) ( P=0.041).
5.2.3) Responses to ‘EDHF agonists’
5.2.3.1) Introduction
Endothelial cells from both LAD and R arteries hyperpolarised in the presence 
of extracellular ATP, substance-P or bradykinin (for example see figures 5.2 to 5.4 
and 5.6). Histamine also hyperpolarised cells (for example see figure 5.5), but 
because desensitisation was apparent with repeat exposure, this agonist was not 
further studied. No change in membrane potential was evoked by the muscarinic 
receptor agonist, carbachol (10pM, n=3) (data not shown).
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Aresting membrane potential (mV)
time in culture 
(days)
resting membrane potential (mV)
Figure 5.1) Resting membrane potentials recorded from rafts of endothelial cells cultured from pig 
left anterior descending (LAD) or right (R) coronary arteries. The same data are presented in two 
different ways: firstly according to artery of origin (irrespective of time in culture) (histogram A), 
secondly according to length of time in culture (irrespective of originating artery) (histogram B).
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5.23.2) ATP
At supramaximal concentrations (1-lOpM), ATP hyperpolarised cells to a 
mean peak membrane potential of -50.7±1.6mV (n=76) (for example see figure 5.2). 
Where cells remained in contact with ATP following the response peak, partial 
repolarisation was often followed by slow oscillations in membrane potential. With 
each oscillation, membrane potential returned closer to resting values until re­
polarisation was complete, usually within 1-2 minutes (for example see figure 5.3).
In the majority of recordings, ATP was washed out of the bath once the 
hyperpolarisation had peaked. In many recordings, removal of ATP triggered a 
second smaller hyperpolarisation (for example see figure 5.2). The reasons for this 
were not explored.
Provided that a recovery interval of at least one minute was allowed between 
applications, repeated ATP exposure evoked reproducible hyperpolarisations in most 
recordings. However, stable recordings were usually only sustainable for a few 
minutes, making determination of a concentration-response relationship for ATP 
particularly difficult. Furthermore, concentration-response relationships were steep, 
and ATP-sensitivity varied considerably between cells; whereas some cells fully 
hyperpolarised to 30nM ATP, others failed to respond to 300nM, yet fully 
hyperpolarised to 1 pM.
Concentration-response data has been compiled in two different ways; firstly 
using mean peak responses to a given ATP concentration (table 5.2A). The second 
comparison uses more stable recordings in which it was possible to express responses 
as a percentage of the hyperpolarisation to 1 pM ATP evoked in the same cell raft 
{table 5.2B).
During some experiments, in order to monitor changing input resistance, 
current pulses were applied to cells at regular intervals (for example see figure 5.2, 
lower trace). In these records, voltage deflections in response to the current pulses 
diminish as the cells hyperpolarise, demonstrating that input resistance decreases 
during hyperpolarisation. This suggests that the change in membrane potential is 
largely due to the opening of potassium channels rather than the closure of chloride or 
non-selective cation channels.
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A[ATP] (pM) peak hyperpolarisation (mV)
including unresponsive cells
number of 
unresponsive cells
10 -48.3±2.4 (44) -
3 -48.4±3.6 (7) 0
1 -49.7±2.6 (37) 2
0.3 -21.0±4.9 (12) 3
0.1 -17.2±3.9 (19) 6
0.03 -9.1±5.1 (14) 11
B
[ATP] (pM)
peak hyperpolarisation 
(as % of paired 1 pM ATP response)
including unresponsive cells
number of 
unresponsive cells
0.3 47.8±9.3 (11) 2
0.1 31.4±7.3 (14) 4
0.03 12.2±9.0 (11) 9
Table 5.2) Mean peak hyperpolarisations to different concentrations of ATP (combined data for 
endothelial cells cultured from left anterior descending and right pig coronary arteries). Data in 
table A refer to absolute values from unpaired recordings. Data in table B refer to paired 
responses; peak hyperpolarisation calculated as a percentage of that to 1 pM ATP. Data is given as 
mean ± standard error (sample size). Neither table contains data from cells which, at the end of the 
experiment, did not respond to ATP at the highest concentration applied (1 or lOpM). Data from 
two cells was omitted since in these, hyperpolarisations were greater in response to lower 
concentrations of ATP than for 1 pM.
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Figure 5.2) Hyperpolarisation evoked by transient application of 1 pM ATP to two rafts of pig 
left anterior descending coronary artery endothelial cells. During the recording depicted in the 
lower trace, current pulses were applied in order to monitor changing input resistance (-50pA, 
duration: 0.5s, 0.25Hz).
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Figure 5.3) Hyperpolarisation and subsequent membrane potential oscillation evoked by 
sustained application of IOjiM ATP in a raft of pig right coronary artery endothelial cells.
5.2.3.3) Substance P
Substance P hyperpolarised cells to a similar extent at 1 and 1 OnM, eliciting a 
peak hyperpolarisation of -45.7±4.7 (n=19) (pooled data) (for example see figure 
5.4). These data were not significantly different from the peak hyperpolarisations 
evoked by 1-1 OpM ATP (table 5.3 & figure 5.7).
Hyperpolarisations to substance P were also similar to those of ATP in terms 
of onset, duration and decay. However, no second hyperpolarisation was seen when 
substance P was removed from the bath. As with ATP, continued presence of 
substance P following peak hyperpolarisation resulted in membrane potential 
oscillations and repolarisation to resting values within 1 -2 minutes (data not shown).
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5.2.3.4) Bradykinin
Bradykinin hyperpolarised cells to a similar extent at 1 to lOOnM; the peak 
hyperpolarisation was -59.1 ±3.5mV (n=16) (pooled data) (for example see figure 
5.6). Bradykinin-evoked hyperpolarisations were found to be significantly larger than 
those evoked by ATP or substance P (P=0.038 and 0.028. respectively) {table 5.3 & 
figure 5.7).
Unlike responses to ATP and substance P, cells did not repolarise 
immediately once bradykinin had been removed from the bath. Instead, the 
hyperpolarisation was sustained, with membrane potential steadily returning to the 
resting value within 2-5 minutes. The membrane potential did not oscillate during the 
sustained hyperpolarisation, and cells responded similarly when bradykinin was 
allowed to remain in the bath after cells had reached peak hyperpolarisation (data not 
shown).
A T P  (1-1 OpM) substance P (1-1 OnM) bradykinin (1 -1 0 0n M )
-5 0 .7 ± 1 .6 m V  ( 7 6 / -4 5 .7 ± 4 .7 m V (1 9 )* -5 9 .1 ± 3 .5 m V (1 6 )r
Table 53) Peak hyperpolarisations to supramaximal concentrations of ATP, substance P and 
bradykinin. Data given is mean ± standard error (sample size). Statistical comparisons were 
carried out using an unpaired two-tailed Student’s t-test (T- P=0.038, *: P=0.028, no significant 
difference was found between ATP and substance P (P>0.05).
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Figure 5.4) Hyperpolarisation evoked by transient application of lOnM substance P in a raft of 
pig left anterior descending coronary artery endothelial cells.
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Figure 5.5) Hyperpolarisation evoked by transient application of lOpM histamine in a raft of pig 
left anterior descending coronary artery endothelial cells. In this recording current pulses were 
applied in order to monitor changes in input resistance (-5pA, duration: 1.5s, 0.25Hz).
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Figure 5.6) Hyperpolarisation evoked by transient application of lOOnM bradykinin in a raft of 
pig right coronary artery endothelial cells.
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Figure 5.7) A histogram depicting the distribution of peak hyperpolarisations to supramaximal 
concentrations of ATP (1-lOpM), substance P (1-lOnM) and bradykinin (1- lOOnM).
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5.2.4) Ion substitution studies
5.2.4.1) Introduction
Although hyperpolarisations recorded in these cells are consistent with 
activation of a potassium conductance(s), cells did not typically hyperpolarise to 
more than —65mV. As the calculated reversal potential for potassium ions in these 
studies is -86mV, this suggests that perhaps an additional conductance!s), with a 
more positive reversal potential than potassium, opposed hyperpolarisation to EK. 
Likely candidates include non-selective cation channels, and chloride channels; both 
of which have been described in endothelial cells. To examine this further, the effects 
of changes in the ionic composition of the extracellular solution were explored.
In the following two studies, ATP-evoked hyperpolarisations were recorded in 
the absence of sodium or chloride ions. Throughout both studies, bath flow was 
increased to ~10ml/min to ensure rapid and efficient substitution of extracellular ions.
5.2.4.2) Sodium-free study
At the peak of a control hyperpolarisation, ATP was washed from the bath 
using an extracellular solution in which N-methyl D-glucamine was substituted for 
sodium. Following one minute of superfusion with sodium-free solution, ATP was re­
applied. At the peak o f the resulting hyperpolarisation, ATP was washed from the 
bath with standard (sodium-containing) extracellular solution. A third ATP response 
was evoked one minute later. To allow for the occurrence of the moderate degree of 
response rundown that was observed, ‘average control’ values were calculated as the 
mean of control responses recorded ‘one minute pre’- and ‘one minute post’-exposure 
to sodium-free solution.
Removal of extracellular sodium caused an apparent depolarisation in resting 
membrane potential (7.2±0.2mV, n=3), likely to reflect a change in the junction 
potential at the bath electrode (for example see figure 5.8). Hyperpolarisation 
amplitudes were not significantly different for sodium-free responses compared to
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‘average control’ values (54.6±5.7mV: 57.0±3.8mV, respectively. Paired t-test, n=3; 
P>0.05).
5.2.4.3) Low-chloride study
Since chloride was the major anion in both the standard extracellular and 
intracellular (patch pipette) solutions, each required modification. Initially, potassium 
gluconate was entirely substituted for potassium chloride in a modified ‘30nM free- 
calcium’ intracellular solution, however the resulting junction potential change placed 
recording signals beyond the range of the amplifier. To overcome this, the chloride 
concentration of the intracellular solution was raised to 5mM. For low-chloride 
extracellular solution, sodium isethionate was substituted for sodium chloride, leaving 
a chloride concentration of 7mM.
In the presence of standard (135mM chloride containing) extracellular 
solution, and assuming complete dialysis with low-chloride intracellular solution, Eci 
is calculated as -84mV. This compares to OmV when using the standard (132mM 
chloride containing) intracellular solution. Despite this difference, in the presence of 
standard extracellular solution, 10pM ATP hyperpolarised cells by 26.5 - 54.4mV 
(n=3), well within the range of responses recorded in the presence of standard 
intracellular solution (6.54 - 61.4mV, n=44). At the peak of hyperpolarisation to 
lOpM ATP in the presence of normal (chloride-containing) extracellular solution, 
ATP was washed from the bath with 7mM chloride-containing extracellular solution. 
Following one minute of superfusion with low chloride solution, ATP was re-applied. 
At the peak of the subsequent hyperpolarisation, ATP was washed from the bath with 
standard extracellular solution.
Lowering the extracellular chloride concentration caused an apparent 
depolarisation of the resting membrane potential (9.8±3.5mV, n=3), when compared 
with control (for example see figure 5.9). As with the sodium-free experiments, this is 
likely to be due to a change in junction potential. ATP evoked hyperpolarisations 
which were significantly larger in amplitude under low extracellular chloride 
conditions than control (55.1±5.7mV: 41.6±8.1mV, respectively. Paired one-tailed t- 
test, n=3; P=0.027).
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Figure 5.8) The effect of extracellular sodium 
substitution on hyperpolarisations evoked by 
transient exposure to lOpM ATP. Recording made 
in a raft of endothelial cells cultured from pig right 
coronary artery. Green shading indicates the 
period in which cells were exposed to extracellular 
solution wherein N-methyl D glucamine was 
substituted for sodium.
low-chloride 
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ATP
Figure 5.9) The effect of reduced extracellular 
chloride on hyperpolarisations evoked by transient 
exposure to lOpM ATP. Recording made in a raft 
of endothelial cells cultured from pig right 
coronary artery. Pink shading indicates the period 
in which cells were exposed to extracellular 
solution wherein sodium isethionate was 
substituted for sodium chloride. The recording was 
made using a patch electrode filled with an 
intracellular solution containing only 5mM 
chloride (most potassium chloride substituted with 
potassium gluconate).
5.2.5) Summary o f current-clamp data
Typical of endothelial cells at rest and indicative of a high degree of 
electrical coupling (Nilius & Droogmans, 2001), large endothelial cell rafts had 
typical input resistances of <200MQ; substantially lower than the Gft values seen 
with small clusters of cells (see section 53.2.2). The mean resting membrane 
potential (Em) was -5.9mV and, despite a small but significant difference following 
three days in culture, values were similar between cells cultured from right and left 
anterior descending coronary arteries {table 5.1). No significant difference was found 
between Ems recorded from cells cultured for different lengths of time.
Although endothelial cell Em is reported to vary greatly between vascular 
beds (ranging from 0 to -80mV; Nilius & Droogmans (2001)), the mean value of 
-5.9mV obtained in the present study is low when compared with Ems reported in 
published studies of isolated pig coronary artery endothelial cells {table 7.1). In the 
present study, altering neither culture conditions nor recording solutions influenced 
Ems. The low Ems recorded in this study are discussed further in chapter seven.
ATP and substance P both hyperpolarised cells to ~-50mV {table 5.3), and 
membrane potential oscillations frequently developed during longer exposure to 
these agonists. Input resistance decreased during the hyperpolarisation, consistent 
with the opening of SKca and IKca channels as previously reported in these cells 
(Frieden et al., 1999; Bychkov et al., 2002; Sollini et al., 2002).
Bradykinin evoked larger hyperpolarisations than ATP or substance P 
(~-60mV) {table 5.3), and responses were sustained for several minutes after the 
agonist was washed from the bath. Unlike responses to ATP and substance P, no 
membrane potential oscillations followed the hyperpolarisation peak. In published 
studies of cultured pig coronary artery endothelial cells, it has been reported that 
bradykinin opens IKca and BKca hut not SKca channels (Frieden et al., 1999; Sollini 
et al., 2002). This has, however been refuted in a study of freshly isolated 
endothelium which concluded that both substance P and bradykinin activated SKca 
and IKca but not BKca channels (Bychkov et al., 2002).
Histamine also evoked hyperpolarisation of endothelial cell rafts, although 
cells rapidly desensitised to this agent. Carbachol, conversely, did not affect
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endothelial cell membrane potential, consistent with a reported lack of UVcoupled 
muscarinic receptors in pig coronary endothelial cells (Ito et a l, 1979).
Ion substitution studies were carried out to determine why cells did not 
hyperpolarise to values closer to EK. In the absence of extracellular sodium ions, 
amplitudes of ATP-evoked hyperpolarisations were comparable with controls, 
indicating that non-selective cation currents are unlikely to play a major role in these 
responses. Under conditions of reduced intracellular chloride, ATP-evoked 
hyperpolarisations were comparable with those occurring in the presence of standard 
ionic gradients. When extracellular chloride was also reduced, the amplitude of 
ATP-evoked hyperpolarisations became significantly larger. However, because of 
the junction potential changes which occurred in this study, the contribution of 
chloride ions to ATP-evoked hyperpolarisations cannot be readily quantified. 
Nevertheless, the larger hyperpolarisations seen in low chloride solutions suggest 
that chloride conductances may limit peak hyperpolarisation, in keeping with 
findings recently reported in a study of mouse aortic endothelial cells (Ahn et a l, 
2004).
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5.3) Voltage-clamp studies: ATP-evoked currents
5.3.1) Introduction
Single cells or clusters of 2-3 cells were used in all voltage-clamp 
experiments to ensure adequate voltage-clamping. For simplification, and in view of 
the apparent high degree of electrical coupling, the term ‘cell’ is applied to both 
single cells and clusters.
Unless otherwise stated, studies were performed using patch electrodes filled 
with the same intracellular solution used for current-clamp studies (30nM free- 
calcium). A holding potential of -50mV was used in all experiments, and currents 
were recorded continuously during agonist application. Voltage-pulses (+50mV, 
200ms duration) were applied at a frequency of 0.5Hz, and voltage ramps (-120 to 
+50mV over 200ms) performed prior to and at the peak of all evoked currents.
Capacitance compensation was applied in all recordings, however this was 
often imperfect or incomplete in clusters of three cells. For recordings in which a 
good balance was achieved, an approximate value for cell capacitance was noted.
It was found that series-resistance constantly fluctuated throughout 
recordings. This resulted in transients, of continuously varying size, appearing at the 
start and end of each voltage pulse and ramp. The brevity of these artefacts was such 
that an impact on any measurement is unlikely. For clarity and to enable distinction 
of pulses at a low timebase gain, artefacts have been removed from all presented 
traces (see appendix iv for examples of unmodified traces and details of the 
procedure).
Data reported in this section were recorded entirely from right coronary 
artery (R) cells, since culture of these was more successful than of cells from the left 
anterior descending coronary artery (LAD) (see section 3.1.2 for comment). In 
preliminary voltage-clamp experiments wherein cells from LAD were studied, no 
difference in electrophysiological properties was noted when compared with R cells 
(data not shown).
ATP was chosen to evoke all responses in these studies, since the sensitivity 
of cells to substance P or bradykinin was more variable (data not shown). Unless
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otherwise stated, ATP was applied at lOpM and was washed from the bath 
immediately following the response peak.
Except for current-voltage relationships, all measurements were made at the 
holding potential (-50mV).
5.3.2) ATP-evoked currents
5.3.2.1) Selection of data
Mean data described in sections 5.3.2.2 and 5.3.2.3 are from a randomly 
selected sample of recordings. To enable fair comparison of data relating to length of 
time in culture, ten culture batches were chosen at random. For each batch, up to five 
studied cells were randomly selected from each day of recording (2, 3 and 4 days 
following culture). Data relates to the first ATP-evoked response recorded from a 
selected cell.
Cells in which ATP evoked an ‘early-inward’ current component (see section
5.3.2.4), or no current at all, were excluded from selection.
5.3.2.2) Control recordings: characteristics of resting cells
As expected, the measured cell capacitance significantly increased 
approximately proportionally to the number of cells in the cluster studied. A 
significant increase was also recorded between cells cultured for two and three days 
(table 5.4).
On average, cells passed a small inward current at the holding potential 
(table 5.5A). Estimates of conductance were made by determining the gradient of a 
linear fit applied to an approximately linear portion of the current-voltage 
relationship (CVR) (-70 to -40mV). The fit was also used to estimate reversal 
potentials for resting cell currents. To control for cluster size, currents are expressed 
as a function of capacitance.
135
Disregarding cluster size, cells had a median input resistance of -5G12, 
irrespective of time in culture (range: 0.4-140 Gfi, n=127). Because of the inability 
of the amplifier to accurately measure very high input resistances, the data is better 
described by the median value rather than the mean.
Resting cell CVRs were varied and could be described as one of four basic 
‘shapes’. Most CVRs exhibited a voltage-activated component at positive potentials, 
with approximately half of these also displaying an inwardly-rectifying component 
(for examples see figures 5.10A&B). A smaller proportion of CVRs showed inward- 
rectification with no voltage-activated component {figure 5.10C), or were 
approximately linear (figure 5.10D).
5.3.2.3) ATP-evoked outward currents
At the holding potential, 10pM ATP evoked an outward whole-cell current in 
the majority of cells to which it was applied (for example see figure 5.11). The
were
amplitude of ATP-activated currents \yatf proportional to cluster size, and inversely 
related to the length of time cells had been in culture (table 5.5B).
Unlike the heterogeneity between CVRs for resting cells, those for ATP- 
activated components were all of a similar shape to the example shown in figure 
5.12. The lack of outward rectification between -50 and +50mV suggests that ATP 
does not activate voltage-dependent channels over this range of potentials.
Voltage-ramps applied prior to- and at the peak of- responses to ATP, 
enabled estimates to be made of conductance and reversal potential for the ATP- 
activated component (table 5.5B). Although reversal at —70mV is consistent with 
the activation of a potassium conductance(s), this is short of the Ek calculated for 
these studies (-86mV). The reversal potentials did not greatly alter with culture age
were
suggesting that age-related reduction in ATP-evoked outward currents due to a 
reduction in the number of open potassium channels, rather than up-regulation of an 
opposing current. Curreryfs
On occasions, ATP-evoked outward c\pr€nt occurred in two or three ‘steps’ 
(for example see figure 5.13). Since this was seen only in clusters of 2-3 rather than 
single cells, this may have been due to a delay in response between compartments 
(cells) of the cluster.
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tim e in culture  
(days)
cluster size
single cell 2 3
2 2 8 .3 ± 1 .2 p F  (21 ) 45 .9 ± 2 .1p F  (2 0 ) 6 8± 2 .9 p F  (3 )
3 3 7 .1 ± 3 .4 p F  (1 0 ) 53 .7 ± 1 .7p F  (3 3 ) 8 9 .3 ± 4 .5 p F  (4 )
4 - 6 1 .2±3 .3p F  (2 3 ) 8 3 .6 ± 4 .5 p F  (10 )
Table 5.4) Capacitance measurements made from clusters of different sizes and ages. Data is mean ± 
standard error (sample size). Using an unpaired two-tailed Student’s t-test, statistical comparison was 
made between time in culture (controlling for cluster size), and between different length of time in 
culture (controlling for artery of origin). All differences were significant (P<0.05), except those 
occurring between days 3 and 4.
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Figure 5.10) Typical examples of whole-cell CVRs recorded from pig right coronary artery 
endothelial cells. Currents were obtained by applying a voltage ramp from -120 to +50mV.
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A resting current
tim e in culture  
(days)
outw ard current at 
-5 0 m V  (pA /pF)
conductance*
(p S /p F )
reversal potential* 
(m V )
2 -0 .2 4 ± 0 .0 9  (4 5 ) 1 0 .6 ± 1 .9  (3 2 ) -2 2 .2 ± 4 .0  (3 2 )f
3 -0 .2 7 ± 0 .0 7  (4 3 ) 8 .0 ± 1 .9  (2 7 ) -25 .1  ± 6 .4  (2 7 )
4 -0 .2 5 ± 0 .0 6  (2 7 ) 7 .0 ± 0 .2  (2 0 ) -1 2 .7 ± 2 .4  (2 0 )f
B ATP-activated current
tim e in culture  
(days)
outw ard current a t 
-5 0 m V  (pA /p F )
conductance*
(p S /p F )
reversal potential* 
(m V )
2 6 .1 9 ± 0 .6 2  (4 6 ) 243 .0± 27 .1  (4 0 ) -7 2 .9 ± 0 .8  (3 5 )J
3 2 .2 7 ± 0 .2 6  (4 4 ) 8 3 .8 ± 1 2 .4  (3 7 ) -7 2 .6 ± 1 .1 (3 3 )
4 0 .8 5 ± 0 .1 3  (2 7 ) 3 0 .7 ± 6 .4  (2 8 ) -6 9 .2 ± 1 .5  (19 )*
Table 5.5) Outward holding current, conductance and reversal potential of whole-cell resting currents 
(A), and currents activated by 10pM ATP (B), recorded from pig right coronary artery endothelial 
cells. Holding potential: -50mV. *data from a linear fit of an approximately linear portion of the C VR 
(-40 to -70mV). Data is mean ± standard error (sample size). Using an unpaired two-tailed Student’s t- 
test, statistical comparison of each parameter was made according to time in culture. For table A, 
significance was only found between groups marked f  (P=0.049). For table B, all differences in 
outward current and conductance were significant (P<0.05), however difference in reversal potential 
was only significant (P=0.40) between groups marked {.
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Figure 5.11) An outward current evoked by lOpM ATP recorded from a pig right coronary artery 
endothelial cell. Holding potential: -50mV, pulse amplitudes: +50mV. Asterisks denote 
application of voltage-ramps (-120 to +50mV).
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Figure 5.12) The current-voltage relationship of a current activated by lOpM ATP. Data are taken 
from the recording depicted in figure 5.11 and are calculated as the difference between whole-cell 
CVRs at rest and in the presence of ATP. The red line is a representation of a linear fit applied to 
the recording at potentials between -70 and -40mV.
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In all experiments ATP was removed from the bath soon after the response 
had peaked, though it was noted that the currents began to decrease before the 
agonist was washed out. The currents in most cells then returned to resting levels 
(for examples see figures 5.11 and 5.13). However, in some cells a small 
‘undershoot’ followed so that the holding current became inward (for example see 
figure 5.14). This ‘delayed-inward’ current was not explored, but its late onset 
together with slow decay (up to 1 minute) suggests that it is unlikely to be related to 
the ‘early-inward’ currents, to be described in section 5.3.2.4.
Many attempts were made to study the concentration-response relationship 
for ATP. However, problems with longevity of recordings and response-rundown 
meant that this could not be satisfactorily achieved. As with current-clamp studies, it 
was noted that cells varied substantially in sensitivity to ATP. An example of a 
recording in which different concentrations of ATP were successfully applied is 
shown in figure 5.15.
Rundown of ATP-evoked responses was a particular concern during voltage- 
clamp studies. Some cells produced outward currents of consistent amplitude when 
ATP was repeatedly applied at intervals of several minutes. However, in other cells, 
the responses fell with each repeat agonist exposure, or increased with the first 
repeat, decreasing thereafter {figure 5.16). An example of progressive rundown is 
shown in figure 5.17.
In an attempt to prevent response rundown, the possibility of using the 
perforated-patch technique was explored. The inclusion of amphotericin-B in the 
intracellular solution made cell-electrode sealing much more difficult. Varying 
amphotericin-B concentration or filling patch electrodes tips with amphotericin-free 
solution made no appreciable difference. When seals were successful, cells failed to 
permeabilise, and the seal was usually lost within ten minutes. These attempts were 
abandoned following several weeks of perseverance.
Some preliminary studies were performed with the solutions used by Sollini 
et al. (2003) in voltage-clamp experiments. Since the ‘Sollini’ intracellular solution 
contained ATP, it was thought possible that this might have prevented rundown of 
responses. Although few experiments were attempted, rundown in response to 
repeated application of ATP was apparent in several of the studied cells. Cell 
capacitance values were not recorded in these studies and so it is not possible to 
make quantitative comparisons of current amplitudes. However, neither control nor
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ATP-evoked whole-cell currents were noticeably different to those recorded when 
using the standard solutions (data not shown).
Several cultures were prepared and maintained in media similar to that used 
by Sollini et al. (2002); only the antibiotic was different. Cells cultured in ‘Sollini’ 
media responded to ATP in a manner indistinguishable from cells cultured in the 
standard culture medium. Response amplitudes and age-related down-regulation of 
currents were not noticeably different to those recorded from cells cultured under 
standard conditions (data not shown). Response-rundown was similarly observed.
5.3.2.4) ATP-evoked ‘early-inward’ currents
In the majority of cells tested, ATP evoked an uninterrupted outward holding 
current in response to ATP. However, in approximately 12% of cells, ATP activated 
an additional ‘early’-inward current component at this potential. Incidences of early- 
inward currents were usually clustered, occurring in some culture batches, but not in 
others. Approximately three times the number of early-inward currents were 
observed in cells cultured for three days when compared with cells cultured for two 
days.
In most of the cells showing an early-inward current component, ATP- 
activated inward and outward components were ‘entangled’, but were noticeable 
either because the inward components had a more rapid onset (for example see 
figure 5.18), or because increases in pulse amplitude were disproportionate to 
increases in holding current (for example see figure 5.19A).
In some cells, ATP evoked only a net-inward holding current (for example 
see figure 5.19B). Voltage ramps conducted prior to at the peak of net-inward 
currents allowed CVRs to be determined in some cells {figure 5.20). Reversal 
potentials for net inward currents ranged between -45 and -8mVr The variation is 
likely to be due to differences in the contribution of potassium conductances.
Data from cells which appeared to contain an early-inward current 
component, such as those in figures 5.18 and 5.19, were excluded from analysis of 
potassium conductance changes.
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Figure §.13) An outward current recorded from a cluster of pig right coronary artery endothelial 
cells, evoked by lOpM ATP. Holding potential: -50mV, pulse amplitudes: +50mV. Asterisk 
denotes application of a voltage-ramp (-120 to +50mV), pre-ATP ramp not shown.
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Figure 5.14) An outward current with following ‘undershoot’ (delayed-inward current) recorded 
from a pig right coronary artery endothelial cell, evoked by 10pM ATP. Holding potential: - 
50mV, pulse amplitudes: +50mV.
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Figure 5.15) Current recordings and a concentration-response plot for ATP in a pig right coronary 
artery endothelial cell. Panel A contains superimposed current traces from the same recording. 
Traces have been staggered vertically and horizontally to enable distinction of pulses. Holding 
potential: -50mV, pulse amplitudes: +50mV. A plot of the measured ATP responses from the 
same recording is shown in panel B.
143
A
120 -i
1 1 0 -
100 -
90-
o, 80-t/>
o 70- Q.
W5
'  60-
2 50-coo
#
40-
30-
2 0 -
2-minute intervals
1 0 -
1 2 3 4
repeat count
B
140-
1 2 0 -
80-
2
C 60-
8
40-
3-minute intervals2 0 -
321
repeat count
Figure 5.16) Effect of repeat application of IOjiM ATP on pig right coronary endothelial cells. 
Applications were repeated at intervals of 2 (A) or 3 minutes (B), and in each case ATP was 
removed once currents had peaked. Each symbol represents a different cell. Data are expressed as 
% of an initial ATP-activated current, recorded at the holding potential (-50m V). Crosses indicate 
loss of recording.
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Figure 5.17) An example of decreasing amplitude of outward currents with repeated ATP 
application; recording from a pig right coronary artery endothelial cell. lOpM ATP was 
repeatedly applied at intervals of two minutes. Holding potential: -50mV, pulse amplitudes: 
+50mV. Traces have been staggered vertically and horizontally to enable distinction of pulses.
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Figure 5.18) An example of a recording in which lOpM ATP evoked both early-inward and 
outward currents in pig right coronary artery endothelial cells. Holding potential: -50mV, pulse 
amplitudes: +50mV. Asterisk denotes application of a voltage-ramp (-120 to +50mV), pre-ATP 
ramp not shown.
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Figure 5.19) Further examples of recordings in which lOpM ATP evoked both early-inward and 
outward (A), or early-inward (B) currents in pig right coronary artery endothelial cells. Holding 
potential: -50mV, pulse amplitudes: +50mV. Asterisks denote application of a voltage-ramp (-120 
to +50mV), pre-ATP ramps not shown.
146
0 .8 -
0 .6 -
<c
g 0 4 -
fc3O
T3 0 .2  -<D|
TS 0.0 -<o■
P-
- 0 .2 -
H<
-0.4-
”1—'—I—1—I—*—I—1—I—'—I—'—I—*—I—•—I—•—I—'—I—»
-140 -120 -100 -80 -60 -40 -20 0 20 40 60
membrane potential (mV)
Figure 5.20) Current-voltage plots o f ‘net early-inward’ currents activated by lOpM ATP. Data 
are calculated as the difference between whole-cell CVRs at rest and in the presence of ATP.
5.3.3) Sensitivity o f ATP-evoked outward currents to Kca channel 
blockers
5.3.3.1) Introduction
In the next part of the study, K ca channel blockers were used to investigate 
the identity of potassium channels underlying ATP-evoked outward currents. A 
comparison of the Kca channel subtype selectivity for each of these agents is given in 
table 5.6.
In each experiment, a control response to ATP was established, and a blocker 
then applied continuously for three minutes (see figure 5.21). ATP was re-applied in 
the presence of the blocker, after which cells were superfused with blocker-free 
solution for a further three minutes. ATP was then applied for a third time to
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determine recovery from block (for example traces see figure 5.22). The rate of onset 
and offset of the agents used, as judged by their effects on calcium-dialysis activated 
currents (see section 5.5.3), suggests that three minutes is sufficient time for block to 
reach equilibrium, and for wash-out.
Owing to the difficulty in maintaining recordings, a large proportion were 
lost prior to completion of the block protocol. Incomplete recordings were excluded 
from analysis.
These experiments were complicated by response rundown, which, as 
discussed in section 5.3.2.3, was highly variable between recordings. To reduce the 
influence of rundown, current evoked in the presence of blocker has been expressed 
as a percentage of the ‘average control’. Average control is defined as the mean of 
the ‘control response’ and the ‘recovery response’. For data to be measured in this 
way two assumptions are made: firstly, that rundown occurred in a linear nature; and 
secondly, that blockers had completely dissociated from their binding sites following 
three minutes of wash-out. Neither premise will hold exactly. However, on account 
of the variability in run-down and difficulty of the experimental procedure, a more 
rigorous method of measurement was not feasible.
Data from recordings in which rundown between ‘control’ and ‘recovery’ 
responses was excessive (>75%), or where responses ‘ran-up’ by more than 5% 
across the same interval, were excluded from analysis.
A second ‘recovery’ response recorded three minutes after the first, was 
almost always smaller in amplitude, so was not used in analysis.
Owing to response rundown and the brevity of recordings, it was not possible 
to investigate more than one blocker concentration in a single recording.
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Figure 5.21) Protocol for determining the effects of Kca channel blockers on 10pM ATP- 
evoked outward currents.
control with blocker recovery
Figure 5.22) ATP-responses from the same recording; evoked prior to, during and following 
washout of a channel blocking agent. In this particular example, the blocker was lOOnM UCL 
1848.
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5.3.3.2) UCL 1848
The contribution of SKca channels to ATP-evoked outward currents was determined 
using the potent and selective non-peptide blocker, UCL 1848 (table 5.6).
Plotting UCL 1848 concentration on a log scale against % block of the ATP- 
evoked current gives a sigmoidal relationship {figure 5.23). Least squares curve 
fitting10 was applied to the data using the Hill equation (see below), although, for the 
reasons set out below, the low end of the curve was not constrained to zero. The 
resulting fit gave an IC50 of 1.18±0.03nM and a Hill coefficient of 1.43±0.05.
Hill equation: % inhibition = 100 x —------
[ I ]n + ICso"
[ I ]= concentration of blocker 
n= Hill coefficient
Low concentrations of UCL 1848 seemed to produce measurable inhibition, 
which is very possibly due to overestimation of block owing to inadequate 
compensation for response rundown. Consistent with this being a systematic error, a 
similar anomaly was noted when studying low concentrations of clotrimazole (see 
section 5.3.3.3). Considering both sets of data, this error accounts for approximately 
15% of the ATP-evoked current. Taking this into account, the apparent block of the 
ATP-evoked current by supramaximal concentrations of UCL 1848 (-70%), has 
been re-calculated as 65% (calculation: 70-15 expressed as a percentage of 100-15).
CVRs for lOnM UCL 1848-sensitive currents are shown in figure 5.24. 
Linear fits applied to these traces between -70 and -30mV give a mean reversal 
potential of -74.0±1.6mV (n=7).
10 Curve fitted using Origin v.7 (OriginLab) software
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Figure 5.23) Concentration-inhibition relationship for UCL 1848 sensitivity of outward currents 
evoked from pig right coronary artery endothelial cells by 10pM ATP. Data are calculated as % 
block of ‘average control’ current, recorded at -50mV. Data are expressed as means, bars 
represent standard error and labels indicate sample size.
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Figure 5.24) Current-voltage plots of 1 OnM UCL 1848 sensitive currents (evoked by 1 OpM
ATP), recorded from pig right coronary artery endothelial cells.
151
SK1 SK2 SK3 IK (SK4) BK ($ k # < ,± )
apam in
7.7nM
(hSK1)
(Shah & Haylett, 2000)
0.08nM
(rSK2) 
(Strobaek et ah, 2000)
1.4nM
(rSK3) 
(Hosseini et ah, 2001)
ineffective at 100nM 
(hSK4) 
(Joiner etah, 1997)
ineffective at 100nM 
(rat SCG neurones) 
(unpublished obs. by 
DCH Benton)
charybdotoxin
ineffective at 100nM 
(hSK1) 
(Strobaek et a/., 2000)
ineffective at 100nM 
(rSK2) 
(Strobaek et ah, 2000)
ineffective at 100nM 
(unpublished obs. by 
DCH Benton)
2.5nM
(hlK1)
(Ishii etah, 1997b)
2.9nM
(bovine aortic SM) 
(Kaczorowski et ah, 
1996)
clo trim azo le not determined
21 pM 
(hSK2) 
(Wulff et ah, 2000)
Ineffective at 100nM1 
28pM2 
(hSK3)
1 :(Carignani et ah, 2002) 
2:(Wulff et ah, 2000)
24.8nM1 / 70nM2
(hlK1)
1:(lshii etah, 1997b) 
2:(Wulff etah, 2000)
24pM
(hSIo)
(Wulff et ah ,2000)
iberio toxin not determined not determined
ineffective at 100nM 
(rSK3) 
(Kohler etah, 1996)
>1pM (hlK1)1 
800nM (rat C6 cells)2 
1 :(Logsdon et ah, 1997) 
2:(de Allie etah, 1996)
1.7nM
(bovine aortic SM) 
(Kaczorowski et ah, 
1996)
UCL 1848
1.1nM
(hSK1)
(Shah & Haylett, 2000)
0.1nM
(rSK2) 
(Hosseini et ah, 2001)
2.1nM
(rSK3) 
(Hosseini et ah, 2001)
not determined1
ineffective at 100nM 
(rat SCG neurones) 
(unpublished obs. by 
DCH Benton)
Table 5.6) Relative sensitivities of different the Kca channel subtypes to five different blocking agents. Values given are IC50s from studies of cloned 
channel proteins expressed in mammalian cell lines, or from studies of native channels of superior cervical ganglion (SCG) neurones, or smooth muscle 
(SM). h and r, as in hSKl or rSK2, denote the human and rat orthologues of the relevant channel proteins, respectively, ‘inh.’ denotes inhibition, ‘obs.’ 
denotes observations. Values highlighted in green are most relevant to these studies, f  Although IKca channel sensitivity to UCL 1848 has not been 
determined, UCL 1684, a sister compound with near-identical pharmacology, failed to block IKca channel -mediated potassium efflux in rabbit erythrocytes 
when applied at lOOnM (Malik-Hall et ah, 2000).
5.3.3.3) Clotrimazole
In the next experiments, clotrimazole was applied in order to evaluate the 
contribution of IKca channels to ATP-evoked currents (see table 5.6). Concentrations 
ranging from lOnM to lOpM were tested. The expected inhibition of IKca channels 
at these concentrations is estimated to be 16 and 99% respectively (based on an IC50 
of 50nM and a Hill coefficient of 1).
At low concentrations (10 to 30nM), clotrimazole appeared to block a similar 
minimum proportion of the whole-cell current as had been observed with low 
concentrations of UCL 1848 (see figure 5.25). Assuming that the same 15% 
systematic error applied, this suggested that little or no block occurred at these 
concentrations. On the same basis, 1 OOnM and 1 pM clotrimazole blocked ATP- 
evoked currents by -20% and -50%, respectively.
At lOpM, clotrimazole blocked ATP-evoked currents by -95%, abolishing 
the response in three of the five cells to which it was applied. On account of ATP- 
evoked currents being partly mediated through SKca channel activity, this high 
degree of block was surprising as SKca channels are frequently reported as being 
insensitive to this concentration of clotrimazole (Carignani et al., 2002). Even taking 
into account IC50S from studies which show higher sensitivity (see table 5.6), lOpM 
clotrimazole would only be expected to block 33% of the SKca channel component 
(based on an IC50 of 20pM and a Hill coefficient of 1 ).
As clotrimazole appears to block both SKca and IKca channels) block of each
So
channel expected to have a distinct IC50* the concentration-inhibition relationship 
would be likely to comprise two components. Consistent with this, fitting a single 
sigmoidal curve to the data gave a low Hill coefficient of 0.8, and an IC50 much 
higher than expected for clotrimazole block of IKca channels (~800nM) (fit not 
shown). The data were not however sufficient to merit an attempt at a two- 
component fit.
CVRs for lpM  clotrimazole-sensitive currents are shown in figure 5.26. 
Linear fits applied to these traces between -70 and -30mV give a mean reversal 
potential of 72.3±1.6mV (n=6 ).
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Figure 5.25) Concentration-inhibition relationship for clotrimazole sensitivity of outward currents 
evoked from pig right coronary artery endothelial cells by 1 OpM ATP. Data are calculated as % 
block of ‘average control’ current, recorded at -50mV. Data are expressed as means, bars represent 
standard error and labels indicate sample size.
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Figure 5.26) Current-voltage plots of 1 pM clotrimazole-sensitive currents (evoked by 1 OpM
ATP), recorded from pig right coronary artery endothelial cells.
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5.3.3.4) Co-application of UCL 1848 and clotrimazole
When applied in combination, lOOnM UCL 1848 and lOpM clotrimazole 
reversibly abolished ATP-evoked outward currents in all seven cells to which they 
were applied (data not shown).
5.3.3.5) Charybdotoxin
The IKca channel contribution to ATP-evoked currents was studied further 
using charybdotoxin. This peptide also blocks BKca channels, although, as will be 
discussed in section 5.3.4, these are thought unlikely to contribute to ATP-evoked 
currents.
Charybdotoxin was applied at concentrations between 1 and 1 OOnM which, 
allowing for ~15% systematic rundown, blocked ATP-evoked currents by -  70-90%
(figure 5.27). Block by the lowest concentrations was surprisingly high considering 
that the IC50 for charybdotoxin block of IKca is reported to be 2.5nM (table 5.6). 
Pooling data for block by 30 and lOOnM charybdotoxin gives an inhibition o f -85%.
Current-voltage plots for lOnM and 30nM charybdotoxin-sensitive currents 
are shown in figure 5.28 (pooled data). Linear fits applied to these traces between 
-70 and -30mV give a mean reversal potential of 74.8±1.6mV (n=6).
5.3.3.6) Other blockers
Apamin (lOOnM) and iberiotoxin (lOOnM) were studied in a small number of 
cells, however, after exclusion of some data due to rundown, only a single example 
of block remained for each. In view of the high variability shown by individual cells 
in response to other blockers, it was decided that these data are insufficient for 
consideration.
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Figure 5.27) Concentration-inhibition relationship for charybdotoxin sensitivity of outward 
currents evoked from pig right coronary artery endothelial cells by lOpM ATP. Data are 
calculated as % block of ‘average control’ current, recorded at -50mV. Data are expressed as 
means. Bars represent standard error and labels indicate sample size.
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Figure 5.28) Current-voltage plots of lOnM or 30nM charybdotoxin-sensitive currents (evoked
by 10pM ATP), recorded from pig right coronary artery endothelial cells (pooled data).
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5.3.4) Summary o f ATP-evoked current data
Consistent with published data, single endothelial cells had input resistances 
in excess of IGti and capacitances of ~30-40pF (Nilius & Droogmans, 2001). 
Interestingly, mean cell capacitance for clusters of all sizes significantly increased 
between cells cultured for two and three days {table 5.4). Although not investigated, 
this could indicate an increase in cell volume, or perhaps an increased number of 
caveolae (membrane folds) which would also increase the cell surface area.
On average, resting cells held at -50mV passed small inward currents which 
had mean reversal potentials of -12 to -25mV {table 5.5A). Current-voltage 
relationships were heterogeneous, indicating different contributions of inwardly 
rectifying and voltage-dependent channels.
CVRs of ATP-evoked outward currents were approximately linear at 
potentials positive to -50mV, and reversed in the region of -73mV. As previously 
reported for cultured endothelial cells, agonist-evoked currents decreased with 
increasing time in culture, and had virtually disappeared five days following 
isolation (Frieden et al., 1999; Ahn et al., 2004). Down-regulation of channel 
expression is a more likely explanation than failure of receptor mechanisms since 
calcium-dialysis activated currents also diminished over this period (see section
5.5.2).
In some batches of cells, particularly following three or four days in culture, 
ATP evoked rapidly activating inward as well as outward currents. These ‘early 
inward’ currents were not observed in cells dialysed with 1.5pM ffee-calcium, 
suggesting that the underlying channels were not calcium-activated. Early inward 
currents were perhaps due to an up-regulation of P2X channels during culture. In 
keeping with this, ATP analogues have previously been demonstrated to activate 
P2X-mediated inward currents in bovine aortic endothelial cells (Ramirez & Kunze, 
2002).
ATP-evoked outward currents were partially sensitive to UCL 1848 
suggesting a contribution by SKca channels. The IC50 of 1.2nM reported in this study 
is similar to values for cloned SKI or SK3 homomultimers, but not of channels 
formed from SK2 which are approximately ten-fold more sensitive to this agent (see
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table 5.6) (Shah & Haylett, 2000; Hosseini et al., 2001). At supramaximal 
concentrations, UCL 1848 blocked -65% of the ATP-evoked whole-cell current.
lOnM UCL 1848-sensitive currents reversed at -74mV and CVRs were 
approximately linear between the reversal potential and +20mV. At potentials 
greater than this, a sharp reduction was seen in currents from some cells (sqq figure 
5.24), which may have been due to divalent cation block as reported for SKca 
channels (Soh & Park, 2001). The reason that this did not occur in all recordings 
may relate to differences in peak intracellular calcium concentration. It should also 
be noted that the intracellular solution contained ImM magnesium ions. CVRs 
similar in shape to those discussed have also been reported in studies of IKca 
currents (Logsdon et a l, 1997; Ahn et al., 2004).
Charybdotoxin, which blocks both IKca and BKca channels, attenuated ATP- 
activated outward currents by a maximum o f-85%. Currents blocked by lOnM 
charybdotoxin reversed at -75mV and CVRs were approximately linear at potentials 
positive to the reversal potential.
An overlap of -50% occurred between UCL 1848- and charybdotoxin- 
sensitive components of ATP-activated currents. This finding is similar to that 
reported for apamin- and charybdotoxin- sensitive components of substance P- 
evoked currents (Frieden et al., 1999; Sollini et al., 2002). Neither apamin nor 
charybdotoxin are believed to significantly block IKca and SKca channels, 
respectively, at the concentrations used in these studies. Although IKca channel 
sensitivity to UCL 1848 has not been studied, UCL 1684, a structurally-related 
compound with near identical pharmacology, is ineffective at blocking IKca channels 
at a concentration of lOOnM (Malik-Hall et a l, 2000). Overlap of UCL 1848 and 
charybdotoxin sensitive current components is discussed in chapter seven.
Clotrimazole sensitivity of ATP-evoked currents was not as expected for two 
reasons. Firstly, currents were little sensitive to concentrations surrounding the 
published IC50S for block of IKca channels. Secondly, at 10jj,M, clotrimazole blocked 
a substantial proportion of the UCL 1848-sensitive current. The unexpected 
sensitivity of SKca channels to clotrimazole is discussed in chapter seven.
Currents blocked by lpM  clotrimazole reversed at -72mV and CVRs were 
approximately linear at potentials positive to the reversal potential. (It is noted that 
despite apparent SKca block by clotrimazole, none of the featured CVRs for
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clotrimazole-sensitive currents are inwardly rectifying as previously discussed; the 
reason for this is unclear).
As anticipated, when clotrimazole and UCL 1848 were applied in 
combination, ATP-evoked responses were completely abolished in all studied cells.
Iberiotoxin sensitivity of ATP-evoked currents was not determined in the 
present study, and thus a contribution by BKca channels cannot be ruled out. It has 
however been reported that substance P- and ATP-evoked potassium currents 
recorded from pig coronary artery- (Frieden et al., 1999; Bychkov et al., 2002) and 
mouse aortic- (Ahn et al., 2004) endothelial cells, respectively, are insensitive to 
iberiotoxin.
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5:4) Voltage-clamp studies: 1-EBIO-activated currents
5.4.1) Introduction
1 -EBIO is reported to activate SKca and IKca channels at similar 
concentrations, in a manner dependent on intracellular calcium. When studied using 
30nM free-calcium -containing intracellular (patch pipette) solution, cells in which 
currents were evoked by lOpM ATP, were insensitive to 300pM 1-EBIO (n=3).
Dialysing cells with an intracellular solution containing 500nM free-calcium 
did not itself activate maintained whole-cell currents. In these cells, however, 1 - 
EBIO activated sustained outward currents (for example see figure 5.29).
That 500nM free-calcium did not itself activate sustained currents is perhaps 
surprising in view of the known calcium-sensitivity of SKca and IKca channels (EC5o 
~500nM). It was noticed in some recordings, however, that a transient outward 
current occurred following entry into whole-cell configuration. An example of this 
can be seen at the beginning of the trace shown in figure 5.30. Although cells 
initially behaved as if  dialysed with the ‘30nM free-calcium’ solution, in some of the 
longer recordings an outward current began to develop several minutes following 
entry into whole-cell configuration. In a few recordings, it was also noticed that, 
following exposure to ATP, outward currents persisted. These findings may suggest 
that cells were temporarily able to buffer cytosolic calcium to a concentration at 
which Kca channels remained inactive.
5.4.2) Control recordings
The amplitude of 1 -EBIO-activated currents varied widely between 
recordings. In some cells, responses to ImM 1-EBIO were larger than those evoked 
by 300pM (for example see figure 5.29), although this was not always so. Where 1- 
EBIO activated currents were small, subsequent application of ATP evoked 
considerably larger responses (for example sqq figure 5.30).
In some recordings, voltage-ramps were applied prior to and at the peak of 
the response, providing CVRs for 1-EBIO-activated currents (for examples, see
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figure 5.31). Linear fits applied to each of these traces at potentials between -70 and 
-40mV/gave a mean reversal potential of -75.1±0.7mV (n=5).
5.4.3) Sensitivity of 1-EBIO-evoked currents to UCL 1848 and clotrimazole
In three cells to which it was applied, lOOnM UCL 1848 reversibly blocked 
1-EBIO-activated currents by 36, 49 and 86% (for an example, see figure 5.32).
1 fxM clotrimazole reversibly blocked a more consistent proportion of 1 - 
EBIO-activated currents (89.0±1.6% (n=4) (for an example see figure 5.33).
When applied in combination, UCL 1848 (lOOnM) and clotrimazole (lpM ) 
almost abolished 1-EBIO-activated currents in three recordings (for an example, see 
figure 5.34). In each case, outward currents reappeared following a return to 
extracellular solution containing only 1 -EBIO.
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Figure 5.29) Currents evoked by 1 -EBIO, recorded from pig right coronary artery endothelial cells 
dialysed with an intracellular solution containing 500nM free-calcium. Holding potential,
-50mV; pulse amplitudes, +50mV. Asterisks denote application of voltage-ramps (-120 to +50mV).
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Figure 5.30) Currents evoked by 300pM 1-EBIO and lOpM ATP, recorded from pig right 
coronary artery endothelial cells dialysed with an intracellular solution containing 500nM free- 
calcium. Holding potential, -50mV; pulse amplitudes, +50mV.
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Figure 5.31) CVRs for 1-EBIO-activated currents recorded from pig right coronary artery 
endothelial cells dialysed with an intracellular solution containing 500nM free calcium. Pink and 
purple traces are from cells exposed to 300pM and ImM 1-EBIO, respectively.
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Figure 5.32) Block by lOOnM UCL 1848 of a current evoked by ImM 1-EBIO, recorded from 
pig right coronary artery endothelial cells dialysed with an intracellular solution containing 
500nM free-calcium. Holding potential, -50mV; pulse amplitudes, +50mV. Asterisk denotes 
application of voltage-ramps (-120 to +50mV).
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Figure 5.33) Block by l(iM clotrimazole of a current evoked by ImM 1-EBIO, recorded from pig 
right coronary artery endothelial cells dialysed with an intracellular solution containing 500nM 
free-calcium. Holding potential, -50mV; pulse amplitudes, +50mV.
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Figure 5.34) Block by lOOnM UCL 1848 and lpM clotrimazole, of a current evoked by ImM 
1-EBIO, recorded from pig right coronary artery endothelial cells dialysed with an intracellular 
solution containing 500nM free-calcium. Holding potential, -50mV; pulse amplitudes, +50mV.
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5.4.4) Summary o f 1-EBIO-activated current data
The ability of 1-EBIO to activate currents in cells dialysed with 500nM- but 
not 30nM- free-calcium, is consistent with this agent modifying calcium-sensitivity 
of SKca and IKca channels rather than acting by an independent mechanism (Syme et 
al, 2000). 1-EBIO is reported not to activate BKca channels (Syme et al., 2000; 
Walker et a l, 2001).
Similar to ATP-evoked currents, 1-EBIO -activated currents reversed at 
-74mV and were mostly linear positive to this potential. When applied to the same 
cells, ATP evoked larger currents than 1-EBIO indicating that at the given cytosolic 
calcium-concentration, ImM 1-EBIO did not fully activate channels.
UCL 1848 reversed 1-EBIO current activation a variable degree (36-86%, 
n=3). Although it is established that SKca channels are activated by 1-EBIO (EC50 
for cloned SK3 channels: 170pM (Wittekindt et a l, 2004b), a previous study of pig 
coronary artery endothelial cells found 1-EBIO-activated currents to be insensitive to 
apamin, indicating no contribution by SKca channels (Bychkov et al., 2002).
Clotrimazole consistently blocked 1 -EBIO activated currents by -90%. This 
is in agreement with previous studies of pig coronary artery endothelial cells which 
found 1-EBIO activated currents to be charybdotoxin sensitive (Sollini et al., 2002; 
Burnham et a l, 2002).
As with ATP-evoked currents, clotrimazole apparently blocked a UCL 1848- 
sensitive component of 1-EBIO -activated currents. Co-application of UCL 1848 and 
clotrimazole essentially abolished 1 -EBIO-activated currents.
It is noted that in the present study, currents were sustained as long as 1- 
EBIO was present, unlike the transient activations reported by /Sollini et a l ,(2002)
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5.5) Voltage-clamp studies: Calcium-activated currents
5.5.1) Introduction
The hypothesis that calcium-activated potassium channels underlay agonist- 
evoked currents was tested by dialysing cells with an intracellular solution 
containing 1.5pM free-calcium. As with previously described voltage-clamp studies, 
the holding potential was set at -50mV with +50mV 200ms pulses applied at 0.5Hz.
+£<’«> 5,4uJu
In tfres£ studies, unlike those where cells were dialysed with 30nM- or 
500nM-free-calcium containing solutions, sustained outward currents began to 
activate immediately upon entry into the whole-cell configuration (see start of trace, 
figure 5.37). Outward currents reached stable plateaus within 30 seconds, at which 
point Kca channel blockers were applied (refer back to table 5.6 for a list of blockers 
and their IC50 values). As with agonist studies, current amplitudes varied greatly 
between cells.
In many recordings, plateau holding currents began to decrease within one 
minute of activation. This was caused by development of an opposing current(s) 
which gradually resulted in a large net inward current. Pulse amplitude increased 
noticeably as inward currents developed, and thus served as a useful indicator to 
distinguish the development of inward currents from the effect of Kca channel 
blockers. In order to maximise recording time prior to the development of delayed 
inward currents, no time was spent balancing capacitance transients or generating 
voltage ramps.
Owing to the immediate nature of current-activation following entry into 
whole-cell configuration, it was not possible to determine an accurate ‘resting’ 
current in these recordings. As a result, net outward currents could not be calculated. 
In order to compare the effects of Kca channel blockers in cells where the calcium- 
activated currents varied widely in amplitude, blocked currents are expressed as a 
percentage of the outward portion of the plateau (control) holding current. This 
presented no problem with most recordings, however in some, an inward holding 
current was apparent immediately following entry into whole-cell configuration, 
which then became net-outward as the outward current developed. Block of outward 
current in these cells revealed net inward current, and so, owing to the method of
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measurement used, some agents caused apparent block of more than 100%. To limit 
the skewing of data, which this inevitably caused, cells in which currents were 
blocked by >105%, were excluded from analysis.
Ideally, data would have been selected only from cells in which, following 
application of a Kca channel blocker, outward currents recovered upon return to 
blocker-free extracellular solution. However, since in many cells, contaminating 
inward currents began to appear before recovery could be established, data were also 
selected from cells in which inward currents occurred only after block had reached a 
plateau.
5.5.2) Control currents
Dialysis-activated currents, as with those evoked by ATP, varied 
considerably in amplitude between different cells. Whilst in some, no outward- 
current was activated, in others, currents exceeded 0.5nA.
The currents recorded in these experiments were not expressed as a function
of cell capacitance. However, some approximate comparisons relating to cell cluster
size and length of time in culture are presented in table 5.7. As with the ATP-studies,
dialysis-evoked outward currents appear to decrease with increasing time in culture.
Unlike the findings with ATP {section 5.3), current amplitudes do not appear to
increase with cluster size. This observation suggests that calcium from the patch
D(?f
electrode dialyses only into the cell to which it is attached, and doesjactivate 
channels in adjoining cells.
In a small number of recordings, including some where dialysis activated 
little or no outward current, lOpM ATP evoked a further outward current (figure 
5.35). It was initially supposed that, in clusters containing two or three cells, this 
resulted from activation of adjoining cells, however ATP-evoked responses were 
also observed in single cells. This indicates that, in these cells at least, 1.5pM 
calcium in the patch pipette did not fully activate Kca channels.
Though voltage-ramps were not performed routinely, two examples of ramps 
recorded at the peak of dialysis-activation are shown in figure 5.36; blue traces. Also 
plotted is a typical trace for an ATP-evoked current (red trace). Although gradients
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are different, reflecting difference in current size, the similar shape of the three traces 
suggest that ATP and calcium activate a similar population of channels. The dialysis- 
activated currents reverse at —60 and —70mV.
In studies described earlier, ATP was shown to evoke transient ‘early- 
inward’ currents in approximately 12% of recordings (see section 5.3.2.4). In 
contrast, in over 300 stable recordings, these currents were never observed in cells 
dialysed with 1.5pM free-calcium containing intracellular solution.
time in culture 
(days)
cluster size
single cell 2 3
2 93.2±22.5pA (15) 117.6±30.3pA (15) 99.6±25.7pA (7)
3 55.8±36.7pA (15) 55.1±18.1pA (15) -
4 29.0±12.7pA (3) - -
Table 5.7) Peak outward currents recorded from pig right coronary artery endothelial cells dialysed 
with 1.5|iM free-calcium containing intracellular solution. Data is mean ± standard error (sample 
size).
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Figure 5.35) A lOpM ATP-evoked outward current recorded from a pig coronary artery 
endothelial cell dialysed with an intracellular solution containing 1.5pM free-calcium. Entry into 
whole-cell configuration, hence onset of dialysis, is indicated by the red arrow. Holding potential, 
-50mV; pulse amplitudes, +50mV.
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Figure 5.36) Blue traces: current-voltage relationships of currents determined following 
stabilisation of activated outward currents. Data recorded from pig right coronary artery 
endothelial cells dialysed with an intracellular solution containing 1.5/zM free-calcium. For 
comparison, an equivalent ramp from the plateau of a cell response to lOpM ATP is shown (red 
trace); this cell was dialysed with an intracellular solution containing 30nM free-calcium.
5.5.3) Sensitivity o f calcium dialysis-activated currents to Kca channel 
blockers
5.5.3.1) UCL 1848 and apamin
At a concentration of lOOnM, UCL 1848 blocked net-outward currents by 
28.3±5.4% (n=27) when applied to cells immediately following stabilisation of 
currents. Where recordings were maintained without contamination by inward 
currents, this block fully reversed upon washout. Attempts at determining the 
concentration response relationship to UCL 1848 when applied at 1, 10 and lOOnM 
sequentially, were hampered by the appearance of inward currents prior to 
completion. When applied immediately following stabilisation of dialysis-activated 
currents, block by InM UCL 1848 was found not to be significantly less than for
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lOOnM; 19.0±6.2% (n=7) and 28.3±5.4% (n=27), respectively (unpaired one-tailed 
Student’s t-Test, P>0.05). However, in some individual recordings concentration- 
dependence of UCL 1848 block was clear (see figure 5.37).
lOOnM apamin, which was applied to a small population of cells, blocked 
20.6±5.0% (n=5) of the outward current. This is not significantly different from 
block by lOOnM UCL 1848 (unpaired one-tailed Student’s t-Test, P>0.05).
5.5.3.2) Clotrimazole
At a concentration of 1 pM, clotrimazole blocked net-outward currents by 
82.6±3.7% (n=22) when applied to cells immediately following stabilisation of 
currents. As with block by UCL 1848, where recordings were maintained without 
contamination by inward currents, clotrimazole block fully reversed upon washout.
In a number of cells, it was possible to sequentially apply rising 
concentrations of clotrimazole, and a concentration-response relationship was 
established for concentrations of 0.01, 0.1 and 1 pM (see figures 5.38 and 5.39).
5.5.3.3) UCL 1848 and clotrimazole in combination
In order to study the effect of the blockers in combination, cells were first 
exposed to either UCL 1848 or clotrimazole, and then to a combination of the two.
For two recordings in which cells were exposed first to lOOnM UCL 1848 
and then a combination of 1 OOnM UCL 1848 and 1 pM clotrimazole, mean block of 
net-outward current was 18.9 and 94.6%, respectively. For an example trace, see 
figure 5.40. For a further two recordings in which cells were firstly exposed to 1 pM 
clotrimazole and then a combination of lpM clotrimazole and lOOnM UCL 1848, 
mean block of net-outward current was 79.2 and 91.0%, respectively. For an 
example trace, see figure 5.41.
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Figure 5.37) Block by 10 and lOOnM UCL 1848 of an outward current recorded from a pig right 
coronary artery endothelial cell dialysed with 1.5jxM free-calcium containing intracellular 
solution. Entry into whole-cell configuration, hence onset of dialysis, is indicated by the red 
arrow. Holding potential, -50mV; pulse amplitudes, +50mV.
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Figure 5.38) Block by 0.01, 0.1 and lpM clotrimazole (CTZ) of an outward current recorded from 
a pig right coronary artery endothelial cell dialysed with 1.5pM free-calcium containing 
intracellular solution. Entry into whole-cell configuration, hence onset of dialysis, is indicated by 
the red arrow. Holding potential, -50mV; pulse amplitudes, +50mV.
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Figure 5.39: Clotrimazole sensitivity of net-outward currents recorded from pig right coronary 
artery endothelial cells dialysed with an intracellular solution containing 1.5pM free-calcium. 
Block is expressed as % dialysis activated net-outward control current. All measurements were 
taken at a holding potential of -50mV. Data are expressed as means. Bars represent standard 
error and labels indicate sample size.
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Figure 5.40) Block by lOOnM UCL 1848, then a combination of UCL 1848 and lpM 
clotrimazole (CTZ), of an outward current recorded from a pig right coronary artery endothelial 
cell dialysed with 1.5pM free-calcium containing intracellular solution. Entry into whole-cell 
configuration, hence onset of dialysis, is indicated by the red arrow. Holding potential, -50mV; 
pulse amplitudes, +50mV.
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Figure 5.41) Block by lpM clotrimazole, then a combination of clotrimazole and lOOnM UCL 
1848, of an outward current recorded from a pig right coronary artery endothelial cell dialysed 
with 1.5pM free-calcium containing intracellular solution. Entry into whole-cell configuration, 
hence onset of dialysis, is indicated by the red arrow. Holding potential, -50mV; pulse 
amplitudes, +50mV.
5.5.3.4) Charybdotoxin
When applied at a concentration of 1 OOnM, charybdotoxin blocked dialysis- 
activated net-outward currents by 101.2±0.5% (n=3). An example of current block is 
shown in figure 5.42. Where recordings were maintained without contamination by 
inward currents, charybdotoxin block fully reversed upon washout.
5.5.3.5) Iberiotoxin
In two recordings, lOOnM iberiotoxin blocked net-outward currents by 26.4 
and 30.9%. After iberiotoxin, cells were immediately exposed to lpM clotrimazole 
which blocked net-outward current by >105% in one cell, and 90.8% in the other, 
similar to data reported in section 5.5.3.2. An example trace is shown in figure 5.43.
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Figure 5.42) Block by lOOnM charybdotoxin of an outward current recorded from a pig right 
coronary artery endothelial cell dialysed with 1.5pM free-calcium containing intracellular 
solution. Entry into whole-cell configuration, hence onset of dialysis, is indicated by the red 
arrow. Holding potential, -50mV; pulse amplitudes, +50mV.
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Figure 5.43) Block by lOOnM iberiotoxin of an outward current recorded from a pig right 
coronary artery endothelial cell dialysed with 1.5pM free-calcium containing intracellular 
solution. Following iberiotoxin block, 1 pM clotrimazole was applied to cells. Entry into whole­
cell configuration, hence onset of dialysis, is indicated by the red arrow. Holding potential, 
-50mV; pulse amplitudes, +50mV.
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5.5.4) Summary o f  calcium-activated current data
When whole-cell recordings were made with patch electrodes containing 
1.5pM free-calcium, an outward holding current began to activate immediately upon 
entry into whole-cell configuration. Unlike ATP-evoked currents, current amplitudes 
were similar in clusters of one, two and three cells suggesting that dialysis raised 
calcium sufficiently to activate Kca channels only in the cell directly attached to the 
patch electrode.
For two cells in which voltage ramps were applied, CVRs were similar in 
shape to those for ATP-activated currents, reversing at -73 and -64mV. The latter 
value suggests that non- potassium-selective channels may also be activated by 
calcium. These may include calcium-activated non-selective cation currents which 
have been described in cultured pig coronary artery (Baron et al., 1996), rat carotid 
artery (Kohler et al., 2001) and mouse aortic (Suh et al., 1999) endothelial cells, and 
perhaps calcium-activated chloride channels; also present in many endothelial cells 
(Nilius & Droogmans, 2001).
The sensitivity of net-outward currents to SKca channel blockers varied 
greatly between recordings, the degree of block ranging from negligible to complete. 
The mean block was 28 and 21% with UCL 1848 and apamin, respectively. 1 pM 
clotrimazole blocked a more consistent component of net-outward currents (mean 
block 83%), however lOOnM charybdotoxin abolished net-outward currents when 
studied in three cells (mean block 101%). Iberiotoxin, a selective BKca channel 
blocker, inhibited net-outward current by a mean of 29% when applied at 1 OOnM.
That UCL 1848 and apamin blocked a relatively small and variable 
component of calcium-activated net-outward currents was surprising. Currents 
evoked by ATP and 1-EBIO had larger UCL 1848-sensitive components, so it seems 
likely that not all SKca channels were activated by calcium-dialysis. Consistent with 
this, ATP further increased outward holding currents when applied to a number of 
cells dialysed with 1.5pM free-calcium. Although at this calcium concentration,
SKca and IKca channels would both be expected to be maximally activated, 
incomplete dialysis at the time of ATP application, or unequal distribution of 
calcium throughout the cell coupled with an uneven expression pattern of SKca and 
IKca channels may explain this discrepancy. Furthermore, SKca channels are
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reported to be a little less sensitive to calcium compared with IKca channels (E C 5 0 S: 
300-700nM (Kohler et al., 1996) and 100-300nM (Joiner et a l , 1997; Ishii et a l , 
1997b), respectively).
The sensitivity of calcium-activated net-outward currents to iberiotoxin 
indicates a contribution by BKca channels. This was also suggested by sensitivity to 
charybdotoxin, which was significantly more effective at abolishing net-outward 
currents than clotrimazole; widely reported to have little BKca blocking activity at 
the concentration used (IC50 24pM (Wulff et a l, 2000)). Previous studies of cultured 
pig coronary artery endothelial cells have suggested that BKca channels are present, 
and, at potentials negative to +50mV, are gated only by intracellular calcium (Baron 
et a l, 1997; Frieden et a l, 1999). The single channel studies by Baron et a l  
suggested that when the inner face of the channel is exposed to 1 pM calcium, the 
open probability of the channel is -0.05 at -50mV (Baron et a l, 1997). Activation of 
BKca channels at potentials exceeding +50mV has also been described in freshly 
isolated pig coronary artery endothelial cells (Bychkov et a l, 2002). As CVRs 
performed in the present study were not continued to potentials beyond +50mV, this 
could explain the apparent absence of a BKca-attributable voltage-dependent 
component.
Although iberiotoxin may cause a small amount of IKca channel block at the 
concentration studied (IC 5 0 S 800nM (de Allie et a l, 1996), >lpM  (Logsdon et a l, 
1997)), this is unlikely to account for the 29% block of net-outward currents reported 
in the present study.
The large component of net-outward currents which was insensitive to UCL 
1848 and iberiotoxin, yet sensitive to clotrimazole and charybdotoxin is likely to be 
due to IKca channel activity.
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Chapter 6: Kca channel protein expression in 
pig endothelial cells
6.1) Introduction
Further to the electrophysiology studies which demonstrated the presence of 
Kca channels in pig coronary artery endothelial cells, fluorescence 
immunohistochemistry experiments were carried out to determine which channel 
proteins are expressed in these cultures.
Cells were immunostained using primary antibodies raised against the SK2, 
SK3 and IK1(SK4) channel proteins (refer back to table 2.1). Each of these have 
been designed to target an N- or C- terminal epitope unique to a specific SK or IK 
protein isoform (see appendices i, ii & iii). For some of the antibodies used, the 
target epitopes are highly conserved between species. For others, only specific 
orthologues are bound.
6.2) Protocol
All studies were performed using pig right coronary artery endothelial cells 
cultured for 2-3 days. In each experiment, primary antibodies were detected using a 
Cy3-conjugated secondary antibody.
Positive controls were carried out in HEK 293 cells transfected to over­
express the relevant channel protein11. To enable identification of Kca protein- 
expressing HEK cells, cultures were co-transfected with green fluorescent protein 
(GFP). Negative controls, whereby the primary antibody was omitted from the 
immunostaining procedure, were carried out in both pig coronary artery endothelial 
and HEK cells.
11 Kindly provided by DCH Benton
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All immunostained cells were viewed using a scanning laser confocal 
microscope. This allowed capture of ‘optical slice’ images, enabling resolution of 
membrane-delimited staining. Using negative control samples, the confocal detector 
gain was calibrated to minimise detection of non-specific (background) fluorescence 
in each experiment.
6.3) SK protein expression
6.3.1) SK2
SK2 expression was determined using the Ml primary antibody (see 
appendix i for epitope).
Though experiments were repeated on five occasions using Ml at dilutions 
between 1:20 and 1:200, no above-background fluorescence was detected in pig 
coronary artery endothelial cells.
In positive controls, however, primary antibody specific fluorescence was 
detected in the sub-plasmalemmal region of all SK2-transfected HEK cells {figure
6.1) (Ml dilution 1:200).
Pig SK2 has yet to be cloned and sequenced, however the epitope to which 
Ml has been designed is present in all currently cloned SK2 orthologues (bovine 
variants 1 &2, chicken, human variants 1 &2, mouse and rat).
Using a commercial antibody (Chemicon SK2) cco appendix i for-opitopo); 
peri-nuclear SK2 immunostaining has previously been reported in the endothelium 
of pig coronary artery sections (Burnham et al., 2002).
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Figure 6.1) Immunostaining of rSK2/GFP co-transfected HEK cells using the Ml primary 
antibody. The primary antibody has been detected using a Cy3-conjugated secondary antibody. 
Corresponding bright-field/fluorescence overlay and red fluorescence images are displayed in the 
left and right panels, respectively. Scale bar: lOjim.
6.3.2) SK3
SK3 expression was determined using the ‘Chemicon SK3’ primary antibody 
(see appendix ii for epitope).
In the majority of pig coronary artery endothelial cells, little could be seen in 
the way of above-background staining. However, in plaques in which some cells had 
become rounded during the immunostaining process, primary antibody specific 
membrane-delimited staining was apparent in the round, but not the flat cells (figure 6-2 
(‘Chemicon SK3’ dilution 1:200).
In positive controls, primary antibody specific membrane-delimited 
fluorescence also was detected in all SK3-transfected HEK cells (figure ^ ) £ - 2 c) 
(‘Chemicon SK3’ dilution 1:200).
The apparent absence of the SK3 protein in flat as opposed to rounded 
endothelial cells may simply reflect a difficulty in detecting membrane-delimited 
fluorescence signals in flat cells. Dense bands of staining are unlikely to be captured 
when viewing very flat cells since most of the membrane lies perpendicular to the 
optical path of the microscope. Conversely, an optical slice of a round cell is likely 
to contain membrane running more parallel to the light path, thus resulting in a 
greater density of the fluorescence signal.
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Figure 6.2) Immunostaining of pig right coronary artery endothelial cells using the Chemicon-SK3 
primary antibody (A) (panel B shows negative control, where primary antibody was omitted). Panel 
C shows a positive control carried out in rSK3-transfected HEK cells. In each case the primary 
antibody has been detected using a Cy3-conjugated secondary antibody (also present in the negative 
control). Corresponding bright-field and red fluorescence images are displayed in the left and right 
panels, respectively. Scale bars: 50pm (A) and 20pm (B&C). Arrows in panel B indicate rounded 
cells similar to those stained in panel A.
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6.4) IK protein expression
IKl expression was determined using both the M4 (anti hIKl) and R212 (anti 
rIKl) primary antibodies (see appendix iii for epitopes).
Though experiments were repeated on five occasions using each antibody at 
dilutions between 1:20 and 1:200, no above-background fluorescence was detected 
in pig coronary artery endothelial cells.
In positive controls, primary antibody specific membrane-delimited 
fluorescence was detected only in HEK cells transfected with the corresponding IKl 
orthologue {figures 6.3 & 6.4) (1:200 dilution used for both antibodies).
Since the target epitope of neither antibody is an exact match for the 
corresponding pig IKl amino acid sequence, the lack of above-background staining 
may be due to poor binding of the primary antibodies.
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Figure 6.3) Immunostaining of hIKl/GFP co-transfected HEK cells using the M4 primary 
antibody. The primary antibody has been detected using a Cy3-conjugated secondary antibody. 
Corresponding bright-field/fluorescence overlay and red fluorescence images are displayed in the 
left and right panels, respectively. Scale bar: 20pm.
Figure 6.4) Immunostaining of an rIKl/GFP co-transfected HEK cell using the R212 primary 
antibody. The primary antibody has been detected using a Cy3-conjugated secondary antibody. 
Corresponding bright-field/fluorescence overlay and red fluorescence images are displayed in the 
left and right panels, respectively. Scale bar: 20pm.
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6.5) Summary of channel protein expression data
These studies have provided evidence of SK3 channel protein expression in 
pig coronary artery endothelial cells, however antibody staining did not demonstrate 
the presence of SK2 or IKl proteins. SK2 and SK3 have previously been identified 
in the endothelium of pig coronary artery sections, using fluorescence 
immunohistochemistry and Western blotting (Burnham et al., 2002). IKl has also 
been cloned from the same preparation (Bychkov et al., 2002).
The reasons that SK2 and IKl were not detected in the present study are 
unclear, but the antibodies used have previously been shown to selectively label the 
respective channel proteins (Chen et al., 2004; Bahia et al., 2005). Although the 
porcine SK2 amino acid sequence has not been published, the epitope to which the 
anti-SK2 antibody is raised (see appendix i) is completely conserved between 
human, rat, mouse, bovine, and chicken orthologues. It is likely therefore that 
porcine SK2 will also contain this sequence. The epitopes to which the IKl 
antibodies are raised (see appendix iii) are only partially conserved in the porcine 
IKl orthologue, indicating that these antibodies may not bind well. Failure to detect 
fluorescence in cells exposed to the SK2 and IKl antibodies may also have resulted 
from a low channel density exacerbated by the narrow cross-section of the cultured 
cells.
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Chapter 7: Discussion
7.1 Foreword
For the past twenty-five years, our laboratory has had an interest in calcium- 
activated potassium channels, in particular the SKca and IKca subtypes.
In the mid-1990’s, pharmacological evidence began to emerge of the 
involvement of SKca and IKca channels in EDHF-mediated vasodilation. At this 
time, the relevant channels were believed to be located on vascular smooth muscle 
cells. However, their location was later reconsidered and is now thought to be the 
endothelium, consistent with earlier studies of endothelial cell electrophysiology.
Of particular interest was the frequent observation that neither apamin nor 
charybdotoxin affected EDHF responses when applied alone, yet abolished when 
administered in combination. This led to speculation in the literature that these toxins 
may target a single novel channel with highly unusual pharmacology.
At the outset of this project in 2001, there were few published studies of the 
SKca and IKca currents which underlay EDHF. Up to this time, the majority of 
conclusions regarding SKca and IKca contribution to the EDHF pathway stemmed 
from the high selectivity of the peptide blockers apamin, charybdotoxin and (to 
distinguish IKca from BKca) iberiotoxin.
It was therefore intended that this study should shed light on the relative 
contribution of SKca, IKca and any novel Kca channel to agonist-evoked endothelial 
cell hyperpolarisation. It was also our intention to identify which of the three SKca 
channel proteins are expressed in vascular endothelial cells.
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7.2) Choice of tissue preparation
At the outset of the study it was undecided whether endothelial cells should 
be investigated immediately following isolation, or established as primary cultures. 
Acute study ensures that the cell phenotype is preserved, but dispersal of cells using 
proteolytic enzymes risks modifying or even destroying cell-surface receptors. The 
advantage of primary culture is that it can provide a convenient source of cells over a 
period of days. However protein expression may alter during culture. BKca channels 
for example are not expressed in endothelium freshly isolated from bovine coronary 
arteries, yet appear following several days of primary culture (Gauthier et al.,
2002b). Conversely, in some endothelial cells, agonist-evoked potassium currents 
begin to disappear after a few days in culture (Frieden et al., 1999; Ahn et a l , 2004).
Endothelial cells were sourced from vascular beds in which EDHF-mediated 
vasodilation had been established. Initial efforts were focussed on isolating cells 
from rat superior mesenteric artery and to a lesser extent rat aorta and carotid artery. 
Numerous unsuccessful attempts were made at enzymatic dispersal of endothelial 
cells from these vessels. Protocols were followed or adapted from the few published 
accounts of endothelial cell isolation from small mammal vessels. Subsequent 
attempts at mechanical isolation were similarly without success.
An alternative method of producing isolated rat vascular endothelial cells is 
by way of explant culture (McGuire & Orkin, 1987). In the present study, explant 
cultures gave rise to large yields of cells morphologically similar to those pictured in 
the McGuire & Orkin paper. These cells did not, however, give rise to the 
electrophysiological responses expected from endothelial cells, and moreover did not 
internalise aLDL or express von Willebrand factor. Based on these findings, it was 
concluded that the explant cells were not of an endothelial phenotype and more 
likely to be fibroblasts or smooth muscle cells. It is noted that similar methods are 
commonly used for the purpose of culturing smooth muscle cells.
In light of continued difficulties with isolating rat endothelial cells, an 
alternative vascular bed was considered. Published work suggested that porcine or 
bovine arteries may be a suitable source of endothelium, and that vessels of large 
mammals are particularly suited to endothelial cell isolation.
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Pig coronary arteries were selected because endothelial SKca and IKca 
channels had recently been reported in this vascular bed (Frieden et al., 1999; 
Burnham et al., 2002; Sollini et al., 2002; Bychkov et al., 2002). Owing to the time 
consuming process of collecting the tissue, it was considered more economical to 
establish primary cultures rather than to attempt studies on acutely isolated cells. 
Concurrent with the literature, pig coronary artery endothelial cells proved 
straightforward to culture, and their identity was subsequently confirmed through 
their ability to internalise aLDL.
7.3) Contribution of SKca and IKca channels to calcium 
mediated changes in endothelial cell membrane potential
Initially, large rafts of cells were exposed to various ‘EDHF-activating’ 
agonists which each evoked substantial hyperpolarisations.
Interestingly, it was noted that bradykinin evoked significantly larger 
responses
hypeq^plartsations than either ATP or substance P, consistent with a previous study 
in which bradykinin caused a larger rise in cytosolic calcium than substance P 
(Frieden et a l, 1999). During current-clamp studies it was also determined that 
hyperpolarisations to each of the agonists were predominantly due an increase in 
potassium ion conductance. However, the peak hyperpolarisation was less negative 
than Ek- Replacing chloride by a less permeant anion increased the amplitude of 
responses suggesting that the peak hyperpolarisation may have been limited by 
chloride conductances.
In voltage-clamp studies of small cell clusters, ATP, 1-EBIO and 1.5pM 
intracellular calcium each evoked outward whole-cell currents. Current-voltage 
relationships of these were consistent with a predominant activation of potassium 
conductances.
The potent novel SKca channel blocker, UCL 1848 maximally blocked -65% 
of ATP-evoked outward currents and 36-86% of 1-EBIO-activated currents (range 
given as only three cells were studied). In cells dialysed with 1.5pM free-calcium, 
UCL 1848 blocked net-outward currents by a variable degree with a mean block of 
only 28%. The difference in % current block according to the method of activation is
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possibly due to 1.5pM calcium failing to activate the entire SKca channel population 
(see section 5.5.4 for comment).
The IKca/BKca channel blocker charybdotoxin maximally blocked -85% of 
ATP-evoked currents but abolished net-outward currents in cells dialysed with 
1.5pM free-calcium. That charybdotoxin blocked the entire net-outward current was 
unexpected. However it is possible that in these cells, as with others, there was little 
or no UCL 1848-sensitive component present. Alternatively, any small UCL 1848- 
sensitive component may have been masked by an inward component of the 
activated current, and was not therefore observed.
Although there have been no detailed pharmacological studies of BKca 
channel contribution to ATP-evoked currents in pig coronary artery endothelial cells, 
currents evoked by substance P are known to be insensitive to iberiotoxin (Frieden et 
al., 1999; Bychkov et al., 2002). ATP-evoked currents recorded from cultured mouse 
aortic endothelial cells are also insensitive to iberiotoxin (Ahn et al., 2004). On the 
other hand, bradykinin, which in this study evoked hyperpolarisations distinct from 
those of ATP and substance P, has been shown to evoke iberiotoxin-sensitive 
currents in cultured pig coronary artery endothelial cells (Frieden et al., 1999). This 
finding has since been challenged, however, in a study of freshly isolated pig 
coronary artery endothelium (Bychkov et al., 2002). Based on the available 
evidence, it would seem unlikely that BKca channels contributed to ATP-evoked 
currents in the present work. As BKca channels have nevertheless been reported in 
pig coronary artery endothelial cells, their contribution to calcium-dialysis -activated 
currents was investigated. lOOnM iberiotoxin blocked -30% of the current indicating 
that BKca(were active under these conditions.
Clotrimazole was applied to cells on account of its IKca blocking activity, but 
appeared to inhibit both charybdotoxin- and UCL 1848-sensitive currents. This was 
true of currents evoked by ATP, 1-EBIO and calcium-dialysis. The finding was 
unexpected and is not easily explained (see section 7.4.5 for discussion). Further 
work would be needed to determine whether this finding relates to a genuine novel 
effect o f clotrimazole on porcine SKca channels, or is an experimental anomaly.
Rundown of ATP-evoked currents made the measurement of block 
particularly difficult. Both UCL 1848 and charybdotoxin inhibition were, however, 
measured and analysed using the same criteria. The calculated block o f 65% and 
85% by UCL 1848 and charybdotoxin, respectively, is therefore a likely reflection of
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relative contribution of SKca and IKca channels to ATP-evoked currents, though 
some uncertainty remains. The overlap of block in response to UCL 1848 and 
charybdotoxin is further considered in section 7.4.4.
In relation to the subtype of SKca channels expressed in pig coronary artery 
endothelial cells, the IC50 for UCL 1848-sensitivity o f the ATP-evoked outward 
current (1.2nM) is close to that for block of cloned rSK3 (2.1nM) (Hosseini et al., 
2001) and hSKl (l.lnM ) (Shah & Haylett, 2000) channels. The published IC50 for 
UCL 1848 block ofrSK2 channels is O.lnM (Hosseini et al., 2001).
Additionally, using fluorescence immunohistochemistry, it was possible to 
identify expression of SK3 proteins in cells cultured for this study. This is in 
agreement with the recent cloning of SK3 from the endothelium of pig coronary 
arteries (Burnham et al., 2002).
7.4) Issues raised during the present studies
7.4.1) Low resting membrane potentials
The resting membrane potential (Em) of endothelial cells is reported to vary 
considerably according to originating species and vascular bed (ranging from 0 to 
-80mV) (Nilius & Droogmans, 2001). Ems recorded in the present study (mean 
-5.9mV), however, were considerably lower than those reported in published studies 
of isolated pig coronary artery endothelial cells {table 7.1). Values recorded in the 
present study were consistent in all ~100 batches of cells cultured; standard deviation 
of mean Em was low, and no outliers were excluded. Furthermore, no significant 
difference was found between Em of cells cultured for two and four days (refer to 
figure 5.1).
To establish the cause of low membrane potentials, culture media and 
experimental salt solutions were in turn substituted for those used in a published 
study of cultured pig coronary artery endothelial cells (reported mean Em -29.7mV) 
(Sollini et al., 2002). Neither substitution made a difference to Em values recorded in 
the present study. When a small number of cells were impaled with KCl-filled
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intracellular electrodes, Ems were similar to those recorded under current-clamp 
conditions (data not shown).
The high input resistance of single endothelial cells is indicative of a low 
resting conductance. Accordingly, a small change in the number and/or type of open 
channels will have a large impact on resting membrane potential. Inwardly rectifying 
potassium channels are generally considered to underlie the negative resting 
membrane potential of endothelial cells (Nilius & Droogmans, 2001). However 
when studied under voltage-clamp, small inwardly-rectifying components of whole­
cell currents were observed in only of cells (refer to figure 5.10).
Whilst it was not established that culture conditions were the reason for low 
membrane potentials, it seems unlikely that an undetermined difference in animal 
strain would account for such a change. In the absence of an obvious cause, it is 
tentatively suggested that a culture-related down-regulation of inwardly rectifying 
potassium channels may underlie this discrepancy.
Vessel Preparation Method Mean Em Reference
LAD/R 2-5 day culture IC/ CC -29.7mV
(Sollini et al., 
2002)
LAD/epi
culture
duration not given
IC -32.3mV
(Olanrewaju 
et al., 2002)
LAD/cir 24hr culture cc -42mV
(Sharma & 
Davis, 1994)
Table 7.1) Mean resting membrane potentials reported in studies of isolated pig coronary artery 
endothelial cells. Abbreviations: left anterior descending coronary artery (LAD), right coronary 
artery (R), epicardial coronary artery (epi), circumflex coronary artery (cir), intracellular electrode 
recording (IC), current-clamp recording (CC), resting membrane potential (Em).
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7.4.2) Comment on the relationship between potassium permeability and 
membrane potential
It is frequently reported in studies of EDHF-mediated vasodilation that 
applying either an SKca- or an IKca-channel blocker makes little difference to 
smooth muscle hyperpolarisation and vasodilation, yet when the same blockers are 
applied in combination, EDHF responses are abolished. Though it has been 
suggested that this may imply the presence of a novel channel with highly unusual 
pharmacology, this phenomenon may simply be due to the non-linear relationship 
between potassium permeability and membrane potential.
To illustrate this, arbitrary values of potassium permeability ( P k)  can be 
substituted into the Goldman-Hodgkin-Katz voltage equation, and the relationship 
between Pk and membrane potential predicted (figure 7.1). Because in the present 
study, ion substitution experiments suggested a contribution by chloride channels to 
endothelial cell membrane potential, the effect of a constant chloride conductance 
has been factored into the calculation. Conversely, since sodium substitution made 
no measurable difference to ATP-evoked hyperpolarisations, a contribution by 
sodium ions will be disregarded for the sake of simplicity. Values relating to ionic 
gradients and temperature are based on the standard conditions used in the present 
study.
Assuming the black trace in figure 7.1 to be representative of the 
PK/membrane potential relationship for a given cell, we see that increasing Pk from 0 
to 20 results in a hyperpolarisation of 62mV. Further increasing Pk by the same 
amount again, however, only hyperpolarises the cell by an additional 8mV.
We can apply this relationship to a theoretical cell in which full activation of 
IKca and SKca equally contribute to a Pk of 80 (refer to figure 7.1). Blocking either 
the SKca or the IKca component, hence reducing Pk to 40, only reduces the 
membrane potential from -78mV to -73mV; a reduction of 6%. Under experimental 
conditions, this small difference may not even be detectable. Consistent with this, it 
was noted in the present study that despite a large reduction in ATP-evoked 
conductance when cells were cultured for more than two days, ATP still evoked 
large hyperpolarisations in cells cultured for three days.
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Figure 7.1) The relationship between PK and membrane potential, accounting for different values 
of Pci- Each curve is plotted using the modified GHK equation given below. Values used were: 
thermodynamic gas constant (R) 8.31 J/K/mol, temperature (T) 298°K, Faraday’s constant (F) 
96500 C/mol, external potassium ion concentration ([K+]0) 5mM, internal potassium ion 
concentration ([K+]j) 140mM, external chloride ion concentration ([Cl']0) 135mM, internal 
chloride ion concentration ([Cl'D 134mM. Other abbreviations: reversal potential (Erev), 
potassium ion permeability (PK), chloride ion permeability (Pci)-
Goldman-Hodgkin-Katz voltage equation: Erev = — ln ^K^  k + p Na[Na ]0 + P cl[CI ],
F PK[K+]i+PNa[Na+]i+Pci[Cr]o
Equation used to construct graphs in figure 7 .1 : Erev = ^ - I n  P|^ K ^  +F>CI^ 1
F PK[K+]i+PCi[Cr]c
The relevance of the above modelling on the EDHF response as a whole will 
depend largely on the events which constitute the remainder of the EDHF response. 
If endothelial cell membrane potential per se is critical, for example in maintaining a 
driving force for calcium-entry, then this may be a valid explanation of how currents 
can be partially blocked without affecting smooth muscle relaxation. If however,
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EDHF is due to release of potassium ions or the activity of myoendothelial gap 
junctions, then membrane potential of the endothelium is of less significance than 
the underlying potassium ion conductance. If this is true then it is more difficult to 
reconcile how a drop in endothelial cell potassium conductance does not directly 
translate to a similar reduction in smooth muscle hyperpolarisation and relaxation. 
This may of course be explained by yet unidentified redundancy further downstream 
in the EDHF pathway.
Figure 7.1 also serves to illustrate the effect of a small, constant chloride 
permeability (Pci) on the PK/membrane potential relationship. Increasing Pci 
effectively limits the membrane potential that can be obtained by increasing PK. This 
is particularly relevant because, in a cell, PK will be finite. In the present study, in 
which a chloride conductance was identified, cells rarely hyperpolarised beyond 
-65mV. This is short of both the calculated EK (-8 6 mV) and the reversal potential of 
SKca/IKca currents (-73 to -75mV; measured in voltage-clamp experiments, see 
section 7.4.3 for comment).
7.4.3) Possible changes in EK consequent on potassium channel 
activation
The calculated Ek for experiments in which ATP-evoked currents were 
studied was -8 6 mV, however the measured mean reversal potential for ATP-evoked 
currents was -72mV. It was initially supposed that this discrepancy could for 
example be due to the chloride conductance identified in current-clamp studies, 
however currents blocked by UCL 1848, charybdotoxin and clotrimazole, or 
activated by 1-EBIO also reversed in the region of -72 to -75mV. Interestingly, 
similar discrepancies in EK are apparent in comparable published studies, but often 
receive little comment. A recent study of mouse aortic endothelial cells has, 
however, questioned the selectivity of identified IKca channels (Ahn et al., 2004).
In the present study CVRs were determined at the plateau of each ATP 
response, hence several seconds into the outward current. Ek may therefore have 
changed as a consequence of the sustained outflow of potassium ions.
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This can be considered as follows:
Based on the volume of a disc 20pm in diameter and 1 pm in depth, an 
endothelial cell would have an approximate volume of 300fl. During the plateau of a 
200pA outward holding current (typical for a single cell), it is calculated that a cell 
would lose intracellular potassium at an initial rate of ~5%/s. Whilst potassium from 
the patch electrode would counteract this loss, constant flux of potassium ions may 
also raise the external potassium concentration in a localised region immediately 
outside the cell perimeter.
Although it would be difficult to calculate accurately the diffusion of 
potassium from the patch electrode into the cell and the localised external potassium 
concentration in a flowing bath, the effect of small potassium concentration 
adjustments on EK can be considered.
The values in table 7.2 demonstrate that relatively small changes in 
intracellular and/or localised extracellular potassium concentration could shift EK by 
+10mV.
One expectation of this phenomenon is that any shift in Ek will be 
proportional to the potassium conductance of a given cell. In the present study, 
however, no such correlation was identified. It is unclear therefore whether 
potassium flux accounts for the discrepancies in potassium reversal potential 
reported in the present study.
RT [X+]
Nernst equation for calculating reversal potential of a given ion (X): Ex = ——In— ^zF [X ]j
RT TK+1
Equation used to derive values in table 7.2: EK = -= -ln —
F [K ]j
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[K*]0 (m M )
localised
[ K l  (m M ) E k (m V )
8 140 -7 3
7 130 -75
6 110 -75
5 90 -7 4
Table 7.2) The effect of altering localised potassium gradient on values of EK. Values were calculated 
using the Nemst equation for potassium ions given on the previous page. Values used were: 
thermodynamic gas constant (R) 8.31 J/K/mol, temperature (T) 298°K, Faraday’s constant (F) 96500 
C/mol. Other abbreviations: reversal potential for potassium (or ion X) (EK (or x>), valency (V), 
external concentration of potassium (or ion X) ([K+ (or X)]0), internal concentration of potassium (or 
ionX) ([K+(orX)]0.
7.4.4) Overlap of UCL 1848- and charybdotoxin-sensitive current 
components
In the present study, UCL 1848 and charybdotoxin maximally blocked ATP- 
evoked whole cell currents by 65 and 85%, respectively. As previously discussed, 
these agents are believed to be reasonably selective for SKca and IKca channels, 
respectively, at the concentrations used {table 5.6). As blockers were always studied 
in different cells, the apparent overlap in block between the two agents may simply 
be due to intercellular variability of the relative proportion of SKca and IKca 
channels. However, this overlap is worthy of consideration, not least because similar 
findings have been reported in another study. In two separate publications on 
cultured pig coronary artery endothelial cells, Beny and colleagues have reported 
that 1 jiM apamin and 50nM charybdotoxin block substance P-evoked currents by 
65% and 80%, respectively (Frieden et a l , 1999; Sollini et al., 2002).
In light of these findings, it is tempting to speculate on the existence of 
heteromeric Kca channels which comprise both SKca and IKca subunits, and are 
sensitive to both SKca and IKca channel blockers. At present, however, there is no
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published evidence that such channels exist; indeed preliminary data from our 
laboratory suggest that when co-transfected into HEK cells, cloned hIKl subunits do 
not co-assemble with hSKl (Monaghan et al., 2004) or hSK2 (unpublished 
observations by YA Shah).
7.4.5) Sensitivity o f SKca channels to clotrimazole
In the present study, clotrimazole was applied to cells with the intention of 
selectively blocking IKca channels. The resulting data, however, suggests that at 1 
and lOpM, clotrimazole also substantially blocked the UCL 1848-sensitive 
component. This was surprising because, compared to IKca channels, SKca channels 
are regarded as relatively insensitive to clotrimazole (IC50S: 21pM (hSK2), 28pM 
(hSK3) (Wulff et al., 2000), insensitive to lOpM (hSK3) (Carignani et al., 2002)).
As the clotrimazole-sensitivity of pig SKca channels has not been studied 
elsewhere, it was considered whether porcine SK3 (cloned from pig coronary artery 
endothelium) may contain a binding site for clotrimazole. Two amino acid residues 
located in the pore-forming region (threonine250) and the S6 transmembrane domain 
(valine275) of the IKl protein have recently been identified as necessary for 
clotrimazole sensitivity of IKca channels (Wulff et al., 2 0 0 1 ). These residues are not, 
however, present in the porcine SK3 orthologue (Burnham et al., 2002). In fact, so 
conserved is the SK3 sequence between species that the amino acid sequence is 
identical between porcine, human and rat orthologues in all but the N and C termini. 
In total, porcine SK3 is 93% identical to the human orthologue. On the basis of 
sequence therefore, there is little reason to suppose that porcine SK3 would be any 
more susceptible to clotrimazole block than the human or rat orthologues.
On account of its cP450 blocking activity, a number of studies have 
investigated the clotrimazole sensitivity of EDHF-mediated vasodilation. In pig 
coronary arteries, 3pM clotrimazole reportedly abolished bradykinin-evoked EDHF- 
mediated dilation in one study (Popp et al., 1996), yet in others concentrations of 10- 
lOOpM caused only partial inhibition (Hecker et al., 1994; Weintraub et al., 1994; 
Ishizaka & Kuo, 1997). This is inconsistent with the present findings because the
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activity of endothelial SKca and IKca channels appears to be essential for EDHF- 
mediated vasodilation.
It has been reported in voltage-clamped mouse aortic endothelial cells that 
both clotrimazole and charybdotoxin unexpectedly inhibit ATP-evoked rises in 
cytosolic calcium (Ahn et a l, 2004). If this occurred in the present study, it could 
account for the absence of an SKca channel component of ATP-evoked currents. 
However, clotrimazole also blocked a substantial portion of the UCL 1848-sensitive 
current in cells stimulated with 1-EBIO or dialysed with 1.5pM free-calcium.
One further consideration is that clotrimazole was dissolved in DMSO, so 
when applied at lOpM, cells would have been exposed to 0.1% solvent. Although no 
vehicle controls were performed in the present studies, this concentration of DMSO 
has no noticeable effect on cloned human or rat SKca channel subunits expressed in 
HEK cells (unpublished observations by DCH Benton).
The reason for clotrimazole-inhibition of UCL 1848-sensitive currents 
therefore remains unresolved.
7.5) Difficulties encountered
Though pig coronary artery endothelial cells were cultured with a high 
success rate, electrophysiological studies were challenging in the extreme. In terms 
of obtaining recordings, the ability of electrodes to form gigaseals with cells varied 
considerably, as did the ease of conversion into whole-cell configuration. Cells from 
many apparently healthy cultures were simply ‘un-patchable’.
In all electrophysiology studies, electrodes were mounted on water- or oil- 
filled micromanipulators. The sub-micron drift associated with this equipment is 
barely noticeable when studying large cells such as neurones or cell lines, however, 
this movement proved destructive when recording from endothelial cells with a 
depth of ~1 pm. A countless number of recordings were lost due to this problem.
Rundown of agonist-evoked responses was perhaps the most frustrating of 
issues since this affected recordings in which whole-cell configuration had been 
achieved and maintained for several minutes. In preliminary studies, it was 
ascertained that rundown still occurred when ATP was included in the intracellular
196
solution. The perforated patch technique often allows more stable recordings and 
was also attempted; but despite many attempts, successful recordings were not 
achieved.
Electrophysiological studies remained demanding throughout, particularly 
where recording stability was required for more than a couple of minutes. In 
particular, it took several months to record data sufficient to construct concentration- 
inhibition relationships for block of ATP-evoked currents. The slow rate of progress 
meant that I was regrettably unable to pursue investigation of novel channel- 
blocking compounds and carry out further biochemical studies.
7.6) Future studies
To more satisfactorily answer questions raised in this study, a number of 
further experiments would be necessary.
In order to carry out further electrophysiological work, it would be 
economical to improve conditions related to recording stability and response 
rundown. This would include the use of low-drift micromanipulators, and further 
attempts at using the perforated patch technique. Altering culture conditions with the 
aim of reducing channel down-regulation would also be beneficial.
It would be a valuable exercise to study the effects of UCL 1848 and 
charybdotoxin on ATP-evoked hyperpolarisation. It is likely that activation of only a 
portion of channels is necessary for maximal hyperpolarisation; therefore it would be 
interesting to determine whether a full response is possible when either SKca or IKca 
channels are fully blocked.
The apparent sensitivity of SKca channels to clotrimazole suggested in the 
present study requires further investigation. It would be useful therefore to establish 
more precisely the concentration-inhibition curve for clotrimazole block of ATP- 
evoked currents. This would include studying clotrimazole at concentrations of 0.3 
and 3pM to enable curve fitting of the concentration-inhibition relationship. Direct 
application of clotrimazole to isolated pig coronary artery endothelial cell membrane 
patches containing SKca channels, could further help in the explanation of this 
finding.
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Although it is not believed that ATP-evoked currents comprise a BKca 
channel component, this could be simply verified using iberiotoxin. Additionally, 
charybdotoxin block of ATP-evoked currents should be further studied at sub- 
maximal concentrations to fully determine the concentration-inhibition relationship.
In addition to SKca channel blocking agents such as UCL 1848 and UCL 
1684, our laboratory has contributed to the design of potential IKca channel blockers 
(Roxburgh et al., 2001). A number of these compounds have yet to be fully 
characterised, so it would be interesting to investigate the pharmacology of these 
agents on pig coronary artery endothelial cells and EDHF-mediated vasodilation.
Despite only partial success with fluorescence immunohistochemistry 
studies, using the same primary antibodies for Western blot experiments would be 
likely to overcome potential detection problems caused by low expression of protein. 
If, as determined by Burnham et al., the SK2 as well as the SK3 channel protein is 
found to be present, it would be useful to clone and sequence this channel.
7.7) Concluding remarks
At the outset of this study, the majority of published electrophysiological data 
regarding EDHF-mediated vasodilation were limited to measurements of smooth 
muscle cell hyperpolarisation. Over the past few years however, single channel 
electrophysiology and protein expression studies have confirmed the presence of 
SKca and/or IKca channels in the endothelium of rat aorta (Marchenko & Sage,
1996), human mesenteric artery (Kohler et al., 2000) rat carotid artery (Kohler et al., 
2001), pig coronary artery (Burnham et a l , 2002; Bychkov et al., 2002), mouse 
mesenteric artery (Taylor et al., 2003) and mouse aorta (Ahn et al., 2004). In vessels 
where SKca channels are present, SK3 but not SKI protein has been detected. SK2 
expression, however, appears to be varied, being absent in rat carotid artery 
endothelium (Kohler et al., 2001), present only in the nuclear region of pig coronary 
artery endothelium (Burnham et al., 2002), and becomes up-regulated in human 
saphenous vein endothelial cells exposed to shear stress (Sultan et al., 2004).
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The lack of endothelial SKca channels in some vascular beds is consistent 
with EDHF-mediated vasodilation being completely inhibited by charybdotoxin in 
these vessels.
It still remains the case that few studies have investigated the contribution of 
SKca and IKca channels to endothelial whole-cell currents. Unlike single-channel 
studies which can be performed on isolated membrane patches, whole-cell voltage- 
clamp experiments require separation of individual endothelial cells. As discussed in 
this thesis, this can be technically difficult and culturing endothelial cells is not 
without drawbacks. Just as important, the geometry of endothelial cells makes their 
study a daunting prospect for electrophysiologists.
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Appendix i
Amino acid sequence alignment for the human (h) and rat (r) orthologues of SK2
(pig SK2 has yet to be identified)
hSK 2 MSSCRYNGGVMRPLSNLSASRRNLHEMDSEAQPLQPPAS-VGGGGGASSPSAAAAAAAAV 5 9
rS K 2 MSSCRYNGGVMRPLSNLSSSRRNLHEMDSEAQPLQPPASWGGGGGASSP SAAAAA 5 6
* * * * * * * * * * * * * * * * * * . * * * * * * * * * * * * * * * * * * * *  * * * * * * * * * *  . * * * *
hSK 2
rSK 2
hSK 2
rSK 2
hSK 2
rSK 2
hSK 2
rS K 2
hSK 2
rSK 2
hSK 2
rSK 2
SSSAPEIWSKPEHNNSNNLALYGTGGGGSTGGGGGGGG SGHGSSSGTKSSKKKNQ 1 1 5
SSSAPEIWSKPEHNNSNNLALYGTGGGGSTGGGGGGGGGGGGSGHGSSSGTKSSKKKNQ 1 1 6  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  * * * * * * * * * * * * * * * * *
TMD1
NIGYKLGHRRALFEKRKRLSD
NIGYKLGHRRALFEKRKRLSD
* * * * * * * * * * * * * * * * * * * * *
TMD 2
if AL IFG M FG IW M VIE  
if A LIFG M FG IW M V IE  
* * * * * * * * * * *  *  * * * *
rELSWGAYDKASLYSLALKC
rELSWGAYDKASLYSLALKC
* * * * * * * * * * * * * * * * * * * *
TMD 3
I S  1 7 5  
L IS  1 7 6
* * * * * * * * * * * * * * *
LSTIILLGLIIVYHAKEIQLFMVDNGADDWRIAMTYE
L S T IIL L G L I IVYHA KEIQLFMVDNGADDWRIAMTYE 
* * * * * * * * * * * * * * * * * * * * * * *
TMD 4
R IF F IC L E IL V C A IH P IP G N
R IF F IC L E IL V C A IH P IP G N
•k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k
ifTF 2 3 5  
ifTF 2 3 6
TWTARLAFSYAPSTTTADVD
TWTARLAFSYAPSTTTADVDlE
* * * * * * * * * * * * * * * * * * * *
IILSIPM FLRLY LIAR VM LLH SK LF I  
ILSIPM FLRLYLIARVM LLHSKLF T
* * * * * * * * * * * * * * * * * * * * * * * * *
D ASSR SIG A LNK IN  2 9 5  
D ASSR SIG A LNK IN  2 9 6  
* * * * * * * * * * * * * * *
TMD 5
FNTRFVMKTL
FNTRFVMKTL
* * * * * * * * * * *
P-loop
M TICPGTVLLVFSISLW IIAAW TVR  
M TICPGTVLLVFSISLW 11AAW T Vr|? 
* * * * * * * *  * * * * * * * * * * * * * * * *
ACERYHDQQDVTSNFLGAMWLISIT 3 5 5  
ACERYHDQQDVTSNFLGAMWLISIT 3 5 6
★★★★★★★★★★★★★★★★★ 'k'k'k'k'k'k'k'k
TMD 6
FLSIGYGDMVPNTYCG
FLSIGYGDMVPNTYCG
* * * * * * * * * * * * * * * *
KG 
KG 
* * *
v  : l l t g i m g a g c t a l w a w  a
V 3 L L T G I MGAGC T A L W A w k  
*******************
RKLELTKAEKHVHNFMMDTQL 4 1 5  
RKLELTKAEKHVHNFMMDTQL 4 1 6  
**********************
hSK 2 TKRVKNAAANVLRETWLIYKNTKLVKKIDHAKVRKHQRKFLQAIHQLRSVKMEQRKLNDQ 4 7 5  
rS K 2 TKRVKNAAANVLRETWLIYKNTKLVKKIDHAKVRKHQRKFLQAIHQLRSVKMEQRKLNDQ 4 7  6 
************************************************************
hSK 2 ANTLVDLAKTQNIM YDM ISDLNERSEDFEKRIVTLETKLETLIGSIHALPGLISQTIRQQ 5 3 5  
rS K 2  ANTLVDLAKTQNIM YDM ISDLNERSEDFEKRIVTLETKLETLIGSIHALPGLISQTIRQQ 5 3 6  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
hSK2 QRDFIEAQMESYDKHVTYNAERSRSSiRRRRSSSTAPPTSSESi 57 9 
rS K 2  Q R D F I E T Q M E N Y D K H V T Y N A E R S R S S S ^ H B ^ ^ ^ H ^ H  5 8 0  ******.*** *********************************
Red highlighted region: ‘M l’ primary antibody designed to recognise this epitope 
Green boxes highlight regions encoding trans-membrane domains (TMD) and P-loop
Genbank accession codes for sequences: NP 067627.2 (human) (Jager et al., 2000), 
U69882 (rat) (Kohler et al., 1996)
Alignment made using ClustalW v.1.82 freeware12
12 www.ebi.ac.uk/clustalw
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Appendix ii
Amino acid sequence alignment for the human (h), pig (p) and rat (r) orthologues of
SK3
:.SK - DTSGHFHDSGVGDLDEDPKC 
pSK 3 r DTSGHFHDSGVGDLDEDPKC 
rS K 3 t !DTSGHFHDS GVGDLDEDPKC
**********************************
PC PS SGDEQQQQQQQQQQQQ P P P PAP PAAPQQPLG PS LQ 6 0
PCPSSGDEQQQQQPPP PPPPPAPPAAPQQPPGPPLQ 5 7
PCPSSGDEQQQQQQPP----------- PPSAPPAVPQQPPGPLLQ 5 5
★ * ★★★★ ★★★★ ★★ ★★
hSK 3 PQPPQLQQQQQQQQQQQQQQQQQQQPP-HPLSQLAQLQSQPVHPGLLHSSPTAFRAPPSS 1 1 9
pSK 3 PQPLQLQQQQQ------------------- QQQQQPP-HPLSQLAQLQSQPVHPGLLHSSPTAFRAPPSS 1 0 7
rS K 3  PQPPQLQQQQQQQQQQQQQQQQQQQAPLHPLPQLAQLQSQLVHPGLLHSSPTAFRAPNSA 1 1 5  
* * *  * * * * * * *  * * * * * a *  * * * _ * * * * * * * *  * * * * * * * * * * * * * * * *  * .
hSK 3 NSTAILHPSSRQGSQLNLNDHLLGHSPSSTATSGPGGGSRHRQASPLVHRRDSNPFTEIA 1 7  9
pSK 3 NSTAILHPSSRQGSQLNLNDHLLGHSPSSTATSGPGGGGRHRQASPLVHRRDSNPFTEIA 1 6 7
rS K 3  NSTAILHPSSRQGSQLNLNDHLLGHSPSSTATSGPGGGSRHRQASPLVHRRDSNPFTEIA 1 7 5  
************************************** ********************.*
hSK 3 M SSCKYSGGVM KPLSRLSASRRNLIEAETEGQPLQLFSPSNPPEIVISSREDNHAHQTLL 2 3 9  
pSK 3 M SSCKYSGGVM KPLSRLSASRRNLIEAEPEGQPLQLFSPSNPPEIIISSREDNHAHQTLL 2 2 7  
rS K 3  M SSCKYSGGVM KPLSRLSASRRNLIEAEPEGQPLQLFSPSNPPEIIISSREDNHAHQTLL 2 3 5  
* * * * * * * * * * * * * * * * * * * * * * * * * * * *  * * * * * * * * * * * * * * * * . * * * * * * * * * * * * * *
TMD 1
hSK 3 HHPNATHNHQHAGTTASSTTFPKANKRKNQNIGYKLGHRRALFEKRKRLSCIYALIFGMFG 2 9 9  
pSK 3 HHPNATHNHQHAGTTASSTTFPKANKRKNQNIGYKLGHRRALFEKRKRLSCYALIFGMFG 2 8 7  
rS K 3  HHPNATHNHQHAGTTAGSTTFPKANKRKNQNIGYKLGHRRALFEKRKRLSCYALIFGMFG 2 9 5  
* * * * * * * * * * * * * * * *  _ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
TMD 2
hSK 3 IW M V IE T  ELSWGLYSKDSMFSLALK
pSK 3 IW M V IE T  ELSWGLYSKDSMFSLALKC
rS K 3 IW M V IE T  ELSWGLYSKDSMFSLALKC 
* ★ ★ * * * ★ ★ * * * * * * * * * * * * * * * * * * *
TMD 3
C |L IS L ST I ILL G L IIA Y H T R E
L IS L S T IIL L G L IIA Y H T R E
L IS L S T IIL L G L IIA Y H T R E  
* * * * * * * * * * * * * * * * * * * *
VQLFVIDNGADDW 3 5 9
VQLFVIDNGADDW 3 4 7
VQLFVIDNGADDW 3 5 5  
★★★★★★★★★★★★★
TMD 4
hSK 3 RIAMTYE 
pSK 3 RIAMTYE 
rS K 3  RIAMTYE 
* * * * * * * *
R IL Y ISL E M L V C A IH PIPG E  
R IL Y IS  LEMLVCAlH P IP G E  
R IL Y ISL E M L V C A IH PIPG E
•k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k
^KFFWTARLAFSYTPSRAEADVD
YKFFWTARLAFSYTPSRAEADVD
rKFFWTARLAFSYTPSRAEADVD
★★★★★★★★★★★★★★★★★★★★★★★
IIL S IP M F L R  4 1 9  
IIL S IP M F L R  4 0 7  
IIL S IP M F L R  4 1 5
TMD 5
hSK 3 LYLIARVMLLHSKLFT
pS K 3 LYLIARVMLLHSKLFT
rS K 3  LYLIARVMLLHSKLFT  
* * * * * * * * * * * * * * * *
DASSRSIGALNKINFNTRFVMKTLM T IC P G T V L L V F S ISL W IIA  4 7  9 
DASSRSIGALNKINFNTRFVMKTLM T IC PG T V L L V F SISL W IIA  4 67  
DASSRSIG ALNK INFNTRFVM K TLM H CPG TVLLVFSISLW IIA 4 7 5
k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k - k ' k
P-\oop
'k'k'k'k’k'k'k'k'k'k'k'k'k'k'k'k'k'k'k
TMD 6
hSK 3 AWTVP VCERYHDQQDVTSNFL 
p SK 3 AWTVP VCERYHDQQDVTSNFL 
rS K 3  AWTVPVCERYHDQQDVTSNFL
'k'k'k'k-k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k
G?\MWLISITFLSIGYGDMVPHTYCG K 
G AMWLISITFLSIGYGDMVPHTYCGK  
G&MWLISITFLSIGYGDMVPHTYCGK
GVCLLTGIMGAGC 5 3 9
GVSLLTGIMGAGC 5 2 7
GVPLLTGIMGAGC 5 3 5  
★★★★★★★★★★★
h SK 3 T A L W A W
p SK 3 T A L W A W
rS K 3  T A L W A W  
* * * * * * * *
ARKLELTKAEKHVHNFMMDTQLTKRIKNAAANVLRETWLIYKHTKLLKKIDH 5 9 9  
ARKLELTKAEKHVHNFMMDTQLTKRIKNAAANVLRETWLIYKHTKLLKKIDH 5 8 7  
ARKLELTKAEKHVHNFMMDTQLTKRIKNAAANVLRETWLIYKHTKLLKKIDH 5 9 5
' k ' k ' k ' k ' k ' k ' k ' k ' k ' k - k ' k ' k ' k ' k ' k i c ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k
continued on the following page
hSK 3 AKVRKHQRKFLQAIHQLRSVKMEQRKLSDQANTLVDLSKMQNVMYDLITELNDRSEDLEK 6 5  9 
p SK 3 AKVRKHQRKFLQAIHQLRSVKMEQRKLSDQANTLVDLSKMQNVMYDLITELNDRSEDLEK 64 7 
rS K 3  AKVRKHQRKFLQAIHQLRGVKMEQRKLSDQANTLVDLSKMQNVMYDLITELNDRSEDLEK 6 5 5
hSK 3 Q IG SLESK LEH LTA SFNSLPLLIA DTLRQ Q Q Q Q LLSA IIEAR G V SV AV G TTH TPISDSPI 7 1 9  
pSK 3 QIGSLESKLEHLTASFNSLPLLIADTLRQQQQQLLSALM EARGVSVAVGTTHTPLSDSPI 7 07  
rS K 3  QIGSLESKLEHLTASFNSLPLLIADTLRQQQQQLLTAFVEARGISVAVGTSHAPPSDSPI 7 1 5
'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k-k'k'jc'jc-k'kjc'k'k'k'k'k • kc • • ★ • ~k kc kc kr kr kr • 'k • ★ kr kr kr kr kr
hSK 3 G V SST SF P T P Y T SSSSC  7 3 6  
pSK 3 G V SST SF P T P Y T SSSSC  7 2 4  
rS K 3  G IS S T S F P T P Y T S S S S C  7 3 2
★ • krkr'k'kkrkrkrkrkrkrkrkrkrkr'k
Red highlighted region: ‘Chemicon’ primary antibody designed to recognise this 
epitope
Green boxes highlight regions encoding trans-membrane domains (TMD) and P-loop
Genbank accession codes for sequences: CAB61331 (human) (Terstappen et a l , 
2001), AY038049 (pig) (Burnham et al., 2002), AF292389 (rat) (Hosseini et a l , 
2001)
Alignment made using ClustalW v.1.82 freeware13
13 www.ebi.ac.uk/clustalw
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Appendix iii
Amino acid sequence alignment for the human (h), pig (p) and rat (r) orthologues of
IK1
TMD 1
h I K l  MGGDLVLGLGALRRRKRLLEQEKSLAGtfALVLAGTGIGLMVLH ^EMLWFGGCSWkLYLFL 6 0
p I K l  MGGELVPGLGALRRRKRLLEQEKHLAG tfAVALAGIGIGLMVLH W5MLWFGGCSWALYLFL 6 0
r I K l  MGGELVTGLGALRRRKRLLEQEKRVAGtfALVLAGTGIGLMVLH&EMLWFLGCKWVLYLLL 6 0  
* * * * * *  * * * * * * * * * * * * * * * *  . * * * • * .  *  *  *  * * * * * * * * * * * * * *  *  *  *  * * * . *
TMD 2 TMD 3
h I K l  VKCTISISTFLLLCLIVAFH^KEVQLFMTDNGLRDW RVALTGRQ^AQIVLELW CGLHPA 1 2 0
p I K l  VKCMISISTFLLLCLIVAFH^REVQLFMTDHGLRDWRVALTGRQ^AQIVLELAVCGLHPA 1 2 0
r I K l  VKCLITLSTAFLLCLIWFH^KEVQLFMTDNGLRDWRVALTRRQ^AQILLELLVCGVHPV 1 2 0
* * *  * . . * *  . * * * * * *  * * * . * * * * * * * * . * * * * * * * * * *  * *  * * * . * * *  * * * . * *
h IK 1  PVRGP PCVQDLGAPLTSPQ PWPG FLGQGE
p I K l  PVRGPPCAQGSG-PLQTAQSWPGFLDQGE
r I K l  PLRSPHCT— LAGEATDSQAWPGFLGEGE 
* . *  *  *  *  * * * * *  . * *
TMD 5
h I K l  SIGALNQVRFRHWFVA ' 
p I K l  SIGALNQVRFRHWFVA 
r I K l  SIGALNQVRFRHWFVA 
* * * * * * * * * * * * * * * * *
P-loop
‘ TMWG
TMD 4
^LLSLAMLLRLYLVPRAVLllR 
^LLSLAMLLRLYLVPRALLIR  
ALLSLAMLLRLYLVPRAVLIJR
SGVLLNASYR 1 8 0
SGVLLNVSYR 1 7  9
SGVLLNASYR 17  8 
* * * * * * *  * * *
KLYMNTHPGRLLLGLTLGLWLTTAWVL 
K LYMNTHPGRLLLCLTLGLWLTTAWVL 
K LYMNTHPGRLLLGLTLGFWLTTAWVL
■k'k'k'k'k'k'k'k'k'k'k'k ★★★★ • ★★★★★★★★
TMD6
3VAERQAVNATGH 
3VAERQTVNATGH 
3VAERQAVNATGH 
* * * * * * . * * * * * *
LSDT 2 4 0
LSDT 2 3 9
LTDT 2 3 8  
* . *  *
h I K l  L W L IPIT F L T IG Y G D W P
p I K l  L W L IPIT F L T IG Y G D W P
r I K l  L W L IPIT F L T IG Y G D W P  
* * * * * * * * * * * * * * * * * *
3TMWG
3TLWG
k *  .  *  *  *
KIVCLCTGVMGVCCTALLVAVV\ 
KIVCLCTGVMGVCCTALLVAW \  
KIVCLCTGVMGVCCTALLVAVV\
* * * * * * * * * * * * * * * * * * * * *
RKLEFNKAEKHVHN 3 0 0  
RKLEFNKAEKHVHN 2 9 9  
RKLEFNKAEKHVHN 2 9 8
'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k
h I K l  FMMDIQYTKEMKESAARVLQEAWMFYKHTRRKESHAARRHQRKLLAAINAFRQVRLKHRK 3 6 0  
p I K l  FMMDIQYAKEMKESAARVLQESWMFYKHTRRKDSGAARRHQRRLLAAINTFRQVRLKHRK 3 5 9  
r I K l  FMMDIHYAKEMKESAARLLQEAWMYYKHTRRKDSRAARRHQRKMLAAIHTFRQVRLKHRK 3 5 8  
* * * * * . * . * * * * * * * * * . * * * . * * . * * * * * * * . *  * * * * * * * * . * * * * . * * * * * * * * * * *
h I K l  L R E Q V N SM V D ISK M H M IL Y D L Q Q N L SSSH R A L E K Q ID T L A G K L D A L T E L L S|^^^^^ 4 2 0  
p I K l  LREQVNSMVDISKMHMILCDLQLGLSSSHQALEKRIDALAGKLDTLTELLGAALGPRQLL 4 1 9  
r I K l  LREQVNSMVDISKMHMILCDLQLGLSASHLALEKRIDGLAGKLDALTELLSTALQQ)BH| 4 1 8  
* * * * * * * * * * * * * * * * * *  * * *  * * . * *  * * * * * * *  * * * * * * * * * * * *  . * *  . *
h I K l  lif lH H ttH  4 2 7
p I K l  EPSQEAT 4 2 6  
r I K l  I f f i i S S i i  4 2 5
* * * . .
Highlighted regions: ‘M4’ (red) and ‘R212’ (turquoise) primary antibodies designed 
to recognise these epitopes
Green boxes highlight regions encoding trans-membrane domains (TMD) and P-loop
Genbank accession codes for sequences: NP 002241.1 (human) (Joiner et al., 1997), 
AY062036 (pig) (Bychkov et a l, 2002), Q9QYW1 (rat) (Warth et al., 1999)
Alignment made using ClustalW v.1.82 freeware14
14 www.ebi.ac.uk/clustalw
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Appendix iv
As discussed in section 5.3.7, transients (see example 7), which resulted from a 
continuously fluctuating series resistance, were removed from all presented voltage- 
clamp records to aid clarity (see example 2). This was achieved by converting traces 
into graphics files and then manually erasing artefacts using Corel Photopaint 
software. This was particularly necessary to enable distinction of pulses in traces 
with a low timebase gain (see example 3).
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Example 1) Series resistance transients displayed at a high timebase gain.
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Example 2) The trace from figure 5.13 prior to (upper) and following (lower) removal of transients.
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Example 3) The trace from figure 5.37 prior to (upper) and following (lower) removal of transients.
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